Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3048816	s-ca(7.4)	mmol/l (mmol/l)	29440	116006	0.44%
3048816	s-ca(7.4)	— (—)	9760	18083	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Any event in cancer register

5610

18718

1.83

322.10

5.1

3.2

1.23

mmol/l

0.27

5132

15796

Pneumonia, organism unspecified

5972

24151

1.77

318.37

6.1

3.3

1.22

1.23

mmol/l

24.93

5402

20545

Heart failure, not strict

5038

19075

1.88

317.49

7.7

3.2

1.22

1.23

mmol/l

61.97

4635

16188

Implicit Sepsis, including avohilmo

5473

22593

1.82

317.12

6.2

3.2

1.22

1.23

mmol/l

48.37

4968

19169

Other disorders of fluid, electrolyte and acid-base balance

2624

11424

2.38

316.19

7.3

3.4

1.21

1.23

mmol/l

26.33

2402

9572

Contact with and exposure to communicable diseases

1994

8111

2.64

315.82

4.0

3.6

1.22

1.23

mmol/l

4.81

1662

7080

Type 2 diabetes, wide definition

5262

18927

1.85

311.82

5.4

3.6

1.22

1.23

mmol/l

12.00

4722

16220

Cardiac arrhythmias

3479

11070

2.12

310.76

4.3

3.2

1.22

1.23

mmol/l

18.46

3092

9387

Hyperlipidaemia, other/unspecified

3176

13687

2.28

307.65

5.3

3.4

1.22

1.23

mmol/l

3.98

2849

11480

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

5892

22606

1.85

307.65

5.7

3.2

1.22

1.23

mmol/l

32.48

5296

19223

Anaemias

1694

1534

7.91

307.65

8.5

1.7

1.22

1.23

mmol/l

10.44

1556

1272

ILD medications: prednisolone, methylprednisolone, prednisone

7218

22783

1.84

307.65

5.7

3.1

1.22

1.23

mmol/l

2.70

6520

19227

Endocrine, nutritional and metabolic diseases

4646

11589

2.12

307.65

4.6

2.8

1.22

1.23

mmol/l

2.77

4083

9787

Any gastric operation

4700

12012

2.05

307.65

4.8

2.3

1.22

1.23

mmol/l

12.30

4174

9942

Liquid cancers, including Hilmo

2735

10822

2.44

307.65

8.1

3.2

1.23

mmol/l

0.34

2593

9011

Abnormalities of breathing

5834

18088

1.93

307.65

4.3

3.7

1.22

1.23

mmol/l

11.61

5104

15516

Solid cancers, including Hilmo

5350

17361

1.88

307.65

5.1

3.1

1.23

mmol/l

0.31

4923

14652

Chronic kidney disease

2968

11641

2.77

307.65

12.9

3.1

1.21

1.23

mmol/l

20.99

2820

9809

Oral corticosteroids

7544

23665

1.97

307.65

4.8

3.6

1.23

mmol/l

1.78

6789

20099

ILD medications

7338

22980

1.80

307.65

5.8

3.1

1.22

1.23

mmol/l

2.95

6621

19390

Renal failure

4060

15830

2.40

307.65

11.0

3.1

1.21

1.23

mmol/l

35.87

3839

13371

Abnormal spermatozoa

1247

3741

4.08

307.65

4.5

4.7

1.21

1.22

mmol/l

0.20

1045

3304

Parasetamol

4204

10858

2.04

307.65

4.4

3.3

1.22

1.23

mmol/l

3.33

3708

9269

Presence of other functional implants

5667

15622

2.78

307.65

4.4

3.6

1.23

mmol/l

4.37

4688

13472

Persons encountering health services in other circumstances

4041

12471

3.65

307.65

4.4

3.5

1.22

1.23

mmol/l

8.99

3369

10425

Persons encountering health services in other circumstances, wide

8856

20396

2.39

307.65

4.7

3.5

1.23

mmol/l

1.40

7990

17113

Persons encountering health services for other counselling and medical advice, not elsewhere classified

8094

20287

2.26

307.65

4.9

3.5

1.23

mmol/l

0.12

7541

17029

Other heart diseases

2885

7501

2.66

307.65

5.5

2.8

1.22

1.23

mmol/l

21.28

2591

6269

Any reimbursement code in KELA

3218

6127

2.77

307.65

4.4

1.9

1.23

mmol/l

0.73

2837

4921

Renal tubulo-interstitial diseases

6494

24017

2.11

307.65

7.9

2.9

1.22

1.23

mmol/l

33.17

5952

20367

ILD medications: immunosuppressive drugs

4561

20701

2.13

307.65

7.4

3.1

1.23

mmol/l

0.28

4235

17524

Dyspnoea

6121

25469

1.82

307.65

4.6

3.8

1.22

1.23

mmol/l

22.19

5356

21951

Other bacterial diseases, including avohilmo

6664

24031

1.81

307.65

6.6

3.1

1.22

1.23

mmol/l

24.35

6124

20343

Persons encountering health services for specific procedures and health care

7042

23313

1.87

307.65

6.8

2.9

1.22

1.23

mmol/l

19.87

6476

19611

Disorders of other endocrine glands

3546

15452

2.47

307.65

8.4

3.3

1.24

1.23

mmol/l

25.59

3289

13188

Hypertensive diseases

4853

14223

2.02

307.65

5.4

3.1

1.23

mmol/l

2.50

4388

12043

General symptoms and signs

6913

18473

1.97

307.65

4.8

3.3

1.22

1.23

mmol/l

10.24

6170

15563

Other symptoms and signs involving the nervous and musculoskeletal systems

3212

15114

2.31

307.65

4.1

3.9

1.23

mmol/l

1.14

2918

12977

Hypothyroidism and >3 levothyroxin purchases

1534

1578

5.90

307.65

4.3

1.7

1.22

1.23

mmol/l

8.14

1324

1308

Hypothyroidism (congenital or acquired)

1549

1582

5.94

307.65

4.3

1.7

1.22

1.23

mmol/l

7.86

1337

1311

Hypothyroidism, levothyroxine purchases

1534

1578

5.90

307.65

4.3

1.7

1.22

1.23

mmol/l

8.14

1324

1308

Sleep apnoea

6274

23168

1.79

307.65

4.1

4.0

1.22

1.23

mmol/l

5.06

5378

20127

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

6591

22623

1.94

307.65

5.8

3.4

1.22

1.23

mmol/l

5.57

5738

19569

All kidney diseases

7050

24296

2.06

307.65

7.2

2.9

1.22

1.23

mmol/l

17.82

6417

20596

Solid cancers

5275

17056

1.91

307.65

5.2

3.1

1.23

mmol/l

0.44

4850

14387

Hypothyroidism, drug reimbursement

806

1133

5.40

307.65

5.9

1.8

1.21

1.23

mmol/l

15.27

719

928

Malaise and fatigue

3992

14305

2.36

307.65

4.9

3.3

1.22

1.23

mmol/l

7.17

3536

11974

All chronic kidney diseases

4466

16273

2.38

307.65

10.0

3.0

1.22

1.23

mmol/l

28.58

4171

13684

Malignant neoplasm

5464

17300

1.95

307.65

5.4

3.1

1.23

mmol/l

0.21

5029

14597

Sleep apnoea, including avohilmo

6564

23297

1.79

307.65

3.9

4.0

1.22

1.23

mmol/l

3.58

5575

20291

Depression medications

1474

1641

4.80

307.65

3.8

1.7

1.23

mmol/l

0.86

1251

1361

Hypertension

4851

14215

2.02

307.65

5.4

3.1

1.23

mmol/l

2.52

4386

12038

Used for control exclusion in common control thyroid runs

6450

18976

1.78

307.65

4.4

3.6

1.22

1.23

mmol/l

7.48

5669

16219

Metabolic disorders

6190

21448

1.81

307.65

5.9

3.2

1.22

1.23

mmol/l

11.48

5608

18214

Inflammatory bowel disease treatment related agents

7692

24045

1.86

307.65

4.8

3.6

1.23

mmol/l

1.64

6916

20406

Malignant neoplasm

5452

17281

1.94

307.65

5.4

3.1

1.23

mmol/l

0.29

5016

14580

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2105

7889

2.93

307.65

7.5

3.2

1.22

1.23

mmol/l

1.02

2039

6574

Other antidepressants

6539

19538

1.78

307.65

4.0

1.23

mmol/l

0.47

5569

17063

Cardiovascular diseases (excluding rheumatic etc)

3685

9155

2.43

307.65

4.9

2.7

1.23

mmol/l

4.10

3310

7633

Malignant neoplasm, including Hilmo

5504

17534

1.92

307.65

5.3

3.1

1.23

mmol/l

0.33

5073

14793

Hypertension, essential

4846

13992

2.06

307.65

5.1

3.1

1.23

mmol/l

3.36

4394

11842

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

7440

24760

2.16

307.65

6.7

3.1

1.22

1.23

mmol/l

29.26

6755

21080

Codes for special purposes

3960

19845

2.12

307.65

5.2

3.7

1.22

1.23

mmol/l

1.57

3609

17000

Provisional assignment of new diseases of uncertain etiology

3955

19834

2.12

307.65

5.2

3.7

1.22

1.23

mmol/l

1.50

3605

16989

Malignant neoplasm, wide definition

5513

17570

1.92

307.65

5.4

3.1

1.23

mmol/l

0.33

5080

14830

Hypertensive diseases (excluding secondary)

3194

7488

2.65

307.65

5.7

2.8

1.23

mmol/l

3.64

2906

6259

GASTRO-related operations

4700

12012

2.05

307.65

4.8

2.3

1.22

1.23

mmol/l

12.30

4174

9942

Cardiovascular diseases

3276

7946

2.29

307.65

4.8

2.7

1.23

mmol/l

3.97

2909

6614

Fever of other and unknown origin

4486

16395

2.57

307.65

6.8

3.3

1.22

1.23

mmol/l

23.99

4156

13775

Other medical care

4375

15439

2.64

307.65

6.3

3.0

1.22

1.23

mmol/l

13.65

4124

12848

First line medication for Crohn's disease

7443

21697

1.94

307.65

5.8

2.9

1.22

1.23

mmol/l

2.34

6778

18133

Other bacterial diseases

6464

23925

1.89

307.65

7.3

3.1

1.22

1.23

mmol/l

28.92

5954

20306

Other heart diseases, wide

5551

19470

1.80

305.15

5.0

3.4

1.22

1.23

mmol/l

24.40

4955

16689

Implicit Sepsis

5097

21721

1.82

296.78

6.5

3.2

1.22

1.23

mmol/l

52.98

4649

18393

Diabetes mellitus

6350

22204

1.72

295.02

4.8

3.6

1.22

1.23

mmol/l

7.24

5563

19070

Polyarthropathies

4455

15784

1.91

294.69

5.5

3.8

1.22

1.23

mmol/l

0.53

4029

13575

Diabetes, varying definitions

6321

22211

1.72

292.91

4.8

3.6

1.22

1.23

mmol/l

6.62

5537

19078

Symptoms and signs involving the nervous and musculoskeletal systems

4042

22340

1.92

291.17

4.2

4.0

1.23

mmol/l

1.22

3609

19161

Secondary hypertension

727

1699

4.98

289.07

18.9

2.9

1.22

1.23

mmol/l

6.23

708

1387

Intracranial trauma

3570

12463

2.03

288.61

4.0

3.9

1.22

1.23

mmol/l

8.48

3100

10656

Autoimmune diseases excluding thyroid diseases

6324

20819

1.71

285.30

4.7

3.7

1.22

1.23

mmol/l

3.45

5667

17879

Autoimmune diseases

6720

20962

1.69

285.21

4.3

3.7

1.22

1.23

mmol/l

6.57

5874

17995

Condition for Implicit Sepsis (Organ dysfunction codes)

5507

22697

1.76

285.08

6.1

3.2

1.22

1.23

mmol/l

45.18

4988

19276

Benzodiazepine use

6461

26992

1.68

285.04

4.4

3.8

1.23

mmol/l

0.99

5507

23382

Pneumonias (Asthma/COPD co-morbidities)

6319

25396

1.69

283.07

6.2

3.3

1.22

1.23

mmol/l

21.88

5733

21614

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1575

6160

2.90

281.95

5.9

3.2

1.23

mmol/l

0.17

1514

5123

Constipation

5858

24109

1.72

279.78

4.8

3.8

1.23

mmol/l

2.07

5046

20859

Heart failure and antihypertensive medication

1706

4253

2.84

279.48

7.6

3.4

1.21

1.23

mmol/l

29.76

1581

3590

All pneumoniae

6339

25442

1.68

279.27

6.2

3.3

1.22

1.23

mmol/l

24.20

5745

21669

Pain in throat and chest

5183

17855

1.79

279.22

4.1

3.7

1.22

1.23

mmol/l

4.89

4569

15324

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5617

19568

1.75

277.98

6.0

3.3

1.22

1.23

mmol/l

20.13

5081

16560

5617

19568

1.75

277.98

6.0

3.3

1.22

1.23

mmol/l

20.13

5081

16560

Autoimmune diseases excluding thyroid diseases, strict definition

6064

19955

1.72

277.69

4.6

3.6

1.22

1.23

mmol/l

2.90

5436

17093

Cerebrovascular diseases (FINNGEN)

1902

5471

2.61

274.95

4.9

2.9

1.22

1.23

mmol/l

14.67

1751

4533

Concussion

3120

12356

2.06

268.76

4.0

3.9

1.22

1.23

mmol/l

4.63

2709

10568

Type 2 diabetes

6075

21578

1.70

268.60

4.7

3.5

1.22

1.23

mmol/l

7.67

5318

18530

Disorders of the thyroid gland

5937

23646

1.70

268.47

4.2

3.8

1.22

1.23

mmol/l

5.97

5133

20409

Oxycodone

2964

12909

2.11

268.20

7.5

3.3

1.22

1.23

mmol/l

9.41

2796

10888

Antihypertensive medication - note that there are other indications

3213

8420

2.08

263.19

4.6

3.0

1.23

mmol/l

0.55

2811

7154

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

6158

25569

1.67

262.68

6.1

3.4

1.22

1.23

mmol/l

20.98

5580

21810

Insulin medication

3974

18504

1.88

262.53

6.4

3.8

1.22

1.23

mmol/l

19.94

3535

15898

Influenza and pneumonia

6470

25107

1.65

262.03

6.0

3.3

1.22

1.23

mmol/l

20.25

5864

21342

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5812

21088

1.70

261.71

4.9

3.6

1.22

1.23

mmol/l

9.42

5085

18127

Disorders of thyroid, IBD co-morbidities

1122

2419

3.42

259.59

4.0

3.1

1.22

1.23

mmol/l

2.25

986

2022

Asthma, unspecified (mode), excluding more controls

3297

12377

2.01

259.52

4.0

3.0

1.22

1.23

mmol/l

17.93

2947

10380

Bacterial infection, other or unspecified, including avohilmo

3990

18681

1.85

248.31

8.0

3.2

1.22

1.23

mmol/l

22.27

3723

15736

Endocrine disorders, other/unspecified

343

497

11.85

248.22

6.3

3.1

1.22

1.23

mmol/l

0.18

305

416

Hypothyroidism, other/unspecified

5520

22336

1.69

248.14

4.2

3.8

1.22

1.23

mmol/l

9.71

4735

19244

Hard cardiovascular diseases

5129

18265

1.73

245.50

4.8

3.7

1.22

1.23

mmol/l

17.67

4637

15576

Osteoporosis

2212

9772

2.30

242.23

6.3

3.6

1.24

1.23

mmol/l

3.71

2068

8215

Diabetes, insulin treatment (Kela reimbursement)

6218

23505

1.64

240.50

4.9

3.7

1.22

1.23

mmol/l

8.43

5437

20259

Ischemic heart diseases

5137

18578

1.72

239.32

5.1

3.6

1.22

1.23

mmol/l

17.45

4589

15914

Hypothyreosis and Thyroxine purchase for inclusion criteria

5730

23545

1.66

238.43

4.3

3.8

1.22

1.23

mmol/l

9.57

4915

20312

Explicit Sepsis, including avohilmo

3199

15799

1.95

238.13

9.2

3.2

1.21

1.23

mmol/l

33.10

2954

13320

Explicit Sepsis

3149

15557

1.96

238.01

9.3

3.2

1.21

1.23

mmol/l

31.95

2909

13109

Aplastic and other anaemias

3369

17114

1.92

237.75

8.7

3.5

1.21

1.23

mmol/l

25.42

3098

14532

Complications of surgical and medical care, not elsewhere classified

6228

26630

1.62

237.30

5.5

3.6

1.22

1.23

mmol/l

6.45

5609

22799

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2358

7039

2.22

236.68

5.3

2.7

1.22

1.23

mmol/l

7.67

2122

5879

Asthma, unspecified (mode)

3419

13516

1.92

236.37

4.0

3.1

1.22

1.23

mmol/l

14.84

3058

11374

Osteopathies and chondropathies

3824

20133

1.83

236.04

6.4

3.6

1.23

mmol/l

1.80

3532

17153

Septicaemia

3033

14895

1.98

234.72

9.5

3.2

1.21

1.23

mmol/l

28.38

2805

12513

Covid-19 confirmed case

2700

14127

2.05

232.05

6.0

3.8

1.22

1.23

mmol/l

6.21

2408

12087

Episodal and paroxysmal disorders

6445

20957

1.61

230.06

3.8

4.0

1.22

1.23

mmol/l

4.40

5628

17972

Care involving dialysis

737

2109

4.18

229.67

33.7

2.9

1.20

1.23

mmol/l

22.79

729

1798

Persons with potential health hazards related to communicable diseases

2219

10724

2.17

228.95

4.3

3.8

1.22

1.23

mmol/l

6.99

1871

9365

Percutaneous Coronary Intervention

4890

18070

1.72

228.88

4.9

3.7

1.22

1.23

mmol/l

17.98

4355

15474

Insulin, fast-acting

2471

12598

2.10

228.70

7.2

3.7

1.21

1.23

mmol/l

17.05

2197

10834

Diabetes medication

6276

23583

1.61

228.30

4.7

3.6

1.22

1.23

mmol/l

4.96

5471

20295

Other soft tissue disorders, not elsewhere classified

5745

20579

1.65

227.68

4.4

3.8

1.22

1.23

mmol/l

1.58

5041

17675

Opioids

5721

18479

1.65

227.06

4.7

3.2

1.22

1.23

mmol/l

5.10

5080

15661

Atrial fibrillation and flutter

1801

5036

2.46

226.28

5.3

2.9

1.22

1.23

mmol/l

25.22

1628

4170

Bacterial infection, other or unspecified

3667

17761

1.84

226.15

8.3

3.2

1.22

1.23

mmol/l

21.74

3428

14949

Other diseases of blood and blood-forming organs, wide

1706

7646

2.47

225.33

7.7

3.8

1.22

1.23

mmol/l

3.77

1568

6595

Other septicaemia, including avohilmo

2788

13962

2.00

223.62

9.7

3.2

1.21

1.23

mmol/l

31.13

2582

11705

Disorders of parathyroid gland

1700

7549

2.48

223.57

12.5

3.3

1.27

1.23

mmol/l

45.28

1604

6365

Disorders of gallbladder, biliary tract and pancreas

6134

24658

1.61

223.08

4.7

3.8

1.22

1.23

mmol/l

8.42

5450

21190

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1231

4787

2.90

222.42

6.6

3.2

1.23

mmol/l

4.52

1197

4004

Spondylosis

3747

16932

1.83

222.38

3.8

4.0

1.23

mmol/l

1.00

3220

14596

Hypothyroidism, strict autoimmune

4438

17418

1.74

222.13

3.9

3.6

1.23

mmol/l

2.29

3749

14831

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

801

1591

3.94

222.01

5.3

3.4

1.22

1.23

mmol/l

3.04

740

1311

Other septicaemia

2737

13728

2.01

221.86

9.8

3.2

1.21

1.23

mmol/l

29.32

2536

11514

Transplanted organ and tissue status

822

2581

3.70

219.82

21.1

3.9

1.22

1.23

mmol/l

3.80

809

2282

Coronary revascularization (ANGIO or CABG)

4852

18073

1.70

219.02

4.9

3.7

1.22

1.23

mmol/l

16.42

4322

15476

Symptoms and signs involving the circulatory and respiratory systems

5734

18112

1.64

218.64

4.1

3.7

1.22

1.23

mmol/l

7.05

5051

15538

Obesity due to excess calories

3008

16569

1.92

218.31

5.1

3.8

1.22

1.23

mmol/l

14.08

2654

14323

Insulin, intermediate and long-acting

3597

20152

1.82

217.65

6.3

3.8

1.22

1.23

mmol/l

18.40

3189

17349

Syncope and collapse

2918

13171

1.95

217.06

4.4

3.3

1.22

1.23

mmol/l

9.57

2588

10994

Pain in limb

5124

20300

1.67

216.88

4.6

3.8

1.23

mmol/l

0.89

4484

17433

Insulin, combination of fast acting with intermediate-acting or long-acting

3977

21513

1.76

215.23

6.4

3.7

1.22

1.23

mmol/l

17.76

3537

18496

Codeine

5401

18296

1.65

214.95

4.3

3.2

1.22

1.23

mmol/l

4.93

4741

15518

Type 2 diabetes, definitions combined

5666

21039

1.62

213.52

4.2

3.6

1.23

mmol/l

4.56

4954

18068

STROKE

3373

12753

1.87

213.08

4.5

3.5

1.22

1.23

mmol/l

13.32

3104

10743

Other and unspecified anaemias

3083

16197

1.91

212.77

8.2

3.5

1.22

1.23

mmol/l

21.24

2827

13745

Headache

3794

17133

1.78

211.96

3.8

3.2

1.23

mmol/l

2.75

3343

14430

Other anaemias

3101

16294

1.90

211.67

8.2

3.5

1.22

1.23

mmol/l

21.59

2845

13829

Insulin, fast-acting or short human

2478

13027

2.03

209.42

7.2

3.8

1.21

1.23

mmol/l

15.78

2204

11231

Emergency coronary revascularization (for ACS)

5277

20160

1.65

209.32

4.8

3.8

1.22

1.23

mmol/l

13.34

4700

17278

Heart failure,strict

3546

14275

1.84

209.04

6.7

3.3

1.21

1.23

mmol/l

66.17

3260

12019

Type 2 diabetes, strict (exclude DM1)

5677

21209

1.61

208.44

4.2

3.6

1.23

mmol/l

4.64

4964

18225

Sleep disorders (combined)

6581

22699

1.56

207.94

3.8

4.0

1.23

mmol/l

1.45

5639

19666

L04AD Calcineurin inhibitors

875

2952

3.41

207.10

18.6

4.0

1.22

1.23

mmol/l

2.34

858

2598

Liquid cancers

2022

9399

2.20

206.45

9.1

3.2

1.22

1.23

mmol/l

1.54

1897

7819

Acute tubulo-interstitial nephritis

3981

20224

1.74

205.10

5.9

3.0

1.22

1.23

mmol/l

10.88

3574

17038

Type 2 diabetes, definitions combined, including avohilmo

5637

20967

1.61

204.84

4.2

3.6

1.23

mmol/l

3.70

4919

18022

Adjustment and management of implanted device

1433

6242

2.55

202.22

5.1

3.0

1.22

1.23

mmol/l

10.74

1243

5131

L04AA Selective immunosuppressants

1587

7243

2.40

199.11

11.5

3.6

1.22

1.23

mmol/l

2.08

1508

6285

Valvular heart disease excluding rheumatic fever

3022

12096

1.89

195.81

5.7

3.5

1.22

1.23

mmol/l

26.66

2649

10259

Exposure to unspecified factor

6126

27785

1.55

194.99

4.8

3.8

1.22

1.23

mmol/l

16.20

5237

24059

Neurological diseases, wide definition

1457

2952

2.59

194.86

3.7

3.1

1.23

mmol/l

0.66

1266

2469

Non-rheumatic valve diseases

3012

12060

1.88

194.49

5.7

3.5

1.22

1.23

mmol/l

26.58

2641

10229

Other arrhythmias

3797

16988

1.74

193.72

3.9

3.4

1.23

mmol/l

13.08

3300

14518

Second line medication for Crohn's disease

3559

21254

1.76

193.68

5.5

3.8

1.23

mmol/l

0.52

3276

18243

Hypo-osmolality and hyponatraemia

1461

6493

2.48

193.43

6.0

3.3

1.21

1.23

mmol/l

19.19

1326

5427

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1856

4219

2.30

193.23

4.0

2.8

1.23

mmol/l

4.21

1613

3461

Other reaction to severe stress, and adjustment disorders

2186

11278

2.05

192.64

4.9

3.7

1.23

mmol/l

1.60

1964

9801

Tramadol

4618

17331

1.66

191.85

5.4

3.2

1.22

1.23

mmol/l

4.77

4082

14720

Exclusions for E4_PCOS_BROAD

1243

5210

2.63

189.53

5.7

4.0

1.22

1.23

mmol/l

2.49

1156

4519

Atrial fibrillation and flutter with reimbursement

1501

4091

2.47

189.07

4.4

3.0

1.22

1.23

mmol/l

15.09

1346

3347

Asthma, excluding more controls

4136

12811

1.72

188.66

3.9

3.0

1.22

1.23

mmol/l

13.65

3688

10745

Nephropathy related operations

975

3687

3.02

187.50

27.9

3.5

1.20

1.22

mmol/l

23.17

963

3226

Malignant neoplasm of breast

2650

9269

1.96

187.33

4.2

2.9

1.24

mmol/l

6.93

2441

7704

Major coronary heart disease event

5063

19479

1.62

187.02

5.0

3.8

1.22

1.23

mmol/l

14.51

4516

16684

Malignant neoplasm of breast, HER2-negative

2646

9263

1.96

186.69

4.2

2.9

1.24

mmol/l

6.83

2437

7698

L04AX Other immunosuppressants

3455

20691

1.75

186.53

5.6

3.8

1.23

mmol/l

0.74

3185

17772

Malignant neoplasm of breast, ER-positive, including Hilmo

2198

8448

2.08

186.27

4.5

2.9

1.24

mmol/l

6.33

2049

6991

Dialysis, with operation codes

976

3709

2.98

185.02

27.9

3.2

1.20

1.23

mmol/l

28.13

964

3189

Finngen Rheumatological endpoints

5466

20247

1.58

184.88

4.2

3.7

1.23

mmol/l

0.13

4859

17323

Malignant neoplasm of breast, HER-positive

2189

8437

2.07

184.71

4.5

2.9

1.24

mmol/l

6.34

2040

6980

Depression or dysthymia

3798

12373

1.74

184.01

4.2

4.1

1.22

1.23

mmol/l

1.20

3230

10862

Drug-induced neutropenia

690

2201

3.80

183.54

10.5

3.9

1.23

mmol/l

0.38

666

1914

Neurological diseases

4726

14893

1.64

183.41

3.9

4.0

1.23

mmol/l

2.59

4122

12787

Glomerular diseases

1319

5792

2.52

182.47

16.7

3.6

1.21

1.22

mmol/l

13.01

1249

5027

Bleeding

5096

23300

1.59

182.35

5.5

3.7

1.22

1.23

mmol/l

20.05

4524

20003

Other endocrine disorders

465

1074

4.99

181.03

6.6

3.7

1.22

1.23

mmol/l

0.53

422

917

Autoimmune diseases related-to ILD

5054

27677

1.58

180.26

4.2

3.9

1.23

mmol/l

1.67

4486

23760

Heart failure, strict

3863

16497

1.71

180.04

6.5

3.8

1.21

1.23

mmol/l

62.43

3530

13979

Malignant neoplasm of breast, including Hilmo

2652

9348

1.92

178.74

4.2

2.9

1.24

mmol/l

6.86

2443

7768

Malignant neoplasm of breast, HER2-negative, including Hilmo

2652

9350

1.92

178.69

4.2

2.9

1.24

mmol/l

6.87

2443

7769

Diseases of arteries, arterioles and capillaries (FINNGEN)

1371

4078

2.47

177.64

7.7

3.0

1.22

1.23

mmol/l

18.22

1243

3337

Kidney transplant status

499

1312

4.67

176.94

26.4

3.7

1.22

1.23

mmol/l

1.63

499

1145

All-cause Heart Failure

3808

16290

1.71

176.92

6.5

3.8

1.21

1.23

mmol/l

62.65

3476

13794

Asthma (only as main-diagnosis), excluding more controls

3834

12811

1.71

176.83

3.8

3.0

1.23

mmol/l

9.13

3405

10745

Any mental disorder

6275

21234

1.52

175.84

4.2

3.9

1.23

mmol/l

0.73

5417

18389

Infections, IBD-co-morbidities

885

2158

3.08

175.79

10.5

3.2

1.22

1.23

mmol/l

3.49

820

1801

Chronic apical periodontitis

6546

25152

1.50

175.58

4.6

3.7

1.22

1.23

mmol/l

3.76

5685

21707

Paroxysmal tachycardia

1294

4632

2.47

175.12

4.4

2.9

1.22

1.23

mmol/l

11.18

1157

3811

Nausea and vomiting

1883

9347

2.10

174.06

6.5

3.6

1.22

1.23

mmol/l

13.53

1691

7893

Asthma

4337

13985

1.65

172.52

3.9

3.1

1.22

1.23

mmol/l

9.78

3869

11769

Pacemaker

2569

13494

1.89

172.44

4.9

4.1

1.22

1.23

mmol/l

12.74

2269

11510

Psychiatric diseases

5526

18316

1.56

170.87

4.1

4.0

1.23

mmol/l

0.28

4729

15930

Codeine or tramadol medication

6558

24550

1.49

169.44

4.3

3.8

1.22

1.23

mmol/l

3.12

5745

21082

Disorders of mineral metabolism

761

2675

3.30

168.64

13.2

3.3

1.24

1.23

mmol/l

1.43

709

2259

Acute renal failure

1632

8042

2.21

168.56

10.2

3.1

1.20

1.23

mmol/l

32.03

1551

6800

Hypothyroidism, strict autoimmune, 3 medication purchases required

4972

22001

1.57

168.11

3.9

3.7

1.23

mmol/l

1.54

4172

18973

Covid-19 suspected case

1403

6497

2.33

167.96

3.9

3.6

1.23

mmol/l

2.04

1344

5603

Mood disorders, excluding more controls

5349

20893

1.55

167.96

4.3

3.9

1.23

mmol/l

1.21

4575

18095

COPD/asthma related infections

5795

19568

1.53

164.21

4.7

3.3

1.22

1.23

mmol/l

10.68

5131

16560

COPD/asthma/ILD related infections

5795

19568

1.53

164.21

4.7

3.3

1.22

1.23

mmol/l

10.68

5131

16560

Extracorporeal dialysis

572

1744

3.98

163.37

37.9

3.6

1.19

1.22

mmol/l

22.48

565

1528

Other (not insulin) diabetes medications

5690

22638

1.52

162.75

4.2

3.7

1.23

mmol/l

3.58

4950

19488

Other nutritional deficiencies

3929

22856

1.63

162.38

4.9

3.8

1.22

1.23

mmol/l

19.46

3466

19703

Neoplasms

3920

12732

1.66

161.77

4.9

2.9

1.22

mmol/l

0.44

3533

10656

Hyperparathyroidism

1414

6646

2.32

161.52

12.6

3.3

1.28

1.23

mmol/l

74.76

1330

5613

Selective serotonin reuptake inhibitors

5593

19571

1.53

160.66

3.8

4.0

1.23

mmol/l

0.08

4694

17090

Other general symptoms and signs

459

1196

4.44

159.37

3.7

3.0

1.23

mmol/l

0.32

392

1010

Spondylopathies

4762

18493

1.58

159.30

4.1

3.9

1.23

mmol/l

0.88

4130

15953

Intracranial injury

3617

21189

1.66

158.77

4.1

3.9

1.22

1.23

mmol/l

6.91

3136

18219

Symptoms and signs involving the digestive system and abdomen

5606

18956

1.52

157.75

4.6

3.7

1.22

1.23

mmol/l

5.54

4950

16215

Asthma (mode)

4211

14073

1.62

156.46

3.7

3.1

1.23

mmol/l

7.94

3750

11846

Reimbursement for rheumatic diseases

3463

21605

1.66

155.30

3.8

3.9

1.23

mmol/l

1.55

3134

18497

Low back pain

4565

20267

1.57

154.91

4.2

3.9

1.23

mmol/l

0.49

4006

17448

Asthma (only as main-diagnosis)

3964

13985

1.64

154.51

3.8

3.1

1.23

mmol/l

6.00

3518

11769

Bacterial Sepsis

3072

15445

1.73

152.78

8.2

3.3

1.21

1.23

mmol/l

37.54

2846

12998

Erysipelas, including avohilmo

4339

21077

1.58

152.53

5.2

3.2

1.22

1.23

mmol/l

21.08

3928

17833

Anxiety disorders, excluding more controls

4601

19400

1.56

151.79

4.2

3.9

1.23

mmol/l

1.24

4007

16810

Other disorders of adrenal gland

449

1225

4.49

151.37

7.3

3.3

1.22

1.23

mmol/l

1.24

431

1043

Agranulocytosis

890

3586

2.82

150.76

10.2

3.8

1.22

1.23

mmol/l

1.46

848

3092

Schizophrenia or delusion, excluding more controls

1709

8723

2.04

149.81

3.9

3.8

1.23

mmol/l

0.65

1473

7597

Abdominal and pelvic pain

5545

18956

1.51

149.36

4.3

3.7

1.22

1.23

mmol/l

3.88

4878

16215

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4143

23694

1.58

148.94

4.9

3.9

1.23

mmol/l

2.23

3751

20294

Implicit bacterial Sepsis, including avohilmo

2986

15165

1.72

146.57

7.9

3.3

1.21

1.23

mmol/l

38.37

2757

12768

Enlarged lymph nodes

1056

4614

2.48

145.74

6.0

3.3

1.23

mmol/l

0.06

1000

3896

Diseases of pulp and periapical tissues, including avohilmo

5915

21235

1.48

145.60

4.2

3.7

1.22

1.23

mmol/l

2.87

5117

18303

Convulsions, not elsewhere classified

1366

6517

2.19

144.64

4.8

3.3

1.21

1.23

mmol/l

17.67

1242

5499

Invasive ventilation

622

2135

3.39

144.07

9.4

3.8

1.20

1.22

mmol/l

19.07

565

1832

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3449

17160

1.65

143.51

5.1

4.0

1.22

1.23

mmol/l

7.03

3013

14720

Oedema, not elsewhere classified

2041

11096

1.90

142.85

5.2

3.3

1.22

1.23

mmol/l

6.09

1806

9283

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1989

11026

1.91

142.38

4.8

3.8

1.23

mmol/l

0.35

1795

9520

Care involving use of rehabilitation procedures

3608

20868

1.61

142.18

4.3

2.9

1.22

1.23

mmol/l

8.46

3202

17558

Adrenocortical insufficiency

388

1005

4.88

141.90

7.3

3.3

1.22

1.23

mmol/l

1.82

372

856

Cholelithiasis, broad definition with cholecystitis

5121

23384

1.51

141.73

4.3

3.8

1.22

1.23

mmol/l

3.26

4495

20037

6571

23673

1.44

141.69

4.7

3.6

1.22

1.23

mmol/l

9.11

5769

20205

Complications of procedures, not elsewhere classified

4741

25972

1.52

141.53

5.4

3.6

1.22

1.23

mmol/l

7.56

4249

22248

COPD differential diagnosis

4291

14078

1.57

139.09

4.5

3.1

1.23

mmol/l

7.84

3808

11851

Excluding asthma or asthma-COPD overlap

4305

14135

1.57

139.00

4.5

3.1

1.23

mmol/l

7.81

3819

11902

Other pulmonary diagnosis

4304

14135

1.57

138.83

4.5

3.1

1.22

1.23

mmol/l

9.36

3818

11902

ILD differential diagnosis

4287

14073

1.57

138.55

4.5

3.1

1.23

mmol/l

7.84

3805

11846

Other disorders of urethra and urinary system

4197

19374

1.56

138.05

4.9

3.7

1.23

mmol/l

1.21

3648

16637

Bronchitis

6282

26860

1.44

137.71

4.9

3.6

1.22

1.23

mmol/l

14.11

5572

22995

Use of hypnotics and sedatives

6045

24439

1.45

137.41

4.6

3.8

1.22

1.23

mmol/l

2.26

5244

21154

Abnormalities of heart beat

2218

12392

1.82

137.38

4.0

3.6

1.23

mmol/l

4.40

1903

10538

Biguanides

5493

23105

1.48

137.33

3.9

3.8

1.23

mmol/l

2.43

4772

19921

Obesity

3610

22082

1.60

137.28

4.9

3.8

1.22

1.23

mmol/l

16.33

3184

19056

Cholelithiasis

4933

23109

1.50

136.94

4.2

3.7

1.23

mmol/l

2.94

4323

19784

Nutritional anaemias

3179

19202

1.65

136.84

5.7

3.8

1.22

1.23

mmol/l

17.31

2827

16410

Kela-code for severe mental illness

2081

11823

1.85

136.18

3.8

3.9

1.23

mmol/l

3.23

1784

10275

Obesity and other hyperalimentation

3620

22166

1.59

136.07

4.9

3.8

1.22

1.23

mmol/l

16.80

3194

19135

Unspecified mental disorder

2274

13242

1.80

136.00

3.8

1.23

mmol/l

3.43

1959

11519

Diarrhoea and gastroenteritis of presumed infectious origin

4089

24355

1.55

135.91

5.9

3.6

1.22

1.23

mmol/l

11.20

3649

20896

Obesity related asthma

2165

12482

1.83

135.74

4.1

3.9

1.22

1.23

mmol/l

9.97

1937

10735

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2124

12188

1.85

135.64

5.2

3.8

1.22

1.23

mmol/l

25.83

1933

10495

Iron deficiency anaemia

2781

16798

1.71

135.60

5.9

3.7

1.22

1.23

mmol/l

15.14

2489

14358

Mood disorders

5776

26086

1.45

135.01

4.2

3.9

1.23

mmol/l

1.21

4937

22607

Other ill-defined and unspecified causes of mortality

773

3083

2.87

134.42

5.0

4.1

1.22

mmol/l

2.35

687

2658

Mood [affective] disorders

5761

26074

1.45

134.41

4.2

3.9

1.23

mmol/l

1.24

4921

22602

Venous thromboembolism

3358

20850

1.62

134.17

5.8

3.7

1.22

1.23

mmol/l

1.82

3032

17817

Heart failure and coronary heart disease

2726

11582

1.74

134.06

6.7

3.9

1.21

1.23

mmol/l

47.58

2488

9794

Type of accident

1858

10286

1.92

133.78

4.8

3.8

1.23

mmol/l

0.24

1671

8875

Disorders of calcium metabolism

588

2050

3.36

133.06

15.1

3.3

1.25

1.23

mmol/l

1.88

554

1742

Other retinal disorders

3992

20171

1.56

133.05

5.3

3.9

1.22

1.23

mmol/l

11.15

3361

17413

Other functional intestinal disorders

2937

16674

1.67

132.47

4.9

3.7

1.23

mmol/l

2.24

2588

14188

Glomerular disorders in diseases classified elsewhere

855

3587

2.66

131.93

18.8

3.7

1.20

1.22

mmol/l

13.28

805

3110

Recurrent or chronic depression

2093

8153

1.85

131.77

3.6

4.0

1.23

mmol/l

1.80

1759

7184

Primary hyperparathyroidism

897

3876

2.63

131.33

8.1

3.7

1.31

1.23

mmol/l

105.28

833

3313

Implicit bacterial Sepsis

2701

14209

1.71

130.87

8.4

3.3

1.21

1.23

mmol/l

37.30

2503

11949

Other disorders of bladder

901

3886

2.58

130.66

4.2

1.22

mmol/l

0.54

707

3361

Ill-defined and unknown causes of mortality

811

3358

2.73

129.80

5.0

4.0

1.22

mmol/l

2.43

720

2894

Other arthritis (FG)

1908

10736

1.88

129.64

4.9

3.7

1.23

mmol/l

0.01

1715

9123

Presbycusis

1157

5477

2.30

129.48

4.1

3.9

1.22

1.23

mmol/l

0.47

921

4686

833

3455

2.60

128.47

6.0

3.2

1.22

1.23

mmol/l

4.87

746

2901

Depression

5304

24936

1.46

128.10

4.2

3.9

1.22

1.23

mmol/l

3.24

4539

21624

Other diseases of pleura

2853

15520

1.68

128.07

6.0

4.0

1.21

1.23

mmol/l

19.19

2601

13240

Personality disorders, excluding more controls

1321

6578

2.11

127.69

3.6

3.7

1.22

1.23

mmol/l

1.70

1109

5781

Implicit viral Sepsis, including avohilmo

2004

11485

1.84

127.62

7.8

3.2

1.22

1.23

mmol/l

22.94

1865

9645

Disorders of choroid and retina

4800

23302

1.49

127.22

5.2

3.8

1.22

1.23

mmol/l

7.82

4048

20201

Other CVD (FINNGEN)

761

2261

2.80

127.01

6.2

3.1

1.22

1.23

mmol/l

7.25

687

1814

Angina pectoris

3338

14262

1.62

126.10

4.8

3.7

1.22

1.23

mmol/l

8.95

2952

12101

Injuries to the head

6292

27019

1.42

125.76

4.2

3.9

1.22

1.23

mmol/l

11.31

5489

23267

Secondary uncertain malignant neoplasm

940

4195

2.46

124.91

7.4

3.2

1.23

mmol/l

1.24

906

3496

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1423

7247

2.03

124.88

4.1

3.7

1.22

1.23

mmol/l

4.97

1215

6357

Other diseases of urinary system

5536

22009

1.45

124.45

4.6

3.8

1.22

1.23

mmol/l

4.84

4807

19004

Other specified/unspecified arthritis

1703

9383

1.92

124.33

4.8

3.8

1.23

mmol/l

0.02

1538

8026

Implicit viral Sepsis

1442

7566

2.05

123.83

9.3

3.2

1.21

1.23

mmol/l

20.40

1362

6359

Ischaemic heart disease, wide definition

4461

18813

1.51

123.50

5.1

3.8

1.22

1.23

mmol/l

18.00

3936

16155

Viral Sepsis

1442

7575

2.04

123.38

9.3

3.2

1.21

1.23

mmol/l

20.36

1362

6367

Problems related to lifestyle

632

2339

2.94

123.28

4.9

3.5

1.21

1.22

mmol/l

3.56

579

2003

Symptoms and signs involving cognition, perception, emotional state and behaviour

5501

26208

1.44

123.07

4.0

1.23

mmol/l

1.55

4780

22624

Anxiety disorders

4925

23660

1.47

122.24

4.2

3.9

1.23

mmol/l

1.99

4284

20434

Heart failure and bmi 25plus

2221

8712

1.80

121.84

6.3

4.0

1.21

1.23

mmol/l

36.13

2010

7455

Other abnormal findings of blood chemistry

445

1392

3.82

121.62

3.9

3.7

1.22

1.23

mmol/l

0.15

418

1192

Type 1 diabetes, wide definition, subgroup 1

1180

5782

2.17

120.83

7.9

3.6

1.21

1.23

mmol/l

11.42

1037

4989

Pain, not elsewhere classified

1619

8842

1.92

120.44

4.7

3.2

1.23

mmol/l

2.39

1447

7412

Genitourinary diseases

2868

8861

1.67

119.73

5.3

2.8

1.22

1.23

mmol/l

4.02

2539

7581

Hernia of abdominal wall, postoperative

1122

5395

2.20

118.97

6.7

2.4

1.22

1.23

mmol/l

8.33

996

4437

Other diseases of intestines

5791

23210

1.42

118.34

4.5

3.7

1.22

1.23

mmol/l

5.11

5095

19888

Neurotic, stress-related and somatoform disorders

4850

23483

1.46

118.03

4.2

3.9

1.23

mmol/l

2.33

4215

20282

Morphin

280

656

5.60

117.78

6.4

3.0

1.21

1.22

mmol/l

5.59

269

534

Type 1 diabetes

1402

7362

2.01

117.45

7.6

3.6

1.21

1.23

mmol/l

12.42

1227

6353

General examination and investigation of persons without complaint and reported diagnosis

3916

13605

1.54

116.78

3.9

3.8

1.23

1.22

mmol/l

3.86

3664

11391

Malignant neoplasm of endocrine gland, including Hilmo

600

2258

2.99

115.74

7.5

3.0

1.21

1.23

mmol/l

13.44

558

1882

Systemic connective tissue disorders

2227

13530

1.74

115.63

4.3

3.8

1.23

mmol/l

1.58

2012

11563

Other acute lower respiratory infections

3121

19453

1.58

115.20

5.4

3.8

1.22

1.23

mmol/l

10.66

2783

16697

Dorsalgia

5443

20595

1.44

115.10

3.9

1.23

mmol/l

0.33

4727

17723

Certain infectious and parasitic diseases

5262

18669

1.45

115.02

5.2

2.8

1.22

1.23

mmol/l

15.77

4722

15685

Medicines for HER+ breast cancer

2273

12924

1.73

114.86

4.4

3.5

1.24

mmol/l

7.01

2116

10894

Substance abuse, excluding more controls

2942

15843

1.60

113.41

4.2

3.9

1.21

1.22

mmol/l

15.94

2579

13802

Primary_lymphoid and hematopoietic malignant neoplasms

1584

8825

1.92

113.16

10.7

3.7

1.23

mmol/l

0.02

1522

7537

Complications of medical and surgical care

4258

26752

1.48

112.11

5.7

3.7

1.22

1.23

mmol/l

6.19

3854

22944

Other metabolic disorders

911

4192

2.36

112.03

6.8

3.0

1.21

1.23

mmol/l

25.14

829

3542

Other systemic involvement of connective tissue (FG)

1647

9104

1.88

111.93

3.8

3.6

1.23

mmol/l

0.40

1467

7686

Malignant neoplasm of endocrine gland

537

1945

3.13

111.71

7.7

3.0

1.21

1.23

mmol/l

11.39

502

1609

Other disorders of kidney and ureter

930

4345

2.36

111.46

15.1

4.0

1.22

1.23

mmol/l

2.43

865

3770

Vocal cord dysfunction

725

2616

2.59

110.56

4.9

3.1

1.22

1.23

mmol/l

7.68

644

2218

Disorders of lens

3731

15635

1.53

110.50

5.7

3.8

1.22

1.23

mmol/l

5.31

3239

13628

Chronic lower respiratory diseases

6605

25820

1.38

110.16

4.0

3.9

1.22

1.23

mmol/l

4.21

5844

22143

Other and unspecified iron deficiency

2168

13227

1.72

109.46

5.6

3.7

1.22

1.23

mmol/l

11.93

1942

11277

L02BG Aromatase inhibitors

1927

11326

1.79

109.00

4.5

3.5

1.24

mmol/l

7.20

1796

9515

Acute bronchitis

2464

15221

1.66

108.78

5.6

3.8

1.22

1.23

mmol/l

10.07

2170

13037

Symptoms and signs involving the urinary system

4393

23327

1.46

108.45

5.3

3.8

1.22

1.23

mmol/l

5.84

3845

20081

Pulmonary heart disease, diseases of pulmonary circulation

2034

12276

1.75

108.41

6.2

3.9

1.22

1.23

mmol/l

3.80

1891

10451

DVT of lower extremities and pulmonary embolism

2582

16435

1.64

108.20

5.9

3.8

1.22

1.23

mmol/l

1.42

2355

14027

Erysipelas

3249

18717

1.55

107.48

5.7

3.2

1.22

1.23

mmol/l

18.54

2930

15847

Malignant neoplasm of digestive organs, including Hilmo

2440

11190

1.67

107.22

4.9

3.2

1.22

1.23

mmol/l

3.95

2228

9329

Cardiodefibrillation

2208

13646

1.71

106.53

4.5

4.2

1.21

1.23

mmol/l

17.27

1930

11707

Volume depletion

726

3112

2.58

106.36

8.3

3.3

1.21

1.23

mmol/l

5.93

668

2635

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1767

10307

1.80

106.10

4.0

1.22

1.23

mmol/l

4.47

1533

8947

Glucagon-like peptide-1 (GLP-1) analogues

1767

10307

1.80

106.10

4.0

1.22

1.23

mmol/l

4.47

1533

8947

Drug-induced adrenocortical insufficiency

228

499

6.25

105.25

6.7

4.0

1.22

1.23

mmol/l

0.83

216

433

Non-selective monoamine reuptake inhibitors

2163

12783

1.70

104.58

3.8

3.9

1.23

mmol/l

0.87

1874

11117

Intestinal infectious diseases

5240

28395

1.41

104.52

5.9

3.6

1.22

1.23

mmol/l

14.95

4663

24361

Lower back pain or/and sciatica

5986

27579

1.38

104.22

4.0

3.9

1.23

mmol/l

0.23

5236

23750

Diagnoses used for exclusion with ILD

1602

9158

1.86

104.16

5.2

4.0

1.22

1.23

mmol/l

0.64

1466

7898

Certain disorders involving the immune mechanism

1180

6142

2.06

103.93

7.3

4.0

1.23

mmol/l

0.14

1096

5336

Postprocedural endocrine and metabolic disorders, not elsewhere classified

844

3885

2.36

103.83

6.9

3.0

1.21

1.23

mmol/l

26.55

769

3281

Other cataract

2578

12220

1.63

103.51

5.3

3.8

1.22

1.23

mmol/l

3.51

2171

10609

Hydronephrosis

804

3643

2.42

103.25

7.9

3.0

1.22

1.23

mmol/l

5.04

736

3085

Diseases of the digestive system

2753

17892

1.59

102.97

6.0

3.8

1.22

1.23

mmol/l

8.56

2474

15310

Type 1 diabetes, wide definition

1202

6279

2.02

102.49

7.9

3.6

1.21

1.23

mmol/l

11.28

1056

5416

Anaemia in chronic diseases classified elsewhere

263

654

5.17

102.18

20.1

3.3

1.20

1.22

mmol/l

5.83

257

564

Fall on same level

6145

24371

1.37

101.14

4.5

3.7

1.22

1.23

mmol/l

6.43

5282

21055

Disorders of lipoprotein metabolism and other lipidaemias

4530

19614

1.44

100.62

4.9

3.3

1.22

1.23

mmol/l

5.20

4078

16640

Asthma (diagnoses ohter than nonallergic)

4842

28438

1.41

99.41

3.9

1.22

1.23

mmol/l

2.98

4328

24395

Senile cataract

3477

14386

1.52

99.36

5.4

3.9

1.22

1.23

mmol/l

5.22

3011

12519

Schizophrenia, schizotypal and delusional disorders

1721

10138

1.78

99.11

3.9

1.23

mmol/l

1.19

1485

8834

Schizophrenia or delusion

1709

10052

1.78

98.95

3.9

1.23

mmol/l

1.31

1473

8775

Malignant neoplasm of digestive organs

2225

10626

1.67

98.16

4.9

3.2

1.22

1.23

mmol/l

4.68

2038

8851

Retention of urine

2107

10543

1.69

97.91

5.1

3.9

1.22

mmol/l

3.28

1840

9034

Fibromyalgia

639

2679

2.62

97.81

2.8

3.4

1.23

1.24

mmol/l

2.26

554

2287

Gout

1724

8730

1.79

97.31

8.4

4.0

1.22

mmol/l

4.84

1566

7457

Pulmonary embolism

1853

11231

1.74

97.28

6.2

3.9

1.22

1.23

mmol/l

2.73

1723

9565

Diabetic maculopathy, excluding more controls

705

3099

2.48

96.81

8.9

3.7

1.21

1.23

mmol/l

10.53

603

2663

Acute upper respiratory infections of multiple and unspecified sites

4190

21724

1.44

96.80

5.0

3.7

1.22

1.23

mmol/l

7.49

3727

18678

Factors influencing health status and contact with health services

1486

4041

1.91

96.71

4.3

2.8

1.22

1.23

mmol/l

0.88

1306

3288

Necrosis of pulp, including avohilmo

3091

20720

1.52

96.28

3.9

4.0

1.22

1.23

mmol/l

2.03

2646

18080

Pulmonary heart disease

1853

11262

1.74

96.26

6.2

3.9

1.22

1.23

mmol/l

2.61

1723

9600

Malignant neoplasm of thyroid gland, including Hilmo

519

1994

2.91

96.13

7.6

3.0

1.21

1.23

mmol/l

14.23

480

1650

Dermatitis

3601

24670

1.47

95.10

5.0

3.8

1.23

mmol/l

0.05

3150

21255

Asthma, hospital admission 2, infections

3345

22565

1.49

94.07

4.2

3.9

1.22

1.23

mmol/l

7.12

3024

19323

Asthma-related infections

3345

22565

1.49

94.07

4.2

3.9

1.22

1.23

mmol/l

7.12

3024

19323

Anxiety (asthma-related co-morbidities)

3016

15422

1.53

93.49

3.5

3.8

1.23

mmol/l

2.43

2571

13419

Malignant neoplasm of thyroid gland

481

1806

2.99

93.39

7.7

2.9

1.21

1.23

mmol/l

13.38

448

1493

Non-Hodgkin lymphoma, all, including Hilmo

839

4025

2.26

93.09

9.1

3.2

1.23

mmol/l

2.08

806

3356

Cholecystectomy

4032

24518

1.44

92.31

4.1

3.9

1.23

mmol/l

1.19

3543

21061

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

5300

24861

1.38

92.11

4.9

3.8

1.22

1.23

mmol/l

2.06

4676

21443

Diseases of liver

2010

12586

1.67

92.01

5.0

4.0

1.22

1.23

mmol/l

8.44

1833

10853

Gastrointestinal diseases

2991

9924

1.55

91.95

4.2

3.0

1.23

mmol/l

4.62

2619

8302

Hyperkinetic disorders, excluding more controls

538

1954

2.69

91.80

2.9

3.4

1.22

mmol/l

0.10

447

1709

Hypopituitarism

467

1734

2.98

91.71

5.4

3.5

1.22

mmol/l

0.75

436

1507

Leisure time condition

1135

6081

1.99

91.38

4.8

3.9

1.23

mmol/l

0.30

991

5267

Pain (limb, back, neck, head abdominally)

3795

13237

1.47

91.19

4.3

3.8

1.23

mmol/l

0.49

3340

11314

Lyme disease

569

12872

0.42

91.09

2.7

3.9

1.23

mmol/l

1.11

506

11136

Lyme disease, including avohilmo

569

12872

0.42

91.09

2.7

3.9

1.23

mmol/l

1.11

506

11136

Conduction disorders

1773

8563

1.74

90.97

4.9

3.5

1.22

1.23

mmol/l

9.78

1579

7209

Organic, including symptomatic, mental disorders

3157

15218

1.52

90.55

4.0

4.2

1.23

mmol/l

2.29

2651

13093

Spirochaetal infections, other/unspecified, including avohilmo

578

12962

0.43

90.42

2.8

3.9

1.23

mmol/l

1.09

514

11212

2462

16030

1.58

90.36

4.1

3.8

1.22

1.23

mmol/l

6.51

2209

13734

Other spirochaetal diseases, including avohilmo

592

13144

0.43

90.17

2.8

3.9

1.23

mmol/l

1.31

528

11365

Thrombocytopenia, unspecified

543

2211

2.77

90.02

10.8

3.8

1.22

1.23

mmol/l

3.16

505

1909

Dizziness and giddiness

4233

23800

1.42

89.99

3.9

1.23

mmol/l

0.42

3664

20488

Other spirochaetal diseases

581

12976

0.43

89.91

2.7

3.9

1.23

mmol/l

1.23

517

11219

Glomerulonephritis

653

2886

2.49

89.30

15.0

4.0

1.22

mmol/l

1.29

626

2516

Coronary atherosclerosis

3518

15478

1.48

89.07

5.3

3.7

1.22

1.23

mmol/l

18.65

3086

13169

Other neurological diseases

4114

23077

1.42

87.58

4.1

4.0

1.22

1.23

mmol/l

2.79

3724

19723

ILD, hospital admission 2, with pulmonary infections

703

3238

2.39

87.22

5.8

3.4

1.22

1.23

mmol/l

5.55

656

2731

Dental operations

3325

11772

1.49

85.82

4.5

3.6

1.23

mmol/l

0.10

2884

10129

Diseases of the musculoskeletal system and connective tissue

2652

8707

1.57

85.68

4.0

3.4

1.22

mmol/l

0.20

2316

7417

Haemorrhage from respiratory passages

2028

11391

1.64

85.58

5.0

3.8

1.22

1.23

mmol/l

8.53

1791

9677

Other anxiety disorders

2314

12823

1.58

85.26

3.4

3.6

1.22

1.23

mmol/l

1.80

1980

11119

Mental and behavioural disorders due to psychoactive substance use

3123

19869

1.48

85.14

4.3

4.1

1.21

1.22

mmol/l

15.47

2733

17269

Noninfective enteritis and colitis

2519

16819

1.55

84.97

5.0

3.8

1.22

1.23

mmol/l

5.15

2264

14486

Diseases of oesophagus, stomach and duodenum

5749

25760

1.35

84.58

4.8

3.7

1.22

1.23

mmol/l

8.90

5129

22083

Special screening examination for infectious and parasitic diseases

203

5298

0.27

83.54

3.9

3.4

1.22

mmol/l

0.12

170

4505

Hypokalaemia

829

4138

2.17

82.90

5.6

3.2

1.22

1.23

mmol/l

8.17

766

3469

Diseases of the skin and subcutaneous tissue

5250

19694

1.37

82.76

4.7

3.4

1.23

mmol/l

0.66

4595

16912

Other disorders of ear

4977

24105

1.36

81.38

4.4

3.9

1.23

mmol/l

0.23

4225

20993

Certain infectious and parasitic diseases, including avohilmo

3848

13744

1.44

81.31

4.7

2.9

1.22

1.23

mmol/l

8.99

3429

11485

Osteoporosis with pathological fracture (FG)

601

2696

2.52

81.02

6.4

3.5

1.24

mmol/l

0.21

563

2207

Extreme obesity with alveolar hypoventilation

348

1199

3.42

80.89

5.6

3.5

1.20

1.23

mmol/l

9.70

288

1030

Other systemic involvement of connective tissue

1679

10404

1.70

80.85

3.9

3.8

1.23

mmol/l

0.58

1497

8868

Soft tissue disorders

5368

20717

1.35

80.51

4.0

3.8

1.23

mmol/l

0.68

4680

17782

All anxiety disorders

3078

16633

1.47

80.29

3.5

3.8

1.23

mmol/l

1.36

2621

14420

Coagulation defects, purpura and other haemorrhagic conditions

1167

6566

1.89

80.20

8.1

3.8

1.22

1.23

mmol/l

7.36

1072

5672

Hypoparathyroidism

325

1088

3.57

79.93

12.2

3.3

1.19

1.23

mmol/l

16.63

314

917

Sensorineural hearing loss

4262

20896

1.40

79.92

4.3

4.0

1.23

mmol/l

0.75

3595

18152

Other and unspecified dermatitis

2961

20711

1.48

79.37

5.1

3.8

1.23

mmol/l

0.10

2594

17838

Special screening examination for other diseases and disorders

834

4226

2.12

79.20

3.8

3.9

1.23

mmol/l

0.43

788

3520

Purpura and other haemorrhagic conditions

851

4366

2.10

78.52

9.1

3.9

1.22

1.23

mmol/l

4.54

787

3776

Exclusions for E4_PCOS_CONSORTIUM

3753

16878

1.42

78.36

4.1

3.6

1.23

mmol/l

0.21

3241

14543

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

869

4471

2.06

78.18

4.5

3.7

1.21

1.23

mmol/l

7.68

751

3898

Diseases of pulp and periapical tissues and dental caries

3580

13050

1.44

77.74

4.5

3.7

1.23

mmol/l

1.00

3078

11252

Other and unspecified nonorganic psychotic disorders

990

5334

1.95

77.19

3.9

1.23

mmol/l

0.11

864

4656

Any operation in hilmo

145

8.29

76.65

3.3

1.3

1.22

1.24

mmol/l

2.97

127

Caries of dentine, including avohilmo

4230

15848

1.40

76.51

4.3

3.8

1.23

mmol/l

0.93

3622

13733

3131

19287

1.45

76.23

4.6

4.1

1.21

1.22

mmol/l

17.56

2776

16750

Falls/tendency to fall

5525

21118

1.34

75.58

4.1

3.8

1.22

1.23

mmol/l

2.43

4786

18254

Stroke, excluding SAH

3424

17759

1.44

75.54

4.6

4.1

1.22

1.23

mmol/l

5.90

3123

15054

Hypercalcemia

378

1419

3.13

75.39

13.8

3.9

1.29

1.23

mmol/l

20.53

357

1211

Cerebrovascular diseases

4138

21235

1.39

75.36

4.6

4.0

1.22

1.23

mmol/l

10.41

3757

18108

Stroke, including SAH

3574

18569

1.42

75.26

4.6

4.1

1.22

1.23

mmol/l

7.52

3249

15749

Mental and behavioural disorders due to alcohol

2636

17316

1.49

75.22

4.3

4.1

1.21

1.22

mmol/l

15.25

2317

15075

Non-ischemic cardiomyopathy

1876

9548

1.63

75.19

5.6

3.6

1.22

1.23

mmol/l

23.15

1695

8031

Other interstitial pulmonary diseases

1003

5524

1.95

75.07

5.1

4.1

1.22

1.23

mmol/l

3.55

916

4753

Interstitial lung disease

1003

5526

1.95

74.98

5.1

4.2

1.22

mmol/l

3.38

916

4759

Interstitial lung disease endpoints

1003

5526

1.95

74.98

5.1

4.2

1.22

mmol/l

3.38

916

4759

Personality disorders

1321

7810

1.76

74.86

3.6

3.8

1.22

1.23

mmol/l

1.27

1109

6840

ILD, hospital admissions

988

5423

1.96

74.80

5.1

4.2

1.22

mmol/l

3.30

901

4680

2990

18835

1.46

74.78

4.6

4.1

1.21

1.22

mmol/l

17.74

2644

16366

Secondary and unspecified malignant neoplasm of lymph nodes

543

2391

2.49

74.76

8.4

3.1

1.23

mmol/l

1.68

525

2014

Diseases of the respiratory system

3398

12081

1.44

73.99

4.3

3.1

1.23

mmol/l

5.59

3004

10143

Conductive and sensorineural hearing loss

4368

21656

1.37

73.99

4.4

4.0

1.23

mmol/l

0.57

3688

18820

Arthropathies

4563

17177

1.37

73.64

4.1

3.7

1.23

mmol/l

0.05

3991

14729

Symptoms and signs concerning food and fluid intake

667

3195

2.24

73.45

5.2

3.3

1.23

mmol/l

1.10

572

2683

Gout, FINNGEN

1724

10941

1.64

72.84

8.4

3.9

1.22

mmol/l

4.08

1566

9318

Disorders of adult personality and behaviour

1372

8251

1.73

72.83

3.7

1.22

1.23

mmol/l

2.42

1147

7220

Nerve, nerve root and plexus disorders

5728

26652

1.32

72.81

4.1

3.9

1.23

mmol/l

0.15

5048

22949

Rheumatoid arthritis

1826

10406

1.62

72.73

3.8

3.7

1.23

mmol/l

0.67

1677

8863

Asthma, including avohilmo

6267

26993

1.30

72.55

3.7

4.0

1.23

mmol/l

1.33

5521

23201

Hyperkalaemia

452

1871

2.71

72.37

12.9

3.4

1.20

1.23

mmol/l

10.96

416

1586

ILD, hospital admissions 3, with pneumonia sepsis

604

2827

2.35

72.30

6.1

3.5

1.21

1.23

mmol/l

4.93

566

2396

Benign thyroid growths and nodules

1889

11442

1.60

72.04

4.5

3.7

1.23

mmol/l

7.77

1689

9827

Poisoning by medicine

1100

6262

1.84

71.67

4.4

3.7

1.22

1.23

mmol/l

7.36

966

5476

Other headache syndromes

2150

14360

1.54

71.45

3.5

3.9

1.23

mmol/l

3.25

1878

12303

Poisoning by drugs, medicaments and biological substances

1198

7010

1.79

70.75

4.4

3.8

1.22

1.23

mmol/l

6.77

1056

6127

ILD medications: azathioprine

787

4055

2.05

70.62

8.2

3.1

1.22

1.23

mmol/l

1.49

739

3444

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1423

8719

1.69

70.29

4.1

3.7

1.22

1.23

mmol/l

4.99

1215

7633

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

363

1375

3.01

70.11

11.9

3.2

1.22

1.23

mmol/l

0.29

350

1158

Chronic pancreatitis

753

3853

2.10

70.09

6.8

4.2

1.21

1.22

mmol/l

5.70

707

3339

Dementia, including avohilmo

2811

13488

1.48

70.09

3.3

4.3

1.23

mmol/l

2.84

2332

11596

Intestinal infectious diseases, including avohilmo, including avohilmo

6120

26716

1.30

69.87

5.2

3.6

1.22

1.23

mmol/l

9.58

5416

22913

Other dorsopathies, not elsewhere classified

5187

20625

1.33

69.87

3.9

1.23

mmol/l

0.02

4539

17751

162

362

5.15

69.63

2.6

2.9

1.23

mmol/l

0.11

137

305

Bipolar affective disorders

936

5124

1.91

69.32

4.1

3.7

1.23

mmol/l

2.91

806

4507

Other respiratory diseases principally affecting the interstitium

1130

6599

1.82

68.95

5.8

4.0

1.22

1.23

mmol/l

4.61

1033

5648

Caries of dentine

1185

6704

1.78

68.87

10.1

3.6

1.22

1.23

mmol/l

4.74

1106

5826

Open wound of head

2970

19978

1.44

68.77

4.8

4.0

1.22

1.23

mmol/l

5.21

2567

17245

Substance abuse

2942

19541

1.44

68.48

4.2

4.1

1.21

1.22

mmol/l

15.54

2579

16991

Glaucoma

3251

20083

1.42

68.47

4.2

4.0

1.23

mmol/l

0.54

2755

17253

External causes of morbidity and mortality

3355

12071

1.42

68.12

4.3

3.5

1.23

mmol/l

1.82

2925

10374

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

565

2646

2.36

67.89

6.0

3.8

1.22

1.23

mmol/l

0.73

518

2260

Infections of the skin and subcutaneous tissue

3028

21471

1.42

67.78

6.0

3.8

1.22

1.23

mmol/l

2.83

2711

18553

Sequelae with surgical and medical care as external cause

1244

7485

1.76

67.76

5.9

4.0

1.22

1.23

mmol/l

1.41

1113

6459

Abnormal findings on examination of blood, without diagnosis

2606

16565

1.47

67.75

5.4

4.1

1.22

mmol/l

0.21

2390

14244

Azathioprine

787

4116

2.02

67.63

8.2

3.6

1.22

1.23

mmol/l

1.35

739

3519

Thyrotoxicosis, other and/or unspecified

1135

6647

1.80

67.56

4.0

3.7

1.23

mmol/l

4.84

1004

5731

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3343

24049

1.40

67.47

5.6

3.7

1.22

1.23

mmol/l

7.00

3013

20584

1889

10726

1.58

67.43

4.0

1.22

1.23

mmol/l

3.07

1553

9191

Meniscus derangement

2950

13926

1.45

67.43

3.9

3.8

1.23

mmol/l

0.08

2552

11990

Unspecified haematuria

2377

13338

1.50

67.43

6.0

3.9

1.22

mmol/l

3.40

2102

11463

Dental pulpitis, including avohilmo

4593

22382

1.34

67.33

3.8

4.0

1.22

1.23

mmol/l

4.27

3927

19481

Pleural effusion

969

5454

1.90

67.16

6.4

3.9

1.21

1.23

mmol/l

4.68

895

4653

Acute upper respiratory infections

5579

26084

1.31

67.13

4.5

3.7

1.22

1.23

mmol/l

3.71

4891

22384

malignant neoplasm of male genital organs, including Hilmo

1439

5258

1.71

67.08

5.0

3.6

1.22

1.21

mmol/l

1.61

1247

4487

Emotional disorders starting during childhood or adolecense, excluding more controls

209

552

3.94

66.83

3.8

3.3

1.23

1.22

mmol/l

0.64

174

467

Dental caries, including avohilmo

3927

14894

1.38

66.55

4.4

3.8

1.23

mmol/l

0.84

3369

12901

Sarcoidosis

790

4185

2.03

66.44

4.8

4.0

1.23

mmol/l

1.08

725

3639

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

892

4208

1.91

66.05

3.2

3.5

1.22

mmol/l

0.02

747

3628

Dementia in Alzheimer disease

1232

6181

1.76

66.01

3.4

4.1

1.23

1.22

mmol/l

2.81

996

5310

AV-block

1116

5566

1.81

65.70

5.3

3.5

1.22

1.23

mmol/l

6.79

988

4677

Dorsopathies

5273

20653

1.32

65.49

3.8

3.9

1.23

mmol/l

0.03

4605

17778

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

5374

26910

1.30

64.94

5.2

3.6

1.22

1.23

mmol/l

10.23

4754

23091

Carbimazole or st.post thyroidectomy, condition for graves disease

1189

7136

1.75

64.90

5.1

3.7

1.21

1.23

mmol/l

22.46

1062

6136

Cystitis

4437

20071

1.34

64.64

4.2

3.7

1.22

1.23

mmol/l

1.93

3867

17248

malignant neoplasm of male genital organs

1408

5180

1.70

64.63

5.0

3.6

1.22

1.21

mmol/l

1.14

1216

4417

Unspecified kidney failure

677

3442

2.12

64.39

12.9

3.1

1.21

1.23

mmol/l

6.25

646

2902

Malignant neoplasm of skin, including Hilmo

2705

12804

1.46

64.34

4.9

3.2

1.23

mmol/l

0.52

2332

10702

Other diseases of liver

1051

6125

1.81

64.05

4.6

4.0

1.22

1.23

mmol/l

1.30

943

5327

Ischaemic Stroke, excluding all haemorrhages

3186

17150

1.41

63.56

4.6

4.1

1.22

1.23

mmol/l

5.29

2906

14524

Rheumatism, unspecified

840

4607

1.95

63.42

3.5

3.6

1.23

1.24

mmol/l

1.29

735

3900

Dental caries

1299

7525

1.69

63.24

10.1

3.6

1.22

1.23

mmol/l

5.49

1208

6519

Diseases of the eye and adnexa

3751

13903

1.38

63.18

4.4

3.6

1.22

1.23

mmol/l

0.69

3283

12128

Other noninfective gastroenteritis and colitis

1364

8511

1.67

63.16

5.9

3.8

1.22

1.23

mmol/l

6.56

1244

7327

Chronic nephritic syndrome

290

1033

3.23

63.05

19.1

3.5

1.22

mmol/l

0.51

285

893

Post-traumatic stress disorder

432

1836

2.50

63.03

3.2

1.23

mmol/l

0.04

364

1584

GI-bleeding

1848

12371

1.55

62.80

6.5

3.9

1.22

1.23

mmol/l

5.44

1672

10577

Viral pneumonia

764

4068

2.00

62.73

7.7

3.3

1.21

1.23

mmol/l

12.34

718

3459

Delirium, not induced by alcohol and other psychoactive substances

807

4380

1.97

62.57

6.1

4.2

1.22

mmol/l

0.07

704

3794

Asthma, hospital admissions , main diagnosis only

4262

28419

1.33

62.15

3.8

3.9

1.23

mmol/l

0.27

3783

24421

Other joint disorders

4333

17161

1.34

61.77

3.7

1.23

mmol/l

0.21

3735

14713

Paralytic ileus and intestinal obstruction

1555

10067

1.61

61.75

5.3

3.7

1.22

1.23

mmol/l

8.04

1387

8519

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

3020

17082

1.41

61.65

4.0

3.7

1.22

1.23

mmol/l

5.38

2558

14754

Papillary adenocarcinoma of thyroid gland

341

1329

2.86

61.59

7.9

3.0

1.21

1.23

mmol/l

9.29

314

1105

Acute pancreatitis

1101

6567

1.76

61.44

5.5

3.9

1.21

1.23

mmol/l

8.11

1023

5661

Malignant neoplasm of skin

2575

12330

1.45

61.08

4.6

3.2

1.23

mmol/l

0.39

2209

10281

Migraine

2368

12864

1.47

61.06

3.3

3.8

1.23

mmol/l

2.65

2063

11031

Other disorders of skin and subcutaneous tissue

3968

25513

1.34

60.85

6.0

3.7

1.23

mmol/l

2.04

3519

21925

Alcohol use disorder, ICD-based

2066

14218

1.50

60.47

4.3

1.21

1.22

mmol/l

13.05

1827

12426

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

4734

28712

1.31

60.12

5.0

3.8

1.23

mmol/l

0.11

4208

24697

Alcohol use disorder, Swedish definition

2752

18078

1.42

60.09

4.6

4.1

1.21

1.22

mmol/l

15.42

2453

15716

ILD, hospital admissions 1, main diag only

856

4822

1.91

59.65

5.0

4.2

1.22

1.23

mmol/l

2.61

782

4176

Other diseases of the digestive system

1831

12368

1.54

59.62

6.5

3.9

1.22

1.23

mmol/l

5.47

1649

10568

Viral infections characterized by skin and mucous membrane lesions

2207

15418

1.48

59.44

6.8

3.8

1.22

1.23

mmol/l

2.17

2009

13271

Viral hepatitis, IBD co-morbidity

245

801

3.26

59.36

4.9

3.2

1.21

1.23

mmol/l

2.34

219

676

Other external causes of accidental injury

4116

15628

1.34

59.29

4.3

3.7

1.22

1.23

mmol/l

3.32

3579

13563

Sub-endpoint used in defining T1D endpoints

1479

9377

1.61

59.18

7.6

3.8

1.21

1.23

mmol/l

8.59

1295

8112

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2216

15384

1.47

58.85

4.3

1.21

1.22

mmol/l

13.73

1956

13431

Accidents

4111

15628

1.34

58.72

4.3

3.7

1.22

1.23

mmol/l

2.91

3577

13563

Specific personality disorders

1114

6732

1.72

58.28

3.5

3.7

1.22

1.23

mmol/l

1.36

934

5886

Sequelae of external causes of morbidity and mortality

1471

9556

1.61

57.93

5.7

3.9

1.22

1.23

mmol/l

1.83

1309

8235

1384

8282

1.64

57.67

4.0

3.9

1.22

1.23

mmol/l

2.88

1124

7068

Degeneration of macula and posterior pole

2821

15902

1.41

57.47

4.1

3.9

1.22

1.23

mmol/l

4.77

2352

13682

Caries of enamel

3062

26893

0.73

57.43

3.8

4.0

1.23

mmol/l

0.54

2589

23340

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2378

11392

1.46

57.35

4.5

3.2

1.23

mmol/l

0.07

2014

9470

Asthma/COPD (KELA code 203)

4917

25800

1.30

57.19

3.8

3.9

1.23

mmol/l

0.68

4312

22126

Examination and observation for other reasons

1591

13511

0.65

57.01

4.7

3.8

1.22

mmol/l

0.21

1449

11318

Other or unspecified ileus, impaction or obstruction

1130

6929

1.72

56.84

5.3

3.8

1.22

1.23

mmol/l

6.08

1005

5869

Gout, unspecified

1196

7460

1.69

56.53

8.1

3.9

1.21

1.22

mmol/l

5.57

1074

6421

Periodontitis

5224

26374

1.29

56.40

4.3

3.9

1.23

mmol/l

0.70

4581

22781

Biological medication for rheuma

892

5140

1.82

56.00

3.0

4.0

1.23

mmol/l

1.00

820

4490

Primary open-angle glaucoma, strict

1595

10615

1.57

55.92

4.1

4.0

1.23

mmol/l

0.08

1337

9054

Intestinal stricture

1755

11925

1.53

55.71

5.6

4.0

1.22

1.23

mmol/l

7.87

1571

10220

Tracheo-bronchomalasia

12.65

55.65

3.1

1.23

1.24

mmol/l

0.46

Polyarthrosis

1252

7102

1.67

55.63

4.1

3.8

1.23

mmol/l

0.41

1100

6016

Gout, strict definition

1077

6576

1.73

55.62

8.4

4.0

1.21

1.22

mmol/l

4.22

966

5672

Psoriatic and enteropathic arthropathies

652

3433

2.02

55.40

3.1

3.8

1.23

mmol/l

0.22

583

2951

Other CVD

1245

7881

1.66

55.34

5.6

3.9

1.22

1.23

mmol/l

3.75

1123

6705

Malignant neoplasm of prostate, including Hilmo

1364

5071

1.65

55.24

5.0

3.6

1.22

1.21

mmol/l

0.85

1175

4325

Outcome of delivery

106

2658

0.24

55.22

2.1

3.3

1.24

1.23

mmol/l

1.63

2283

Methotrexate

786

4398

1.89

55.12

3.4

3.6

1.23

mmol/l

0.36

718

3714

Suicide or other Intentional self-harm

1184

7381

1.67

54.92

4.4

3.8

1.22

1.23

mmol/l

4.57

1024

6471

Malignant neoplasm of prostate

1343

4999

1.65

54.83

5.0

3.6

1.22

1.21

mmol/l

0.64

1153

4257

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2439

11760

1.44

54.77

4.7

3.2

1.23

mmol/l

0.18

2074

9791

Urinary track infection

2957

10818

1.40

54.65

3.9

3.1

1.23

1.24

mmol/l

2.20

2577

9181

Other diseases of pancreas

537

2678

2.18

54.34

5.6

4.2

1.22

1.23

mmol/l

2.25

495

2301

Other degenerative diseases of the nervous system

1547

7417

1.57

54.17

3.6

3.9

1.23

mmol/l

0.20

1291

6251

Dementia

2582

12812

1.43

53.96

3.3

4.2

1.23

mmol/l

4.23

2135

11000

Other diseases of the respiratory system

1191

7501

1.67

53.88

6.3

3.9

1.21

1.23

mmol/l

7.46

1095

6417

Other respiratory disorders and diseases

1191

7501

1.67

53.88

6.3

3.9

1.21

1.23

mmol/l

7.46

1095

6417

Thyrotoxicosis

1398

9123

1.60

53.86

4.0

3.8

1.23

mmol/l

3.34

1228

7834

Gout, idiopatic and unspecified

1425

9352

1.60

53.85

7.8

4.0

1.21

1.22

mmol/l

5.26

1284

8064

Respiratory conditions due to other external agents

195

613

3.90

53.85

7.2

3.5

1.23

mmol/l

0.10

185

533

Cough

2096

13762

1.46

53.75

4.3

3.6

1.23

mmol/l

1.73

1854

11767

Other hearing loss

1673

10976

1.54

53.69

4.7

3.9

1.22

1.23

mmol/l

0.70

1378

9480

Alzheimer’s disease (Atypical or mixed), excluding more controls

619

2385

2.08

53.50

3.5

3.9

1.23

1.22

mmol/l

3.08

503

2012

Primary open-angle glaucoma

1880

12560

1.50

53.31

4.0

4.1

1.23

mmol/l

0.38

1579

10758

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3065

23004

1.36

52.77

5.6

3.8

1.22

1.23

mmol/l

5.86

2760

19731

Sulfasalazine

1420

9316

1.58

52.71

3.6

3.5

1.23

mmol/l

0.25

1294

7917

COPD (mode)

1658

8704

1.54

52.71

5.1

3.3

1.21

1.23

mmol/l

24.15

1504

7226

Diseases of the ear and mastoid process

5782

23282

1.26

52.56

4.2

3.8

1.23

mmol/l

0.89

4998

20199

Chronic periodontitis, including avohilmo

5185

26404

1.28

52.56

4.3

3.9

1.23

mmol/l

0.70

4551

22806

Abnormal findings on diagnostic imaging of lung

2677

18708

1.40

52.51

5.1

4.0

1.23

mmol/l

0.88

2440

15977

Dysphagia

1408

9260

1.58

52.17

5.2

3.7

1.22

1.23

mmol/l

3.81

1238

7857

Gingivitis and periodontal diseases

5170

21242

1.28

51.81

4.1

3.9

1.23

mmol/l

0.11

4468

18366

KRA_PSY_EATING, excluding more controls

343

1420

2.51

51.51

3.6

2.8

1.22

1.23

mmol/l

0.17

291

1217

Diabetic retinopathy, excluding more controls

1537

5679

1.59

51.49

7.2

3.5

1.22

1.23

mmol/l

8.00

1321

4874

Acute pancreatitis (for exclusion)

1101

6878

1.68

51.40

5.5

4.0

1.21

1.23

mmol/l

6.47

1023

5947

Zoster [herpes zoster], including avohilmo

2845

20556

1.37

50.62

4.5

3.8

1.23

mmol/l

0.50

2534

17562

Diseases of oral cavity, salivary glands and jaws

3013

11528

1.38

50.46

4.5

3.6

1.22

1.23

mmol/l

0.60

2610

9921

Gonarthrosis [arthrosis of knee](FG)

3800

16852

1.32

50.17

3.9

3.8

1.23

mmol/l

0.03

3305

14433

Symptoms and signs involving appearance and behaviour

200

6.61

49.92

4.8

3.5

1.21

1.22

mmol/l

0.77

172

Injuries to the abdomen, lower back, lumbar spine and pelvis

2196

15603

1.43

49.75

4.6

3.9

1.22

1.23

mmol/l

3.75

1935

13375

Abnormal results of function studies

527

2689

2.10

49.56

4.9

3.9

1.22

1.23

mmol/l

1.69

463

2327

Other diseases of biliary tract

558

2918

2.06

49.23

5.9

3.8

1.22

1.23

mmol/l

6.04

517

2489

Dermatitis and eczema

5775

27771

1.25

49.14

4.8

3.8

1.23

mmol/l

0.22

5036

23952

Schizophrenia

785

4536

1.81

48.96

3.6

4.1

1.23

mmol/l

1.63

678

3984

Dissociative [conversion] disorders

241

882

3.01

48.92

3.6

3.3

1.22

1.23

mmol/l

0.83

210

770

Other condition

782

4527

1.82

48.80

4.7

4.0

1.23

mmol/l

0.02

739

3936

Other/unspecified dorsalgia

1949

13630

1.45

48.80

4.3

3.9

1.23

mmol/l

0.29

1672

11679

Acute sinusitis

2505

16776

1.39

48.41

4.5

3.6

1.22

1.23

mmol/l

6.66

2188

14464

Diseases of arteries, arterioles and capillaries

3590

20378

1.32

48.35

6.3

3.8

1.22

1.23

mmol/l

23.14

3222

17451

Hypocalcemia

197

664

3.51

47.96

19.0

3.9

1.14

1.23

mmol/l

35.58

184

576

Major coronary heart disease event excluding revascularizations

3082

15407

1.35

47.70

5.5

3.8

1.22

1.23

mmol/l

22.67

2795

13103

Diabetic nephropathy, excluding more controls

913

4502

1.76

47.62

14.8

3.6

1.20

1.23

mmol/l

20.15

847

3876

Arthrosis

3560

14995

1.33

47.43

3.9

3.8

1.23

mmol/l

0.05

3132

12907

Malnutrition

181

584

3.66

47.28

7.3

4.0

1.21

1.23

mmol/l

3.50

162

502

Intestinal malabsorption

310

1313

2.62

47.19

7.3

3.5

1.22

1.23

mmol/l

3.02

278

1118

Tumor necrosis factor alpha inhibitors

783

4569

1.79

47.11

3.0

3.9

1.23

mmol/l

1.15

718

3982

Disturbance of activity and attention

526

2636

2.02

46.82

3.0

3.4

1.22

mmol/l

0.04

436

2263

Respiratory insufficiency

505

2582

2.09

46.79

6.6

3.3

1.20

1.23

mmol/l

16.06

466

2144

Viral pneumonia (unknown virus, not influenza)

405

1918

2.28

46.72

8.8

4.0

1.21

1.23

mmol/l

5.54

386

1650

Malignant neoplasm of urinary organs, including Hilmo

632

3488

1.92

46.65

6.9

3.3

1.23

1.22

mmol/l

0.24

585

2937

Actinic keratosis

2235

14877

1.41

46.58

4.9

4.0

1.23

mmol/l

0.49

1890

12735

Hypotension

1081

6900

1.65

46.58

5.6

3.9

1.22

1.23

mmol/l

4.00

969

5880

Injury, poisoning and certain other consequences of external causes

2650

9774

1.39

46.57

4.1

3.5

1.23

mmol/l

1.03

2314

8347

Abnormal findings on diagnostic imaging of other body structures

839

5031

1.76

46.46

4.9

3.9

1.23

mmol/l

0.56

758

4327

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

223

806

3.06

46.41

9.3

3.4

1.22

1.23

mmol/l

1.75

204

715

Colorectal cancer, including Hilmo

1373

8567

1.55

46.21

4.6

3.2

1.22

1.23

mmol/l

1.44

1231

7125

Brachial plexus disorders

493

2518

2.08

45.85

3.1

3.7

1.23

mmol/l

0.31

431

2180

Disorders of eyelid, lacrimal system and orbit

4528

26572

1.27

45.60

4.1

3.9

1.23

mmol/l

1.27

3915

22961

2379

15864

1.39

45.44

4.9

4.0

1.23

mmol/l

0.50

2014

13592

Other and unspecified effects of external causes

1316

8769

1.55

45.42

4.2

3.8

1.22

1.23

mmol/l

1.75

1141

7639

Basal cell carcinoma, including Hilmo

2311

11448

1.40

45.21

4.5

3.2

1.23

mmol/l

0.05

1952

9514

Other complications of surgical and medical care, not elsewhere classified

564

3036

1.98

45.16

5.6

3.4

1.23

mmol/l

0.76

520

2590

Acute alcohol intoxication, ICD10

978

6114

1.66

45.10

4.6

4.2

1.21

1.22

mmol/l

11.04

858

5362

Coxarthrosis [arthrosis of hip](FG)

2855

14849

1.35

45.07

3.7

3.9

1.23

mmol/l

1.77

2476

12648

Iron deficiency anaemia secondary to blood loss (chronic)

931

5775

1.70

45.02

6.2

3.7

1.22

1.23

mmol/l

7.05

836

4929

Asthma-related pneumonia

1977

14214

1.43

44.86

4.9

4.0

1.22

1.23

mmol/l

10.66

1826

12131

Ulcerative ileocolitis

252

990

2.82

44.85

4.8

3.8

1.22

1.23

mmol/l

1.85

228

850

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

351

1587

2.36

44.82

3.8

3.7

1.21

1.23

mmol/l

3.15

311

1376

Asthma-related pneumonia or sepsis

1978

14244

1.43

44.44

4.9

4.0

1.22

1.23

mmol/l

10.62

1827

12153

Asthma, hospital admissions 3, pneumonia

1978

14244

1.43

44.44

4.9

4.0

1.22

1.23

mmol/l

10.62

1827

12153

Malignant neoplasm of urinary organs

545

2920

1.99

44.29

7.1

3.3

1.23

1.22

mmol/l

0.15

508

2457

Transient ischemic attack

2837

17187

1.35

44.29

3.9

4.0

1.23

mmol/l

1.31

2597

14547

Lung diseases due to external agents

788

4702

1.77

44.27

5.7

4.1

1.22

mmol/l

1.87

716

4060

Collagenous colitis

557

3019

1.98

44.01

5.7

3.8

1.22

1.23

mmol/l

3.30

507

2597

Primary Sclerosing Cholangitis, IBD and UDCA required

151

451

3.83

43.91

6.3

3.6

1.22

1.23

mmol/l

0.59

144

391

Unspecified fall

2670

19841

1.35

43.87

4.6

3.9

1.22

1.23

mmol/l

5.26

2294

17084

Basal cell carcinoma

2235

11149

1.40

43.81

4.3

3.2

1.23

mmol/l

0.08

1882

9263

Psoriatic arthropathies

552

2977

1.97

43.75

3.1

3.8

1.23

mmol/l

0.05

500

2579

Phlebitis and thrombophlebitis (not including DVT)

1213

8039

1.57

43.61

5.9

3.8

1.22

1.23

mmol/l

1.81

1081

6919

Skin changes due to chronic exposure to nonionizing radiation

2267

15210

1.39

43.53

4.9

4.0

1.23

mmol/l

0.37

1914

13031

Injuries to the thorax

2404

17952

1.37

43.49

4.9

4.0

1.22

1.23

mmol/l

3.36

2142

15441

Disorders of sclera, cornea, iris and ciliary body

2759

21027

1.34

43.40

4.5

3.9

1.23

mmol/l

0.50

2426

18157

Nontoxic multinodular goitre

1088

7070

1.61

43.20

4.8

3.7

1.22

1.24

mmol/l

9.42

976

6063

Weight loss

610

3423

1.90

43.06

4.7

4.0

1.23

mmol/l

0.40

520

2964

Colorectal cancer

1234

7876

1.56

43.05

4.5

3.3

1.22

1.23

mmol/l

1.42

1108

6558

Irritable bowel syndrome

1422

9744

1.51

42.91

3.4

3.5

1.23

mmol/l

1.43

1237

8305

Speech therapy

1393

9541

1.52

42.68

3.6

4.0

1.24

1.23

mmol/l

9.70

1347

8176

Diffuse large B-cell lymphoma, including Hilmo

312

1389

2.48

42.49

12.4

3.3

1.24

1.23

mmol/l

2.19

302

1184

Diffuse large B-cell lymphoma

312

1389

2.48

42.49

12.4

3.3

1.24

1.23

mmol/l

2.19

302

1184

Diffuse large B-cell lymphoma, helper endpoint

312

1389

2.48

42.49

12.4

3.3

1.24

1.23

mmol/l

2.19

302

1184

Other diseases of blood and blood-forming organs

421

2105

2.17

42.39

4.3

3.9

1.22

1.23

mmol/l

0.81

366

1820

Any death

3406

18635

1.31

42.36

7.7

3.5

1.22

1.23

mmol/l

23.77

3217

15780

Nonorganic sleeping disorders, excluding more controls

908

5647

1.66

42.32

4.0

3.6

1.22

1.23

mmol/l

1.46

798

4957

Disorders of magnesium metabolism

220

5.96

42.27

10.0

3.6

1.18

1.23

mmol/l

4.45

188

Inflammatory bowel disease

1510

10491

1.48

42.25

4.2

3.9

1.22

1.23

mmol/l

0.93

1345

9114

Non-follicular lymphoma

568

3147

1.94

42.04

10.4

4.1

1.23

1.22

mmol/l

1.82

549

2751

Missing teeth due to accident, extraction or parodontitis

3305

23117

1.31

41.88

4.7

4.0

1.23

mmol/l

1.29

2825

19972

Hypertrophy of (infrapatellar) fat pad

222

5.49

41.79

4.4

3.6

1.22

1.23

mmol/l

0.32

197

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

546

2982

1.95

41.78

7.0

3.3

1.23

1.22

mmol/l

0.35

507

2507

Hyperkinetic disorders

540

2834

1.92

41.76

3.0

3.4

1.22

mmol/l

0.00

449

2435

Substance use, excluding alcohol

918

5759

1.65

41.59

4.1

4.0

1.22

1.23

mmol/l

4.61

802

5044

Gastro-oesophageal reflux disease

3535

23520

1.29

41.53

4.4

3.8

1.23

mmol/l

1.02

3120

20185

Cholangitis (primary sclerosing, PSC)

379

1835

2.24

41.46

5.7

3.7

1.22

1.23

mmol/l

1.36

358

1561

Pneumonia due to other infectious organisms, not elsewhere classified

232

915

2.85

41.36

9.7

3.6

1.22

mmol/l

0.33

218

770

Rheumatoid arthritis, including avohilmo

2006

14719

1.40

41.32

3.8

3.9

1.23

mmol/l

0.00

1838

12580

Clear cell adenocarcinoma of kidney

291

1272

2.53

41.30

6.4

3.1

1.23

mmol/l

0.20

271

1068

Streptococcal septicaemia

507

2716

1.99

41.25

9.7

3.2

1.21

1.23

mmol/l

3.69

470

2310

Abnormal weight loss

568

3166

1.92

41.13

4.5

4.0

1.23

mmol/l

0.11

487

2747

Injuries to the hip and thigh

2626

17931

1.34

41.08

4.6

3.9

1.22

1.23

mmol/l

1.46

2327

15365

Protein-energy malnutrition of moderate and mild degree

104

259

5.27

40.89

7.3

4.5

1.20

1.23

mmol/l

4.23

227

Myocarditis

236

932

2.71

40.68

5.2

2.9

1.22

1.23

mmol/l

1.36

219

772

Infective dermatitis

628

3608

1.84

40.57

5.0

3.8

1.23

mmol/l

0.47

549

3138

Emotionally unstable personality disorder

546

2992

1.91

40.53

3.5

3.4

1.23

mmol/l

0.42

457

2592

Traumatic subdural haemorrhage

761

4294

1.74

40.44

4.7

4.1

1.22

1.23

mmol/l

4.37

666

3617

Postmenopausal osteoporosis with pathological fracture

472

2516

2.07

40.38

6.0

3.5

1.24

mmol/l

0.04

438

2113

Early onset COPD, excluding more controls

960

6127

1.62

40.33

5.3

3.3

1.21

1.23

mmol/l

10.72

876

5117

All influenza

1315

8985

1.51

40.25

7.0

3.4

1.22

1.23

mmol/l

5.96

1209

7625

Emotional disorders and disorders of social functioning with onset specific to childhood

220

823

2.78

40.10

4.2

3.5

1.23

mmol/l

0.08

184

702

Epilepsy

1465

10185

1.47

40.01

4.3

4.0

1.22

1.23

mmol/l

8.78

1340

8718

Multiple myeloma, including Hilmo

289

1278

2.50

40.01

22.1

3.3

1.22

1.23

mmol/l

1.89

282

1082

Noninfectious colitis NAS

729

4374

1.75

40.00

5.9

3.8

1.22

1.23

mmol/l

4.39

675

3757

Other disorders of white blood cells

337

1588

2.32

39.87

5.5

3.7

1.21

1.23

mmol/l

2.63

300

1364

Gonarthrosis

3210

14094

1.31

39.85

3.8

1.23

mmol/l

0.06

2793

12121

Iron deficiency

193

701

3.03

39.80

2.9

3.0

1.21

1.23

mmol/l

5.13

160

590

Mixed and other personality disorders

398

1987

2.13

39.51

4.3

3.8

1.22

1.23

mmol/l

2.45

333

1740

Streptococcal septicaemia, including avohilmo

512

2792

1.95

39.40

9.6

3.3

1.21

1.23

mmol/l

3.78

475

2367

Malignant neoplasm of kidney, except renal pelvis

488

2624

1.98

39.30

7.2

3.3

1.23

1.22

mmol/l

0.36

455

2213

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

762

4490

1.72

39.27

7.8

4.1

1.22

1.23

mmol/l

0.39

710

3898

Seropositive rheumatoid arthritis

1305

8910

1.51

39.27

3.7

1.23

mmol/l

0.45

1205

7530

Nonalcoholic fatty liver disease

534

2957

1.91

39.04

4.1

4.2

1.22

1.23

mmol/l

0.71

478

2588

Benign neoplasm: Pancreas

221

885

2.90

39.03

5.1

3.8

1.23

mmol/l

0.16

209

765

Attention to artificial openings

262

1121

2.58

38.98

5.5

2.9

1.22

1.23

mmol/l

0.03

244

946

Arthropathic psoriasis

594

3399

1.85

38.91

3.2

4.2

1.23

mmol/l

0.13

534

2955

Other infectious diseases, including avohilmo

518

2850

1.94

38.90

8.2

3.8

1.22

mmol/l

0.07

485

2457

Pain in joint

2718

12749

1.33

38.78

3.8

1.23

mmol/l

0.09

2375

10910

Insulin, fast-acting (human)

663

3902

1.77

38.70

8.5

3.5

1.22

1.23

mmol/l

3.46

581

3377

Other viral diseases

1286

8777

1.50

38.58

7.3

3.7

1.22

1.23

mmol/l

0.70

1163

7643

Hypertensive heart and/or renal disease

1274

6317

1.52

38.43

8.2

3.4

1.22

1.23

mmol/l

6.43

1161

5217

Thyrotoxicosis with diffuse goitre

715

4312

1.74

38.39

3.9

3.6

1.22

1.23

mmol/l

3.57

623

3738

Internal derangement of knee

1805

13011

1.41

38.38

4.1

3.8

1.23

mmol/l

0.18

1547

11201

Undetermined asthma, excluding more controls

663

3912

1.77

38.27

4.0

3.0

1.22

1.23

mmol/l

4.14

594

3227

Polymyalgia rheumatica

808

5056

1.69

38.23

4.0

1.23

mmol/l

0.30

732

4316

Fibrosis and cirrhosis of liver

463

2482

2.01

38.09

5.6

4.2

1.21

1.23

mmol/l

6.08

441

2154

Benign neoplasm of other and unspecified endocrine glands

720

4390

1.73

37.50

4.2

1.23

mmol/l

0.41

664

3800

Hypertensive Renal Disease

239

1001

2.62

37.19

17.4

3.1

1.20

1.22

mmol/l

3.44

221

821

Other pleural conditions

581

3354

1.84

37.14

6.3

3.9

1.21

1.22

mmol/l

3.66

539

2876

Other symptoms and signs involving the digestive system and abdomen

898

5771

1.62

37.11

4.9

3.5

1.23

mmol/l

0.65

785

4885

Benign neoplasms

4803

21418

1.24

37.09

4.6

3.7

1.22

mmol/l

0.13

4243

18408

Injuries to the elbow and forearm

3566

24459

1.27

37.06

4.2

3.9

1.23

mmol/l

1.24

3056

21098

Carrier of infectious disease

171

610

3.17

37.04

5.8

3.5

1.21

1.23

mmol/l

1.70

157

527

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

809

4921

1.66

36.97

7.6

4.1

1.23

mmol/l

0.35

749

4273

Implicit fungal Sepsis, including avohilmo

435

2306

2.03

36.96

8.7

3.1

1.22

1.23

mmol/l

4.00

407

1949

Coxarthrosis

2583

12764

1.33

36.90

3.8

3.9

1.23

mmol/l

1.14

2252

10937

Alzheimer disease, excluding more controls

999

4194

1.60

36.90

3.4

4.0

1.23

mmol/l

1.20

817

3527

IBD patients in KELA-register

1049

6969

1.55

36.87

3.9

3.8

1.22

1.23

mmol/l

0.64

925

6081

Disease of hard tissues of teeth, NOS

2739

11010

1.33

36.84

3.8

3.6

1.23

mmol/l

0.76

2359

9512

In situ neoplasms

2154

16260

1.36

36.83

4.9

3.8

1.23

mmol/l

0.54

1832

13951

Coxibs

1445

5248

1.48

36.80

3.2

4.9

1.22

mmol/l

0.08

1245

4577

Seronegative rheumatoid arthritis

643

3826

1.77

36.70

3.8

3.9

1.23

mmol/l

0.24

591

3206

Periapical abscess

2226

16868

1.35

36.62

4.3

4.1

1.22

1.23

mmol/l

1.97

1929

14674

Crohn disease

627

3697

1.77

36.55

4.7

3.8

1.22

1.23

mmol/l

1.14

561

3206

Acute and transient psychotic disorders

571

3285

1.83

36.48

4.3

4.0

1.23

mmol/l

0.76

509

2857

Artificial joint operation, meniscal resection

4668

24532

1.24

36.44

3.7

4.1

1.23

mmol/l

0.26

4043

21240

Panic disorder

630

3712

1.76

36.33

3.4

3.6

1.23

mmol/l

0.60

546

3211

L02BX Other hormone antagonists and related agents

353

1766

2.19

35.98

7.3

4.7

1.21

mmol/l

0.11

331

1552

Other special examinations and investigations of persons without complaint or reported diagnosis

3404

13637

1.29

35.94

4.2

3.8

1.23

1.22

mmol/l

0.23

3008

11412

Other necrotizing vasculopathies

437

2349

2.01

35.82

6.0

4.1

1.22

1.23

mmol/l

1.13

409

2030

Spinal stenosis

2689

15375

1.32

35.80

3.9

4.0

1.23

mmol/l

1.26

2332

13200

Psychotic depression

295

1365

2.29

35.63

4.7

3.9

1.22

1.23

mmol/l

0.99

250

1200

Emotional disorders starting during childhood or adolescence

210

826

2.67

35.61

3.9

3.7

1.23

mmol/l

0.11

175

703

Explicit bacterial Sepsis

568

3292

1.82

35.46

9.3

3.3

1.21

1.23

mmol/l

4.65

527

2787

Paracetamol or NSAID medication

721

2151

1.73

35.45

4.0

3.8

1.22

mmol/l

0.24

613

1838

Alcohol abuse, main dg, excluding more controls

650

3896

1.73

35.34

4.7

4.0

1.21

1.22

mmol/l

8.37

578

3439

Acute peritonitis

374

1922

2.10

34.87

14.6

4.1

1.21

1.22

mmol/l

3.13

355

1666

Psoriasis

1397

9927

1.45

34.86

3.9

4.0

1.23

mmol/l

0.03

1242

8609

Other necrotizing vasculopathies (FG)

370

1898

2.11

34.83

5.8

3.8

1.22

1.23

mmol/l

2.94

347

1605

Congenital malformations, deformations and chromosomal abnormalities

2629

19392

1.31

34.82

5.0

3.7

1.23

mmol/l

0.73

2324

16770

Polycystic ovarian syndrome, consortium definition

3487

15991

1.27

34.55

3.6

3.4

1.23

mmol/l

1.35

2990

13625

Undetermined asthma

663

4028

1.71

34.35

4.0

3.1

1.22

1.23

mmol/l

3.09

594

3356

Statin medication

3140

13954

1.29

34.26

4.4

3.6

1.23

mmol/l

1.80

2748

12110

Other psoriatic arthropathies

527

3025

1.84

34.25

3.0

4.2

1.23

mmol/l

0.08

478

2631

Faecal incontinence

558

3265

1.82

34.19

4.1

3.5

1.23

1.24

mmol/l

2.29

478

2738

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

494

2786

1.88

34.15

6.4

3.6

1.23

mmol/l

0.63

455

2382

Myocardial infarction

2392

12842

1.33

34.02

5.8

3.8

1.21

1.23

mmol/l

24.59

2160

10901

5-aminosalicylic acid

938

6193

1.56

33.90

4.3

3.6

1.23

mmol/l

0.13

820

5329

Explicit bacterial Sepsis, including avohilmo

574

3379

1.78

33.89

9.2

3.3

1.21

1.23

mmol/l

4.60

532

2861

Other disorders involving the immune mechanism, not elsewhere classified

196

784

2.78

33.86

16.0

4.0

1.22

mmol/l

0.93

189

685

Other diseases of pericardium

276

1282

2.35

33.82

9.4

3.6

1.21

1.23

mmol/l

3.51

261

1089

Excessive earwax

3271

23794

1.27

33.66

4.0

4.1

1.23

mmol/l

0.41

2713

20634

Follicular adenocarcinoma of thyroid gland, including Hilmo

230

4.76

33.50

6.9

2.7

1.20

1.23

mmol/l

2.99

198

Inflammatory bowel disease, strict (require KELA)

1049

7111

1.52

33.49

3.9

1.22

1.23

mmol/l

0.42

925

6225

Obesity, other/unspecified

1526

11072

1.41

33.33

4.1

3.6

1.22

1.23

mmol/l

6.37

1320

9581

Eosinophilic disease (BM)

117

357

3.81

33.32

4.9

3.3

1.22

1.23

mmol/l

0.33

103

292

Multiple myeloma and malignant plasma cell neoplasms

309

1517

2.24

33.21

21.5

4.0

1.22

mmol/l

1.13

302

1300

Psoriatic arthropathies, ICD10

536

3120

1.81

33.17

3.0

4.2

1.23

mmol/l

0.14

487

2715

Migraine with aura

1047

7096

1.51

33.04

3.3

3.5

1.23

mmol/l

1.85

937

6077

Other viral diseases, including avohilmo

1642

11939

1.39

33.03

6.4

3.6

1.22

1.23

mmol/l

0.49

1487

10392

L01XE Protein kinase inhibitors

327

1644

2.18

32.96

9.3

3.9

1.22

1.23

mmol/l

0.36

316

1429

Other specific joint derangements/joint disorders

3342

16673

1.27

32.84

3.9

3.7

1.23

mmol/l

0.67

2928

14311

Schizoaffective disorder

376

1970

2.02

32.66

3.9

3.8

1.24

1.23

mmol/l

2.10

332

1721

Alcohol dependence

1222

8577

1.47

32.57

4.5

4.3

1.21

1.22

mmol/l

7.92

1092

7499

Patent foramen ovale

141

485

3.28

32.57

3.8

4.1

1.23

mmol/l

0.09

134

425

Fluid overload

9.49

32.37

41.8

3.4

1.18

1.22

mmol/l

3.02

Fungal Sepsis

267

1248

2.34

32.36

10.9

3.3

1.21

1.23

mmol/l

3.35

244

1053

Protozoal diseases

200

832

2.70

32.16

10.3

3.8

1.22

1.23

mmol/l

0.99

191

717

Cholangitis (primary sclerosing, PSC), with reimbursement 202

127

417

3.47

31.91

5.9

4.2

1.23

mmol/l

0.22

120

360

Diabetic retinopathy

1918

8961

1.37

31.86

6.9

4.3

1.22

mmol/l

6.50

1642

7875

Congenital malformations of the urinary system

309

1533

2.16

31.65

13.7

3.7

1.22

1.23

mmol/l

0.43

295

1324

Viral and other specified intestinal infections, including avohilmo

1204

8124

1.46

31.65

5.7

3.4

1.22

1.23

mmol/l

3.83

1078

6961

Zoster [herpes zoster]

1006

6872

1.52

31.51

6.0

3.8

1.23

mmol/l

0.26

921

5900

Cystic kidney disease

200

837

2.65

31.50

16.4

3.9

1.23

mmol/l

0.15

195

726

Urolithiasis

1580

11661

1.39

31.43

4.3

4.2

1.23

1.22

mmol/l

4.25

1400

10095

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

679

4218

1.67

31.29

5.8

3.3

1.22

mmol/l

0.00

598

3502

Other diseases of anus and rectum

1621

11988

1.38

31.02

4.4

3.7

1.22

1.23

mmol/l

1.96

1415

10189

Dermatographic urticaria

354

1857

2.03

30.78

4.1

3.5

1.23

mmol/l

0.30

297

1604

Other and unspecified drugs and medicaments

469

2691

1.85

30.75

6.5

3.8

1.23

mmol/l

0.20

434

2332

Elevated blood glucose level

454

2579

1.87

30.72

6.2

3.9

1.22

1.23

mmol/l

1.35

412

2225

Protozoal diseases, including avohilmo

203

869

2.61

30.61

10.2

3.8

1.22

1.23

mmol/l

0.91

193

749

Congenital malformations of the urinary system, including avohilmo

322

1641

2.10

30.56

13.3

3.7

1.22

1.23

mmol/l

0.31

304

1420

Colitis, primary sclerosing

281

4.02

30.56

5.6

3.3

1.22

1.23

mmol/l

0.72

248

Ulcerative colitis

1129

7906

1.47

30.50

4.4

3.8

1.22

1.23

mmol/l

0.52

1012

6881

Other eating disorders

216

935

2.44

30.45

3.9

3.1

1.22

1.23

mmol/l

0.81

184

797

Papulosquamous disorders

1931

14743

1.34

30.40

3.8

4.0

1.23

mmol/l

0.73

1703

12734

Cutaneous abscess, furuncle and carbuncle

1221

8677

1.45

30.37

6.3

3.7

1.22

1.23

mmol/l

3.77

1102

7540

Other disorders of glucose regulation and pancreatic internal secretion

432

2423

1.88

30.36

7.6

3.8

1.21

1.22

mmol/l

3.47

388

2101

Nontoxic goitre/thyroid nodule

1539

11398

1.39

30.28

4.5

3.8

1.23

mmol/l

6.47

1375

9735

Combinations of oral blood glucose lowering drugs

1372

9970

1.42

30.21

3.9

4.2

1.22

1.23

mmol/l

1.39

1203

8590

Fracture of rib(s), sternum and thoracic spine

1574

11692

1.38

30.09

4.5

4.0

1.22

1.23

mmol/l

3.42

1397

10064

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

178

720

2.74

30.06

16.0

4.0

1.22

mmol/l

0.54

171

626

Cellulitis

1084

7565

1.48

30.00

6.7

3.8

1.22

1.23

mmol/l

3.42

979

6560

Mental and behavioural disorders due to opioids

188

777

2.60

29.78

5.8

3.5

1.21

1.23

mmol/l

3.98

160

669

Maternal care for other conditions predominantly related to pregnancy

812

5203

1.56

29.76

2.7

3.3

1.23

mmol/l

0.11

698

4551

Cardiomyopathy

834

5538

1.56

29.67

5.3

3.6

1.21

1.23

mmol/l

13.41

763

4698

Wet age-related macular degeneration

1024

6854

1.50

29.56

3.6

4.0

1.22

1.23

mmol/l

2.00

839

5846

Malignant neoplasm of colon, including Hilmo

917

6194

1.53

29.54

4.4

3.3

1.22

1.23

mmol/l

0.69

832

5139

Panhypopituitarism

128

444

3.32

29.51

5.5

3.8

1.22

mmol/l

0.39

120

384

Acute alcohol intoxication

1169

8287

1.45

29.49

4.8

4.2

1.21

1.22

mmol/l

10.65

1032

7227

Diabetic retinopathy, strict definition

931

5636

1.54

29.46

8.8

4.2

1.21

1.22

mmol/l

6.79

799

4969

Phobic anxiety disorders

518

3059

1.74

29.35

3.8

3.5

1.22

1.23

mmol/l

0.67

432

2661

Iridocyclitis

1108

7801

1.47

29.31

4.3

3.9

1.23

mmol/l

0.37

975

6754

Diabetic nephropathy

921

6219

1.54

29.25

14.7

3.8

1.20

1.22

mmol/l

14.21

852

5412

155

594

2.89

29.20

4.9

3.7

1.22

1.23

mmol/l

1.30

120

512

Other and unspecified vasculitis limited to skin

169

682

2.81

29.12

5.5

3.5

1.22

1.23

mmol/l

1.20

156

593

Haemorrhage, not elsewhere classified

237

1101

2.34

29.07

7.0

2.9

1.21

1.23

mmol/l

3.53

213

924

Viral and other specified intestinal infections

875

5732

1.53

28.97

6.8

3.4

1.22

1.23

mmol/l

2.60

789

4883

Artrosis, including avohilmo

4010

18131

1.23

28.94

3.6

4.2

1.23

mmol/l

0.14

3495

15755

Injuries to the shoulder and upper arm

4273

27534

1.21

28.91

4.2

4.0

1.23

mmol/l

1.19

3699

23799

Other specified and unspecified personality disorders

416

2341

1.87

28.75

3.9

3.8

1.22

1.23

mmol/l

1.94

358

2033

Calculus of kidney and ureter

1449

10706

1.39

28.70

4.3

4.2

1.23

1.22

mmol/l

3.59

1288

9271

Implicit fungal Sepsis

243

1150

2.31

28.61

11.5

3.3

1.21

1.23

mmol/l

2.88

224

972

Autism spe, excluding more controls

102

307

3.54

28.51

2.7

4.3

1.22

mmol/l

0.20

265

Wide developmental disorders, excluding more controls

123

406

3.12

28.18

3.3

3.9

1.22

mmol/l

0.40

104

352

Radiculopathy

849

5732

1.54

28.18

4.0

3.9

1.22

1.23

mmol/l

1.24

706

4899

Malignant neoplasm of colon

768

5076

1.57

28.17

4.5

3.3

1.22

1.23

mmol/l

0.54

697

4210

Diseases of peritoneum

535

3259

1.73

28.13

11.5

4.0

1.21

1.23

mmol/l

3.80

488

2832

COPD

2301

14706

1.30

28.01

5.0

4.1

1.21

1.23

mmol/l

17.62

2078

12530

Ulcer of lower limb, not elsewhere classified

793

5297

1.56

27.95

10.6

3.8

1.21

1.23

mmol/l

7.15

736

4545

Cystic kidney disease, including avohilmo

207

927

2.45

27.93

16.0

3.8

1.23

mmol/l

0.03

200

798

Primary biliary cholangitis, wide definition

154

606

2.85

27.79

5.2

3.6

1.23

mmol/l

1.13

146

525

Glaucoma suspect

1882

14507

1.33

27.79

4.0

1.23

mmol/l

0.13

1558

12482

Hyperplasia of prostate

1602

6702

1.38

27.72

4.8

4.7

1.22

1.21

mmol/l

0.85

1408

5893

Fitting and adjustment of external prosthetic device

8.44

27.72

17.7

2.8

1.20

1.23

mmol/l

1.37

Abnormal findings on diagnostic imaging of central nervous system

275

1375

2.15

27.68

4.0

3.6

1.22

1.23

mmol/l

0.49

252

1182

Calcific aortic valvular stenosis, including rheumatic fever

1616

11739

1.36

27.67

5.7

4.0

1.22

mmol/l

4.04

1416

10036

Other sleep disorders

534

3254

1.71

27.61

4.2

4.1

1.22

1.23

mmol/l

0.08

466

2806

Calcific aortic valvular stenosis

1612

11723

1.36

27.61

5.7

4.0

1.22

mmol/l

4.02

1412

10023

Calcific aortic valvular stenosis, operated

1612

11723

1.36

27.61

5.7

4.0

1.22

mmol/l

4.02

1412

10023

Operations 2 for CAVS

1611

11717

1.36

27.57

5.7

4.0

1.22

mmol/l

3.96

1411

10018

Calcific aortic valvular stenosis, diagnosis (helper)

1611

11717

1.36

27.57

5.7

4.0

1.22

mmol/l

3.96

1411

10018

Fracture of femur

1495

10052

1.38

27.51

5.1

3.9

1.22

1.23

mmol/l

1.16

1323

8525

Sicca syndrome [Sjögren]

468

2775

1.79

27.47

3.8

1.23

1.24

mmol/l

1.65

406

2387

Ovarian cyst

1601

6816

1.37

27.42

3.7

3.5

1.23

mmol/l

0.54

1378

5811

Hypoglycaemia, other or unspecified

348

1891

1.95

27.22

7.5

3.9

1.21

1.22

mmol/l

2.25

313

1634

Varicose veins

3107

19132

1.25

27.18

4.1

3.8

1.23

mmol/l

0.64

2690

16409

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1109

4901

1.45

27.12

2.8

3.0

1.22

1.23

mmol/l

1.68

949

4225

Any dementia, excluding more controls

1994

10603

1.32

27.12

3.5

4.0

1.23

mmol/l

1.65

1669

9033

Crohn's disease NAS

319

1690

2.00

26.94

4.6

3.6

1.22

1.23

mmol/l

0.51

288

1462

Rare circulating lymphoid malignancy, including Hilmo

164

671

2.68

26.93

9.0

3.2

1.23

1.22

mmol/l

0.59

158

575

Other abnormal uterine and vaginal bleeding

1132

5784

1.45

26.93

3.5

3.6

1.24

1.23

mmol/l

0.21

978

4942

L04AC Interleukin inhibitors

318

1683

2.00

26.91

3.0

3.8

1.23

mmol/l

0.46

288

1468

Persons encountering health services for specific procedures, not carried out

414

2374

1.83

26.85

5.7

2.7

1.21

1.23

mmol/l

8.62

364

2008

Acute and subacute iridocyclitis

917

6344

1.49

26.77

4.5

4.0

1.23

mmol/l

0.69

804

5522

Other infectious diseases

407

2337

1.85

26.67

9.1

3.8

1.22

mmol/l

0.51

383

2007

Migraine without aura

771

5134

1.54

26.63

3.6

3.5

1.23

mmol/l

1.85

682

4433

Disorders of skin appendages

2265

17839

1.29

26.55

4.9

3.7

1.23

mmol/l

0.50

1967

15406

Follicular lymphoma, hilmo

261

1311

2.18

26.50

8.2

4.0

1.23

mmol/l

1.43

251

1125

Unspecific neurodegenerative disorder

2340

12701

1.29

26.44

3.0

4.2

1.23

mmol/l

2.89

1896

10907

Mental and behavioural disorders due to sedatives or hypnotics

329

1771

1.96

26.43

4.5

3.8

1.21

1.23

mmol/l

4.04

282

1540

Testicular hypofunction

178

762

2.52

26.25

5.7

3.8

1.22

mmol/l

0.22

162

683

Generalized anxiety disorder

648

4166

1.60

26.23

3.2

3.5

1.23

mmol/l

0.45

538

3614

Diseases of male genital organs

2094

8167

1.31

26.19

5.0

4.5

1.22

mmol/l

0.26

1846

7207

DVT of lower extremities

957

6707

1.48

26.17

5.7

3.8

1.23

mmol/l

0.07

846

5769

Diabetic maculopathy

689

4291

1.60

26.03

9.0

4.3

1.21

1.22

mmol/l

7.82

590

3796

Other embolism and thrombosis

653

4246

1.60

26.00

6.9

3.8

1.22

1.23

mmol/l

2.57

590

3667

Alzheimer’s disease (Atypical or mixed)

661

4265

1.61

25.96

3.5

3.8

1.23

1.22

mmol/l

4.72

536

3667

Maltreatment syndromes

239

1156

2.19

25.95

3.7

3.3

1.22

1.23

mmol/l

2.39

210

995

Cirrhosis of liver, NAS

314

1687

2.01

25.92

6.5

4.2

1.20

1.22

mmol/l

7.46

300

1467

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

727

4842

1.56

25.92

5.9

4.4

1.20

1.22

mmol/l

13.15

683

4227

Misadventures to patients during surgical and medical care

737

4923

1.56

25.88

6.4

3.7

1.22

1.23

mmol/l

1.64

686

4230

Colorectal adenocarcinoma

972

6747

1.47

25.88

4.6

3.3

1.22

1.23

mmol/l

1.03

873

5609

Other obstetric conditions, not elsewhere classified

1128

5054

1.44

25.85

2.8

3.0

1.22

1.23

mmol/l

2.00

966

4368

Parkinson's disease, excluding more controls

669

4012

1.59

25.78

3.1

4.0

1.23

mmol/l

0.23

563

3385

Vitreous haemorrhage

529

3286

1.69

25.78

8.5

4.3

1.22

1.23

mmol/l

2.66

472

2851

Etanercept

326

1768

1.95

25.68

3.0

3.8

1.23

mmol/l

0.37

300

1535

Other ulcerative colitis

290

1515

2.03

25.63

5.7

3.6

1.23

mmol/l

0.10

270

1303

Molar incisor enamel hypoplasia, with caries

7.15

25.57

21.4

7.2

1.24

1.23

mmol/l

0.18

Squamous cell neoplasms and carcinomas of the skin

536

3344

1.68

25.49

6.0

3.2

1.22

mmol/l

0.07

476

2773

Ulcerative colitis (strict) with PSC

142

5.10

25.45

5.5

3.6

1.22

1.23

mmol/l

0.56

127

Behavioural syndromes associated with physiological disturbances and physical factors

4529

25985

1.19

25.30

3.5

4.0

1.23

mmol/l

1.16

3916

22474

Other chronic obstructive pulmonary disease, including avohilmo

2724

18164

1.26

25.24

4.7

4.1

1.22

1.23

mmol/l

15.12

2424

15547

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

2852

21194

1.24

25.12

4.9

3.7

1.23

mmol/l

0.96

2519

18314

Vasculitis limited to skin, not elsewhere classified

177

781

2.53

25.06

5.5

3.4

1.22

1.23

mmol/l

1.02

163

675

Adverse effects, not elsewhere classified

897

6252

1.48

25.05

4.4

3.8

1.23

mmol/l

1.12

770

5410

Urticaria and erythema

1645

12618

1.33

24.93

4.7

3.7

1.23

mmol/l

1.56

1416

10902

Aortic aneurysm

1170

8393

1.41

24.77

5.1

3.9

1.22

mmol/l

2.77

1042

7236

Disorders of ocular muscles, binocular movement, accommodation and refraction

2160

16999

1.28

24.76

4.6

3.8

1.23

mmol/l

0.17

1839

14735

Eosinophilia

117

427

3.15

24.73

4.9

3.6

1.22

1.23

mmol/l

0.15

103

367

Other follicular disorders

359

2027

1.86

24.69

6.0

3.6

1.23

mmol/l

0.06

317

1756

Other specified disorders of kidney and ureter

196

905

2.38

24.68

10.5

3.7

1.22

1.23

mmol/l

0.42

174

784

Adalimumab

446

2675

1.74

24.60

2.9

4.0

1.23

mmol/l

0.20

398

2326

Eating disorder

344

1908

1.87

24.55

3.6

2.9

1.22

1.23

mmol/l

0.33

292

1608

Mouth breathing

1749

13541

1.32

24.55

4.1

4.2

1.22

1.23

mmol/l

0.48

1478

11839

IBD (strict) with PSC

181

4.42

24.52

6.2

3.6

1.22

1.23

mmol/l

0.88

160

Other diseases of hard tissues of teeth

2724

11391

1.26

24.44

4.2

3.6

1.23

mmol/l

0.38

2328

9816

L02BB Anti-androgens

486

3000

1.71

24.38

6.6

4.4

1.21

mmol/l

0.78

449

2597

Migraine with aura and triptan purchases

655

4303

1.57

24.38

2.8

3.5

1.23

mmol/l

0.17

583

3741

Ascites

410

2422

1.79

24.36

6.7

3.9

1.20

1.23

mmol/l

12.35

391

2048

Sciatica+with lumbago

2455

17517

1.26

24.35

3.7

3.9

1.23

mmol/l

0.26

2151

15117

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

330

1828

1.91

24.34

4.8

3.1

1.21

1.22

mmol/l

2.59

304

1537

Graves disease, strict definition

488

3009

1.70

24.33

3.9

3.6

1.22

1.23

mmol/l

2.61

426

2612

Fracture of lumbar spine and pelvis

1198

8815

1.40

24.25

5.2

3.9

1.22

1.23

mmol/l

2.39

1051

7532

Non-allergic asthma (mode), excluding more controls

844

5792

1.48

24.18

3.8

3.0

1.23

mmol/l

2.72

734

4783

Hyperfunction of pituitary gland

237

1177

2.14

24.17

5.2

2.9

1.23

mmol/l

0.61

213

1004

Unspecified misadventure during surgical and medical care

321

1776

1.93

24.11

5.7

3.8

1.22

1.23

mmol/l

0.14

309

1535

Other and unspecified tonsillitis

1237

7560

1.38

24.05

4.4

3.6

1.22

mmol/l

1.53

1068

6574

Hernia of abdominal wall

2189

17498

1.28

24.02

5.4

4.0

1.22

1.23

mmol/l

5.23

1919

15140

Unstable angina pectoris

1818

11129

1.31

23.96

4.8

3.9

1.22

1.23

mmol/l

9.83

1650

9410

Secondary polycythaemia

150

626

2.66

23.91

4.4

4.1

1.22

mmol/l

0.28

133

541

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

268

1398

2.04

23.90

5.1

3.1

1.21

1.22

mmol/l

2.73

249

1171

Anterior Iridocyclitis

957

6818

1.45

23.84

4.4

4.0

1.23

mmol/l

0.63

841

5947

Arthropathies in other diseases classified elsewhere

206

984

2.27

23.66

11.7

3.5

1.21

1.23

mmol/l

2.05

183

837

Malignant neoplasm of small intestine, including Hilmo

173

771

2.45

23.63

5.9

3.2

1.22

mmol/l

1.19

166

644

Sleep disorders

4348

25461

1.19

23.63

3.4

4.0

1.23

mmol/l

1.40

3758

22015

Colitis, primary sclerosing, strict definition

205

4.11

23.55

4.7

3.7

1.21

1.23

mmol/l

2.09

184

Eating disorders

418

2487

1.74

23.39

3.7

3.1

1.22

1.23

mmol/l

0.35

353

2110

Carcinoma in situ of skin of other and unspecified parts of face

512

3246

1.67

23.35

5.9

3.9

1.22

1.23

mmol/l

0.14

424

2773

Testicular dysfunction

189

873

2.31

23.29

5.5

3.7

1.22

mmol/l

0.26

171

782

Mental and behavioural disorders due to use of other stimulants, including caffeine

130

507

2.75

23.28

3.5

3.6

1.20

1.23

mmol/l

3.68

115

444

Hypogonadotropic hypogonadism

153

649

2.54

23.13

4.4

4.5

1.22

mmol/l

1.23

140

580

Other (seronegative) rheumatoid arthritis, wide

954

6846

1.44

23.00

4.1

3.9

1.23

mmol/l

0.45

876

5863

Ulcerative colitis (strict definition, require KELA)

719

4885

1.52

22.96

4.1

4.0

1.22

1.23

mmol/l

0.38

641

4280

Benign paroxysmal vertigo

1516

11666

1.33

22.95

4.0

3.9

1.23

mmol/l

0.87

1301

10030

Fall on same level involving ice and snow

2807

23120

1.23

22.95

4.2

3.9

1.23

mmol/l

1.21

2439

19932

Use of pramipexole

1118

8239

1.40

22.91

4.7

4.0

1.23

mmol/l

0.95

946

7082

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

696

4703

1.53

22.84

4.1

4.0

1.22

1.23

mmol/l

0.37

622

4121

Excessive attrition of teeth

2753

22408

1.23

22.78

3.9

1.23

mmol/l

0.19

2337

19475

Cardiomyopathies, Primary/intrinsic

566

3676

1.60

22.61

5.0

3.6

1.21

1.23

mmol/l

9.58

516

3142

Other and unspecified disorders of white blood cells

227

1145

2.14

22.61

5.8

3.7

1.21

1.23

mmol/l

2.91

203

975

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1280

9645

1.37

22.54

3.7

3.9

1.23

mmol/l

0.51

1184

8236

Vitamin D deficiency

120

463

2.88

22.48

5.7

3.5

1.21

1.23

mmol/l

2.18

109

397

Osteonecrosis

339

1949

1.85

22.35

9.8

3.7

1.23

mmol/l

0.63

319

1677

Deforming dorsopathies

1321

9995

1.35

22.24

3.8

3.9

1.23

mmol/l

0.11

1160

8555

Autoimmune hyperthyroidism

298

1644

1.91

22.22

3.9

3.7

1.22

1.23

mmol/l

2.59

270

1411

Vitamin deficiency

257

1357

2.02

22.19

5.3

3.5

1.22

1.23

mmol/l

2.31

233

1152

Vitamin deficiency, wide

257

1357

2.02

22.19

5.3

3.5

1.22

1.23

mmol/l

2.31

233

1152

Lung cancer and mesothelioma

973

5949

1.43

22.17

5.6

3.3

1.23

mmol/l

0.34

919

4912

Other and unspecified myopathies

461

2879

1.68

22.11

5.7

4.0

1.21

1.22

mmol/l

3.64

411

2491

Normotensive glaucoma

503

3220

1.65

22.06

4.0

3.8

1.23

mmol/l

0.03

404

2730

Nonischemic cardiomyopathy

492

3116

1.65

22.01

5.2

3.8

1.21

1.23

mmol/l

5.91

451

2672

Intentional self-harm by sharp object

126

499

2.72

22.00

4.0

3.3

1.22

1.23

mmol/l

0.37

110

434

Nontoxic single thyroid nodule

373

2209

1.78

22.00

4.4

3.6

1.23

mmol/l

0.08

340

1908

Disorders of refraction and accommodation

1223

9129

1.36

21.92

4.8

3.8

1.23

mmol/l

0.34

1025

7957

Diverticular disease of intestine

3550

18582

1.21

21.92

4.7

3.8

1.23

mmol/l

0.87

3126

15902

Gonarthrosis, primary, with knee surgery

2999

19408

1.22

21.91

3.4

4.1

1.23

mmol/l

1.58

2545

16697

Disorders of lacrimal system

2216

17631

1.26

21.87

4.3

3.8

1.23

mmol/l

1.08

1919

15162

Cardiomyopathy (excluding other)

580

3817

1.58

21.82

5.0

3.6

1.21

1.23

mmol/l

10.19

529

3266

Benign neoplasm: Pituitary gland, craniopharyngeal duct

268

1445

1.98

21.74

3.8

1.23

mmol/l

0.05

243

1245

Other/unspecified seropositive rheumatoid arthritis

1293

9810

1.35

21.72

3.7

3.9

1.23

mmol/l

0.49

1194

8377

Other and unspecified glaucoma

397

2406

1.75

21.64

4.7

3.8

1.23

mmol/l

0.29

351

2055

IgA nephropathy (IgA glomerulonephritis)

139

587

2.61

21.58

17.2

4.2

1.22

mmol/l

0.05

133

516

Asthma mixed form (mode), excluding more controls

247

1293

2.01

21.58

3.7

3.1

1.23

mmol/l

0.15

232

1081

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1103

6694

1.39

21.56

5.7

3.3

1.23

1.22

mmol/l

0.57

1039

5548

Emphysema

386

2319

1.75

21.54

4.5

4.3

1.21

1.22

mmol/l

1.89

339

1995

Chronic periodontitis, complicated

2740

22098

1.23

21.53

4.7

4.0

1.23

mmol/l

0.25

2382

19114

Seropositive rheumatoid arthritis, wide

1305

9928

1.35

21.50

3.7

3.9

1.23

mmol/l

0.51

1205

8473

Other chronic obstructive pulmonary disease

2160

14254

1.26

21.50

5.1

4.1

1.21

1.23

mmol/l

17.91

1959

12141

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

764

5323

1.48

21.43

4.0

1.22

1.23

mmol/l

0.53

675

4659

Transport accidents

2114

14137

1.26

21.33

3.8

3.7

1.23

mmol/l

1.40

1872

12294

Abnormal findings on examination of urine, without diagnosis

235

1223

2.06

21.31

10.5

3.8

1.22

mmol/l

0.10

223

1054

Ulcerative colitis, NAS

612

4094

1.54

21.21

4.8

3.9

1.22

1.23

mmol/l

0.92

551

3537

Endocarditis

197

965

2.20

21.16

9.7

3.5

1.21

1.23

mmol/l

3.45

182

822

Gonarthrosis,primary

4444

23016

1.18

21.13

3.8

4.1

1.23

mmol/l

0.17

3857

19929

Diseases of the myoneural junction and muscle

610

4098

1.55

21.01

5.5

4.1

1.21

1.23

mmol/l

3.64

542

3567

Valvular operations

666

4548

1.51

20.93

4.6

3.5

1.21

1.23

mmol/l

7.80

588

3854

Excessive, frequent and irregular menstruation

1686

7002

1.31

20.92

3.6

3.5

1.23

mmol/l

0.11

1468

5960

Dentofacial anomalies [including malocclusion]

3140

20565

1.21

20.91

3.5

3.8

1.23

mmol/l

0.49

2678

17839

Chronic diseases of tonsils and adenoids

2566

19637

0.81

20.88

3.9

4.0

1.23

mmol/l

0.10

2246

16962

Type 1 diabetes, definitions combined

350

2044

1.76

20.87

4.2

3.4

1.22

1.23

mmol/l

0.79

298

1766

Acute pharyngitis

571

3728

1.55

20.81

4.6

3.6

1.22

mmol/l

0.16

506

3208

Obsessive-compulsive disorder

256

1367

1.94

20.77

2.6

3.2

1.22

1.23

mmol/l

0.61

215

1177

Impingement syndrome of shoulder

556

8293

0.65

20.68

4.1

4.0

1.23

mmol/l

0.49

498

7182

Endometriosis

1496

6687

1.33

20.68

3.2

3.5

1.23

mmol/l

0.28

1257

5713

Thyroiditis, ILD-related definition

532

3479

1.59

20.64

3.8

3.6

1.23

mmol/l

0.34

452

2968

Spondylopathies (FG)

583

3882

1.55

20.60

3.9

3.8

1.23

mmol/l

0.01

517

3335

Non-small cell lung cancer, including Hilmo

713

4634

1.49

20.59

5.5

3.3

1.23

1.22

mmol/l

2.39

671

3862

Superficial injury of abdomen, lower back and pelvis

722

5019

1.48

20.59

4.2

3.8

1.22

1.23

mmol/l

1.48

642

4350

Fracture of shoulder and upper arm

1770

14041

1.28

20.59

4.6

3.9

1.23

mmol/l

2.07

1555

12037

Pleural plaque

484

3112

1.63

20.58

3.7

4.0

1.21

1.22

mmol/l

2.85

412

2659

Other specified/unspecified inflammatory spondylopathies

224

1155

2.05

20.58

4.7

3.6

1.22

1.23

mmol/l

0.81

195

985

Other disorders starting during childhood or adolecense, excluding more controls

145

594

2.42

20.57

5.1

3.5

1.23

1.22

mmol/l

0.24

129

515

Type 1 diabetes, strict (exclude DM2)

348

2038

1.76

20.56

4.2

3.5

1.22

1.23

mmol/l

0.76

297

1762

Functional dyspepsia

1318

10099

1.34

20.49

4.0

3.6

1.23

mmol/l

0.65

1176

8615

Parkinson's disease, strict definition, excluding more controls

608

3812

1.54

20.47

2.9

4.0

1.23

mmol/l

0.14

512

3218

Pain and other conditions associated with female genital organs and menstrual cycle

863

5148

1.43

20.46

2.8

3.3

1.23

mmol/l

0.28

725

4412

Primary biliary cholangitis (PBC)

135

578

2.58

20.42

5.4

3.6

1.23

mmol/l

0.92

130

501

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

104

5.58

20.30

6.6

2.8

1.22

1.23

mmol/l

0.32

Malignant neoplasm of bladder, including Hilmo

534

3459

1.58

20.30

4.9

3.4

1.22

mmol/l

0.58

473

2912

Non-allergic asthma (mode)

844

5987

1.43

20.24

3.8

3.2

1.23

mmol/l

1.71

734

4970

Folate deficiency anaemia

254

3.57

20.23

6.9

4.1

1.21

1.23

mmol/l

1.52

223

Spondyloarthritis

788

5581

1.45

20.19

4.9

3.9

1.22

1.23

mmol/l

0.77

708

4817

Childhood asthma (age<16), excluding more controls

398

1874

1.69

20.19

3.2

2.7

1.23

mmol/l

0.02

347

1597

Injuries to the knee and lower leg

5790

27443

1.15

20.10

4.3

3.8

1.23

mmol/l

0.56

5069

23618

Personal history of certain other diseases

101

376

2.92

20.06

4.3

2.7

1.21

1.23

mmol/l

2.30

309

Myeloproliferative diseases

436

2756

1.67

20.05

3.5

4.0

1.22

1.23

mmol/l

2.76

378

2388

Disorders of vitreous body and globe

2583

20245

1.23

20.04

4.8

4.0

1.23

mmol/l

0.47

2247

17400

Later onset COPD, excluding more controls

1098

6247

1.38

19.98

4.9

3.3

1.21

1.23

mmol/l

13.93

988

5140

Somatoform disorder

726

5082

1.47

19.96

3.8

3.7

1.22

1.23

mmol/l

1.98

638

4433

Other obstructive and reflux uropathy

213

1093

2.07

19.95

9.2

2.8

1.22

1.23

mmol/l

0.21

191

916

Colectomy operation

842

6071

1.43

19.87

5.2

4.0

1.22

1.23

mmol/l

1.16

765

5220

Other Crohn's disease

308

1774

1.82

19.86

4.8

3.5

1.23

mmol/l

0.58

266

1537

Superficial injury of hip and thigh

765

5418

1.46

19.81

4.4

3.9

1.22

1.23

mmol/l

0.47

677

4639

Crohn's disease of small intestine

312

1806

1.81

19.79

4.9

3.4

1.23

mmol/l

0.10

284

1560

Total colectomy

211

1086

2.08

19.74

6.6

3.9

1.22

1.23

mmol/l

0.93

194

941

Total colectomy operation

211

1086

2.08

19.74

6.6

3.9

1.22

1.23

mmol/l

0.93

194

941

Right side

178

4.57

19.73

3.4

4.5

1.24

1.23

mmol/l

0.72

159

Non-Hodgkin lymphoma, all

231

1227

2.01

19.68

12.6

3.2

1.23

1.22

mmol/l

1.78

224

1028

Benign neoplasm: Adrenal gland

406

2535

1.69

19.68

3.8

4.2

1.23

mmol/l

0.45

379

2208

Other arthrosis

2469

13604

1.23

19.59

3.9

3.8

1.23

mmol/l

0.33

2153

11715

Hypertensive Heart Disease

1062

5983

1.38

19.58

6.6

3.4

1.22

1.23

mmol/l

3.28

962

4941

Coeliac disease

558

3731

1.55

19.57

4.6

3.7

1.22

1.23

mmol/l

2.46

493

3204

Other disorders of lacrimal gland

1809

14508

1.27

19.49

4.5

3.8

1.23

mmol/l

1.46

1565

12476

Ventral hernia

1196

9116

1.35

19.48

5.5

3.9

1.22

1.23

mmol/l

2.29

1050

7823

Malignant melanoma

702

4912

1.48

19.46

5.3

3.2

1.23

mmol/l

0.76

613

4089

Intussusception

137

605

2.50

19.34

3.4

1.23

1.24

mmol/l

0.24

128

507

Disorders of vitreous body

2511

19823

1.23

19.27

4.8

4.0

1.23

mmol/l

0.40

2189

17041

Shoulder lesions

3611

18412

1.19

19.25

3.8

3.9

1.23

mmol/l

0.19

3183

15884

Osteomyelitis

321

1894

1.79

19.23

11.7

3.7

1.21

1.22

mmol/l

1.63

302

1625

Injuries to the neck

1004

7464

1.38

19.17

3.5

3.9

1.22

1.23

mmol/l

0.44

863

6500

Fracture of forearm

2663

19937

1.22

19.17

4.3

3.8

1.23

mmol/l

1.98

2281

17166

Hyperaldosteronism

163

776

2.29

19.13

6.0

3.8

1.22

mmol/l

0.24

150

668

Mantle cell lymphoma, including Hilmo

339

3.07

19.07

10.0

3.5

1.23

1.22

mmol/l

0.97

283

Any dementia

2137

12044

1.25

19.04

3.5

4.1

1.23

mmol/l

2.20

1785

10300

Childhood asthma (age<16)

398

1905

1.66

19.00

3.2

2.7

1.23

mmol/l

0.04

347

1626

Tubulo-interstitial nephritis, not specified as acute or chronic

338

2026

1.75

18.99

7.4

2.9

1.22

1.23

mmol/l

2.29

295

1693

Insomnia

4204

25250

1.17

18.98

3.3

4.0

1.23

mmol/l

1.25

3634

21827

Malignant neoplasm of testis, including Hilmo

336

2.98

18.97

5.7

3.1

1.23

1.22

mmol/l

1.90

283

Myalgia

1081

8138

1.36

18.96

3.8

3.7

1.23

mmol/l

1.13

950

7006

severe traumatic brain injury, does not include concussion

1097

8291

1.36

18.95

4.4

4.1

1.22

mmol/l

4.04

945

7138

FESS (DNB20)

558

3759

1.54

18.87

4.1

1.23

mmol/l

0.17

472

3282

Malignant neoplasm of breast, HER-negative

918

6491

1.40

18.77

3.7

2.9

1.24

mmol/l

0.35

804

5331

Mental and behavioural disorders due to cannabinoids

124

524

2.51

18.76

2.3

3.7

1.22

1.23

mmol/l

0.50

461

Mixed disorders of conduct and emotions, excluding more controls

248

3.23

18.75

3.9

2.9

1.22

mmol/l

0.05

212

Autoimmune hepatitis, wide definition

223

1189

1.99

18.69

5.3

3.5

1.22

1.23

mmol/l

1.42

208

1031

Malignant neoplasm of breast, ER-negative, including Hilmo

984

6850

1.38

18.68

3.7

2.9

1.24

mmol/l

0.36

862

5635

Complications of internal orthopaedic prosthetic devices, implants and grafts

1160

8867

1.34

18.63

4.7

3.7

1.23

mmol/l

1.56

1045

7481

Asthma mixed form (mode)

247

1361

1.90

18.52

3.7

3.3

1.23

mmol/l

0.40

232

1137

Carcinoid syndrome

265

3.46

18.49

5.7

3.6

1.22

mmol/l

0.20

223

Assault

511

3385

1.55

18.47

4.7

3.9

1.22

1.23

mmol/l

2.13

450

2978

Keratitis

1637

13053

1.28

18.46

4.7

3.9

1.22

1.23

mmol/l

1.28

1442

11252

Hypoplasia of dental enamel

5.37

18.39

25.5

8.3

1.24

mmol/l

0.13

Lung transplant status

182

4.01

18.37

12.9

4.9

1.22

mmol/l

0.20

161

Immunodeficiencies

235

1284

1.95

18.37

9.4

3.9

1.22

1.23

mmol/l

0.66

221

1106

Lung transplantation

182

4.00

18.36

12.9

4.9

1.22

mmol/l

0.20

161

Disturbances of skin sensation

1223

9412

1.33

18.35

3.6

3.7

1.23

mmol/l

1.27

1094

8138

Left ventricular outflow tract obstruction (LVOTO), broad definition

425

2716

1.63

18.34

5.7

4.5

1.22

mmol/l

2.55

384

2392

Disorders of adrenal gland, other and/or unspecified

131

4.76

18.33

4.8

2.9

1.23

mmol/l

0.20

106

Disorders of vestibular function (Vertigo)

2333

18833

1.23

18.23

3.8

3.9

1.23

mmol/l

0.65

2006

16188

Budesonide

612

4221

1.49

18.23

3.8

3.6

1.23

mmol/l

0.22

547

3587

Other viral diseases, not elsewhere classified

758

5413

1.43

18.20

6.5

3.8

1.23

mmol/l

0.13

692

4732

Polyglandular dysfunction

8.44

18.16

18.5

3.1

1.21

1.23

mmol/l

0.57

Mental retardation, excluding more controls

153

690

2.26

18.15

4.6

4.4

1.24

1.23

mmol/l

0.91

137

607

Malignant melanoma, including Hilmo

776

5595

1.43

18.15

5.4

3.2

1.23

mmol/l

0.79

679

4664

Fitting and adjustment of other devices

1734

12258

1.27

18.14

3.3

3.0

1.23

mmol/l

0.63

1647

10150

Aortic valve malfunction, age under 60 years

400

2528

1.65

18.14

5.7

4.5

1.22

mmol/l

2.42

362

2228

Giant cell arteritis

248

1392

1.92

18.12

4.7

3.9

1.22

1.23

mmol/l

0.51

229

1180

Cushing syndrome

300

3.18

17.99

4.7

3.0

1.23

mmol/l

0.11

253

Fentanyl

522

3498

1.54

17.98

8.3

3.4

1.23

mmol/l

0.28

495

2904

Myocardial infarction, without ST-elevation

2008

14810

1.25

17.96

5.9

4.0

1.21

1.23

mmol/l

13.33

1804

12649

Extrapyramidal and movement disorders

1915

15604

1.25

17.92

3.6

4.0

1.23

mmol/l

0.01

1618

13424

Carpal tunnel syndrome

2925

21443

1.20

17.74

3.8

3.9

1.23

mmol/l

0.94

2549

18443

Septal defects

263

1464

1.84

17.74

3.9

4.1

1.22

1.23

mmol/l

0.86

245

1266

Menorrhagia

1487

6499

1.30

17.72

3.5

1.24

1.23

mmol/l

0.37

1275

5547

Pleural plaque with presence of asbestos

370

2320

1.68

17.70

3.8

4.5

1.21

1.22

mmol/l

1.62

317

2022

Myocardial infarction, strict

2100

12177

1.24

17.65

5.8

3.8

1.22

1.23

mmol/l

21.32

1882

10341

Mucosal proctocolitis

526

3546

1.53

17.62

3.6

3.8

1.22

1.23

mmol/l

0.62

473

3069

Amenorrhoea

266

1517

1.82

17.59

4.4

3.0

1.22

1.23

mmol/l

0.65

241

1301

Ethmoidectomy

572

3928

1.51

17.59

4.0

4.1

1.23

mmol/l

0.09

483

3434

Pneumonitis due to solids and liquids

413

2655

1.62

17.53

5.6

4.0

1.21

1.22

mmol/l

2.93

374

2292

Isolated proteinuria

153

735

2.25

17.48

12.6

3.7

1.22

mmol/l

0.21

146

627

Traumatic subarachnoid haemorrhage

195

1020

2.03

17.41

4.0

4.1

1.22

1.23

mmol/l

0.43

168

867

L01XX Other antineoplastic agents

318

1933

1.75

17.35

4.7

4.0

1.22

1.23

mmol/l

2.32

277

1673

Seropositive rheumatoid arthritis, strict definition

719

5171

1.44

17.28

3.5

3.9

1.23

mmol/l

1.07

659

4459

Malignant neoplasm of respiratory system and intrathoracic organs

966

6000

1.37

17.27

5.6

3.3

1.23

1.22

mmol/l

1.19

915

4963

Intentional self-harm by unspecified means

248

3.24

17.26

3.3

2.6

1.22

1.23

mmol/l

0.62

214

Thoracic aortic aneurysm

692

4947

1.45

17.25

5.0

3.9

1.22

mmol/l

0.73

617

4307

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1045

7836

1.34

17.19

4.8

3.5

1.23

mmol/l

0.07

894

6819

Unspecified acute lower respiratory infection

679

4829

1.45

17.17

5.1

3.8

1.22

mmol/l

2.67

635

4210

Temporomandibular joint disorders, including avohilmo

1904

15047

1.24

17.16

3.3

3.7

1.23

mmol/l

0.07

1628

12997

Redundant prepuce, phimosis and paraphimosis

789

5650

1.40

17.14

5.1

4.5

1.22

mmol/l

0.24

703

4981

Pain in thoracic spine

700

5007

1.44

17.13

3.9

3.8

1.23

mmol/l

0.09

630

4313

Alcohol abuse, main dg

650

4590

1.46

17.09

4.7

4.2

1.21

1.22

mmol/l

8.59

578

4030

Myeloproliferative diseases (CML excluded)

391

2505

1.64

17.08

3.4

4.0

1.22

1.23

mmol/l

2.10

335

2174

Crohn's disease of large intestine

234

1305

1.89

17.01

5.7

3.6

1.22

1.23

mmol/l

1.00

208

1123

Other and unspecified types of non-Hodgkin lymphoma, hilmo

229

1278

1.92

16.97

8.4

4.1

1.23

1.22

mmol/l

0.20

219

1096

Urticaria

1274

9962

1.30

16.88

4.3

3.7

1.23

mmol/l

1.09

1082

8639

Chronic myeloproliferative disease

382

2.83

16.80

3.8

4.0

1.20

1.23

mmol/l

4.20

327

Disorders of synovium and tendon

2456

17432

1.21

16.80

4.0

3.9

1.23

mmol/l

0.60

2107

15025

Nonorganic sleeping disorders

908

6787

1.37

16.78

4.0

3.8

1.22

1.23

mmol/l

1.32

798

5903

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

234

1312

1.88

16.76

4.9

3.1

1.21

1.22

mmol/l

1.23

215

1106

Congenital malformations of cardiac septa

272

1539

1.79

16.65

4.1

1.22

1.23

mmol/l

0.72

254

1331

Focal epilepsy

941

7085

1.36

16.62

4.2

4.1

1.21

1.23

mmol/l

8.84

874

6119

Simple and mucopurulent chronic bronchitis

212

1158

1.94

16.59

4.0

1.23

1.22

mmol/l

0.04

182

984

Unspecified nephritic syndrome

128

587

2.39

16.57

11.0

3.7

1.22

1.23

mmol/l

0.87

120

504

Other viral diseases, not elsewhere classified, including avohilmo

1071

8151

1.33

16.56

5.5

3.6

1.23

mmol/l

0.03

974

7096

Malignant neoplasm of bronchus and lung, including Hilmo

963

6054

1.36

16.51

5.6

3.3

1.23

1.22

mmol/l

1.32

908

5018

Diabetes mellitus in pregnancy

1092

5278

1.33

16.48

3.0

3.2

1.22

1.23

mmol/l

4.10

912

4622

Idiopathic pulmonary fibrosis

398

2581

1.62

16.47

4.3

4.1

1.21

1.22

mmol/l

1.70

364

2232

Injuries to the ankle and foot

3201

23424

1.18

16.46

4.2

3.9

1.22

1.23

mmol/l

2.83

2772

20290

Other blood glucose lowering drugs, excl. Insulins

758

5544

1.41

16.46

5.4

4.0

1.22

1.23

mmol/l

3.44

652

4741

Malignant neoplasm of pancreas, including Hilmo

405

2630

1.60

16.44

5.7

3.1

1.22

1.23

mmol/l

0.73

376

2201

Visual disturbances

2310

19325

1.21

16.41

4.2

3.9

1.22

1.23

mmol/l

3.73

2055

16606

Malignant neoplasm of head and neck, including Hilmo

428

2810

1.58

16.40

5.0

3.2

1.23

1.22

mmol/l

0.40

396

2367

Benign neoplasm of thyroid gland

184

969

2.05

16.40

4.8

3.5

1.22

1.23

mmol/l

0.96

166

835

SLE (Finngen)

169

861

2.09

16.32

5.4

3.5

1.23

mmol/l

1.04

160

735

Fracture of foot, except ankle

1069

8212

1.33

16.31

4.5

3.9

1.22

1.23

mmol/l

2.15

923

7142

Impotence

260

1516

1.80

16.28

6.5

4.7

1.21

mmol/l

0.71

231

1349

Herpesviral [herpes simplex] infections

537

3701

1.50

16.28

7.5

3.6

1.22

1.23

mmol/l

2.50

488

3186

Other noninflammatory disorders of uterus, except cervix

1046

5317

1.35

16.25

3.8

3.7

1.24

mmol/l

0.37

910

4548

Crystal arthropathies, rheuma endpoint

126

581

2.40

16.23

5.1

3.6

1.22

1.23

mmol/l

0.63

115

480

Memory loss

169

3159

0.51

16.21

4.0

1.23

mmol/l

0.18

147

2747

Manic episode

149

727

2.19

16.18

4.7

3.9

1.24

1.23

mmol/l

1.60

130

630

Malignant neoplasm of rectum, including Hilmo

538

3713

1.50

16.18

4.6

3.3

1.22

mmol/l

1.00

472

3104

Other diseases of spinal cord

164

833

2.12

16.15

5.3

4.0

1.22

1.23

mmol/l

0.99

137

720

Other problems related to primary support group, including family circumstances

421

2680

1.57

16.11

6.1

3.5

1.23

mmol/l

0.13

368

2313

Secondary right heart disease

225

1268

1.89

16.11

5.4

3.5

1.21

1.23

mmol/l

2.31

205

1077

Unspecified jaundice

246

1418

1.83

16.07

5.1

3.8

1.22

1.23

mmol/l

0.63

223

1197

Other diseases of oesophagus

472

3186

1.54

16.02

5.1

4.0

1.22

1.23

mmol/l

1.21

416

2720

Malignant neoplasm of stomach, including Hilmo

277

1649

1.76

16.02

4.9

3.2

1.22

mmol/l

0.54

256

1389

Malignant neoplasm of stomach

247

1427

1.82

15.94

4.6

3.2

1.22

mmol/l

0.60

228

1200

Hypertrophy of breast

752

5513

1.40

15.94

3.3

3.4

1.23

mmol/l

0.11

633

4767

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2406

19506

1.21

15.93

3.9

4.1

1.22

1.23

mmol/l

0.94

2102

16889

Ulcerative rectosigmoiditis

352

2227

1.64

15.93

4.2

3.7

1.23

mmol/l

0.07

320

1933

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

293

1773

1.72

15.88

4.9

3.6

1.22

1.23

mmol/l

2.58

265

1526

Oxicams

1119

4873

1.33

15.88

3.2

4.9

1.23

1.22

mmol/l

0.74

968

4262

Malignant neoplasm of adrenal gland, including Hilmo

143

4.04

15.85

6.7

3.5

1.22

1.23

mmol/l

0.17

119

Thiazolidinediones

536

3720

1.50

15.84

5.2

4.1

1.22

1.23

mmol/l

1.32

464

3221

Haemorrhage in early pregnancy

1085

8136

1.32

15.84

3.2

3.4

1.23

mmol/l

0.38

910

7041

Endometriosis of pelvic peritoneum

660

4295

1.43

15.83

3.0

3.4

1.23

mmol/l

1.51

543

3721

Other disorders of nervous system

329

2062

1.67

15.73

5.5

4.2

1.22

1.23

mmol/l

0.65

282

1784

Spirochaetal infections, other/unspecified

155

2947

0.51

15.67

2.8

4.1

1.23

mmol/l

0.01

134

2563

Postprocedural disorders of nervous system

292

1771

1.71

15.63

3.4

3.3

1.22

1.23

mmol/l

1.11

261

1511

Hypertrophy of breast in women and men

847

6343

1.37

15.61

3.6

3.5

1.23

mmol/l

0.01

723

5492

Inflammatory diseases of prostate (prostatitis)

534

3706

1.48

15.55

3.9

4.7

1.21

mmol/l

0.05

455

3243

Dislocation, sprain and strain of joints and ligaments at neck level

622

4432

1.44

15.54

3.2

3.7

1.22

1.23

mmol/l

0.46

537

3856

Presence of other devices

645

8751

0.71

15.52

2.9

3.7

1.23

mmol/l

0.19

614

7519

Excessive vomiting in pregnancy

324

2021

1.66

15.49

3.3

3.1

1.23

mmol/l

1.26

276

1747

Seborrhoeic dermatitis

460

3110

1.53

15.45

6.6

3.9

1.22

mmol/l

0.51

395

2705

Charcot foot

413

2.60

15.36

17.0

3.7

1.20

1.23

mmol/l

2.56

348

Malignant neoplasm of bone and articular cartilage, including Hilmo

419

2.57

15.33

10.5

3.3

1.23

1.22

mmol/l

0.65

343

Autism

106

458

2.44

15.30

2.9

4.1

1.22

mmol/l

0.35

398

Wide developmental disorders

123

563

2.28

15.27

3.3

4.3

1.22

1.23

mmol/l

0.98

104

488

Hypermobility syndrome

226

1288

1.84

15.25

2.7

3.2

1.23

mmol/l

0.68

189

1098

Other pulmonary heart/vessel disease

242

1416

1.81

15.21

5.9

3.6

1.21

1.23

mmol/l

1.42

222

1197

Cyst of kidney

363

2350

1.62

15.20

5.6

3.8

1.23

1.22

mmol/l

0.82

325

2038

Other crystal arthropathies

126

598

2.32

15.15

5.1

3.4

1.22

1.23

mmol/l

0.74

115

498

Other and unspecified follicular disorders

202

1120

1.91

15.12

7.1

3.7

1.23

mmol/l

0.13

185

963

Other abnormalities of plasma proteins

104

457

2.54

15.10

9.7

4.1

1.21

1.22

mmol/l

1.85

390

Disorders of muscles

461

3130

1.52

15.08

4.3

3.9

1.23

mmol/l

0.04

400

2701

Polyuria

1054

8184

1.32

15.07

4.1

3.9

1.22

mmol/l

0.01

902

7049

Alcohol-induced chronic pancreatitis

285

1741

1.72

15.06

6.1

4.6

1.21

1.22

mmol/l

1.32

268

1531

Pericarditis

177

943

1.99

15.03

7.6

3.5

1.22

1.23

mmol/l

1.43

169

807

Colon adenocarcinoma

568

4018

1.46

15.02

4.5

3.3

1.22

1.23

mmol/l

0.43

514

3335

Congenital malformations of the circulatory system

572

3924

1.45

15.01

4.1

1.22

1.23

mmol/l

0.77

517

3421

Superficial injury of thorax

680

4963

1.41

14.87

5.3

3.9

1.22

1.23

mmol/l

0.79

598

4302

Cholecystitis

663

4825

1.41

14.81

4.4

4.0

1.22

1.23

mmol/l

0.88

591

4126

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

119

555

2.33

14.77

4.6

3.1

1.21

1.23

mmol/l

2.28

111

467

Presence of cardiac and vascular implants and grafts

1944

11847

1.22

14.70

5.1

3.8

1.22

1.23

mmol/l

10.67

1794

10232

Eustachian salpingitis and obstruction

319

2008

1.64

14.70

3.8

3.5

1.22

1.23

mmol/l

2.42

282

1749

Hepatocellular carcinoma

119

555

2.31

14.69

5.0

3.2

1.21

1.22

mmol/l

1.04

111

474

Acidosis

124

591

2.29

14.63

11.2

3.2

1.19

1.22

mmol/l

4.20

115

509

Irregular menses

2001

12489

1.22

14.60

3.6

3.3

1.23

mmol/l

3.33

1740

10701

COPD, hospital admissions

2174

15386

1.21

14.56

5.0

4.1

1.21

1.23

mmol/l

16.28

1972

13146

Psoriasis (vulgaris), strict definition

162

847

2.03

14.55

3.3

4.1

1.22

1.23

mmol/l

0.44

140

740

Other gastritis (incl. Duodenitis)

1074

8403

1.31

14.50

5.4

3.8

1.22

1.23

mmol/l

3.68

980

7147

Unspecified/other endometriosis

359

2278

1.59

14.48

3.0

3.1

1.23

mmol/l

0.01

301

1969

Hepatocellular carcinoma, including Hilmo

146

739

2.11

14.47

4.5

3.2

1.21

1.22

mmol/l

0.88

137

630

All influenza (not pneumonia)

605

4347

1.43

14.44

6.6

3.3

1.22

1.23

mmol/l

0.57

551

3723

Candidiasis, including avohilmo

1373

11060

1.26

14.34

5.2

3.7

1.22

1.23

mmol/l

3.29

1205

9480

Neuromuscular dysfunction of bladder

418

2818

1.54

14.31

5.4

4.0

1.22

1.23

mmol/l

1.66

354

2448

Congenital malformations of heart and great arteries

506

3423

1.47

14.30

4.0

4.2

1.22

1.23

mmol/l

0.58

458

2977

Pneumonia due to Streptococcus pneumoniae

194

1080

1.89

14.29

6.4

3.5

1.22

1.23

mmol/l

0.32

173

913

Anorexia (incl.atypical)

226

1309

1.79

14.27

4.1

3.3

1.22

1.23

mmol/l

0.20

196

1125

Renal agenesis and other reduction defects of kidney

102

4.61

14.24

16.1

4.6

1.21

1.23

mmol/l

0.55

Pyogenic arthritis

306

1928

1.65

14.21

7.4

4.0

1.22

mmol/l

0.89

282

1664

Oesophageal varices

204

1159

1.87

14.20

6.4

4.2

1.20

1.22

mmol/l

4.30

195

995

Chorioretinal inflammation

146

747

2.09

14.09

4.4

3.7

1.23

mmol/l

0.14

129

645

COPD related to multimorbidity

1923

13552

1.22

14.06

5.3

4.1

1.21

1.23

mmol/l

15.60

1751

11567

Gastroduodenal ulcer

1274

10179

1.27

14.02

6.2

3.9

1.22

1.23

mmol/l

2.88

1155

8634

Other inflammatory liver diseases

306

1939

1.65

13.98

5.9

3.9

1.22

1.23

mmol/l

0.87

283

1667

Ulcerative colitis (strict definition, all Crohn cases excluded)

572

4096

1.43

13.98

3.5

4.0

1.23

mmol/l

0.15

509

3567

Thyrotropin deficiency

270

2.95

13.95

5.2

3.8

1.23

mmol/l

0.02

236

Autism spe

102

453

2.37

13.89

2.7

3.6

1.22

1.23

mmol/l

0.43

396

Premature rupture of membranes

756

3996

1.37

13.85

2.8

3.4

1.23

mmol/l

0.72

640

3473

Malignant neoplasm of tonsil and base of tongue, including Hilmo

117

555

2.27

13.84

5.3

3.3

1.24

1.22

mmol/l

1.23

110

464

Artificial opening status

254

1542

1.73

13.82

8.1

3.7

1.22

1.23

mmol/l

2.22

232

1343

Hernia

4385

25790

1.14

13.82

4.5

3.8

1.22

1.23

mmol/l

3.28

3839

22250

Use of biperiden

242

1451

1.75

13.81

3.8

4.0

1.23

mmol/l

0.47

204

1262

Non-small cell lung cancer

476

3271

1.48

13.81

5.4

3.3

1.23

1.22

mmol/l

1.60

453

2729

Cardiomyopathy, other and unspecified

346

2260

1.59

13.77

6.1

3.6

1.21

1.23

mmol/l

7.21

320

1916

Essential (haemorrhagic) thrombocythaemia

180

994

1.92

13.75

3.5

3.1

1.22

1.23

mmol/l

0.46

151

829

Orchitis and epididymitis

382

2544

1.55

13.74

5.6

4.7

1.22

mmol/l

0.82

332

2244

Malignant neoplasm of adrenal gland

4.93

13.71

7.3

3.9

1.23

1.22

mmol/l

0.54

Focal epilepsy, strict definition

860

6585

1.34

13.62

4.2

4.1

1.22

1.23

mmol/l

6.43

799

5685

Cerebral cysts

254

1545

1.72

13.62

5.1

3.7

1.22

mmol/l

0.72

229

1316

Other bacterial intestinal infections

846

6469

1.34

13.61

9.4

3.7

1.22

1.23

mmol/l

6.04

769

5534

Systemic sclerosis (FG)

128

634

2.18

13.61

4.0

3.5

1.23

mmol/l

1.11

119

528

Malignant neoplasm of oropharynx, including Hilmo

105

481

2.37

13.61

5.3

3.4

1.25

1.22

mmol/l

1.72

410

Osteonecrosis due to drugs

421

2.52

13.60

15.9

3.9

1.24

1.23

mmol/l

0.82

362

Temporal arteritis

208

1210

1.84

13.58

4.8

3.9

1.22

1.23

mmol/l

1.41

194

1029

Mixed connective tissue disease

104

477

2.39

13.57

3.9

3.7

1.22

1.23

mmol/l

1.02

415

Malignant neoplasm of liver and intrahepatic bile ducts

153

805

2.02

13.56

5.4

3.1

1.21

1.22

mmol/l

1.11

141

677

Superficial injury of head

1096

8650

1.29

13.55

3.7

3.9

1.23

mmol/l

0.76

966

7431

COPD, early/later onset

2185

15514

1.20

13.54

5.1

4.1

1.21

1.23

mmol/l

16.29

1983

13254

Pure hypercholesterolaemia

3401

18821

1.16

13.52

4.6

3.3

1.23

mmol/l

3.56

3060

15954

Hidradenitis suppurativa

164

881

1.96

13.51

4.7

3.3

1.22

1.23

mmol/l

0.64

139

756

Acute suppurative otitis media

930

6687

1.32

13.51

4.5

3.6

1.22

1.23

mmol/l

2.01

809

5785

Disorders of parathyroid gland, other and/or unspecified

216

3.32

13.48

13.0

3.9

1.24

1.23

mmol/l

0.21

184

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

257

2.93

13.42

8.9

2.9

1.22

mmol/l

0.06

216

Hypermetropia

316

2032

1.61

13.40

5.5

4.0

1.23

mmol/l

0.80

264

1748

Use of other anti-dementia drugs

1491

9815

1.25

13.38

2.8

4.1

1.23

mmol/l

4.83

1209

8391

Use of memantine

1491

9815

1.25

13.38

2.8

4.1

1.23

mmol/l

4.83

1209

8391

Acute epiglottitis

327

2.66

13.38

6.3

3.7

1.22

mmol/l

0.16

282

Acetic acid derivatives and related substances

1264

5189

1.28

13.38

3.5

4.9

1.22

mmol/l

0.11

1075

4524

Early onset COPD

960

7484

1.31

13.36

5.3

4.2

1.21

1.23

mmol/l

6.72

876

6503

Scoliosis

374

2501

1.55

13.26

3.8

3.5

1.23

mmol/l

0.22

332

2109

Urethral stricture

267

1659

1.68

13.25

5.8

4.7

1.22

mmol/l

0.05

227

1461

Malignant neoplasm of head and neck

346

2277

1.57

13.24

5.3

3.3

1.23

1.22

mmol/l

0.34

321

1922

Use of disulfiram, acamprosate or naltrexone

350

2309

1.57

13.23

3.9

4.5

1.22

mmol/l

0.12

319

2047

Universal erythroderma, KELA reimbursement

343

2.64

13.22

5.3

4.7

1.22

mmol/l

0.46

303

Focal brain injury

269

1670

1.67

13.19

3.8

4.3

1.21

1.22

mmol/l

2.99

233

1441

Polyneuropathies and other disorders of the peripheral nervous system

1008

7925

1.30

13.18

6.8

4.1

1.22

mmol/l

2.07

899

6847

Other symptoms and signs involving general sensations and perceptions

218

1291

1.78

13.14

3.9

3.7

1.23

mmol/l

0.10

187

1098

Focal epilepsy, mode (most common among epilepsy diagnosis)

812

6202

1.34

13.12

4.4

4.1

1.22

1.23

mmol/l

6.82

757

5356

Abnormalities of gait and mobility

571

4149

1.42

13.07

3.8

4.2

1.22

1.23

mmol/l

1.00

482

3586

Monoamine oxidase A inhibitors

496

3513

1.45

13.05

4.2

3.9

1.23

mmol/l

0.17

416

3089

Renal agenesis and other reduction defects of kidney, including avohilmo

123

4.04

13.04

15.0

4.2

1.21

1.23

mmol/l

0.73

104

Scabies

200

1155

1.81

13.00

7.0

4.0

1.22

1.23

mmol/l

0.72

180

1006

Other specified/unspecified soft tissue disorders

243

1484

1.72

12.97

3.7

3.8

1.23

mmol/l

0.12

205

1244

Giant cell arteritis with polymyalgia rheumatica

208

1227

1.82

12.95

4.8

3.9

1.22

1.23

mmol/l

1.42

194

1051

Arthropod-borne viral fevers and viral haemorrhagic fevers

409

2804

1.51

12.92

4.5

4.2

1.22

mmol/l

0.14

367

2444

Malignant neoplasm of bronchus and lung

838

5370

1.33

12.92

5.4

3.3

1.23

1.22

mmol/l

2.07

792

4454

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

291

1853

1.63

12.91

5.9

3.0

1.22

1.23

mmol/l

1.24

269

1564

Viral warts

416

2860

1.50

12.85

9.2

3.6

1.22

1.23

mmol/l

0.85

377

2473

Malignant neoplasm of pancreas

322

2104

1.59

12.85

5.9

3.2

1.22

1.23

mmol/l

0.36

302

1766

Psoriasis vulgaris

791

6041

1.34

12.84

4.2

1.23

mmol/l

0.22

699

5264

Gestational diabetes (for exclusion)

1237

6808

1.27

12.84

2.7

3.2

1.22

1.23

mmol/l

5.88

1036

5939

Juvenile arthritis (FINNGEN)

172

951

1.88

12.83

3.9

3.2

1.22

1.23

mmol/l

0.55

150

801

Other coagulation defects

333

2192

1.58

12.83

5.5

3.5

1.22

1.23

mmol/l

2.37

299

1881

Malignant neoplasm of rectum

429

2971

1.49

12.81

4.5

3.3

1.22

mmol/l

1.39

377

2503

Chronic iridocyclitis

229

1383

1.74

12.76

4.2

3.7

1.23

mmol/l

0.15

206

1182

Benign neoplasm of other and ill-defined parts of digestive system

838

6467

1.33

12.76

5.1

4.0

1.23

mmol/l

0.47

762

5569

Heterophoria

339

2241

1.57

12.73

5.1

3.7

1.22

1.23

mmol/l

0.96

292

1926

Wegener granulomatosis

400

2.48

12.72

6.7

3.9

1.22

1.23

mmol/l

0.23

346

Migraine without aura and triptan purchases

600

4395

1.39

12.71

3.3

3.6

1.22

1.23

mmol/l

1.16

531

3818

Noninflammatory disorders of female genital tract

1694

7010

1.23

12.67

3.6

3.5

1.23

mmol/l

0.26

1450

5968

Visual disturbances and blindness

2456

21098

1.18

12.66

4.2

3.9

1.22

1.23

mmol/l

3.09

2179

18120

Diseases of inner ear

2597

21451

1.17

12.63

3.8

4.0

1.23

mmol/l

0.11

2231

18457

Symptoms and signs involving the skin and subcutaneous tissue

3363

27895

1.15

12.60

4.6

3.9

1.23

mmol/l

1.14

3023

23993

Acute lymphadenitis

244

1499

1.69

12.59

6.6

3.5

1.22

1.23

mmol/l

0.40

214

1288

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

279

1771

1.63

12.56

3.9

3.6

1.23

mmol/l

0.27

245

1540

Cardiac arrest

262

1380

1.66

12.54

6.5

3.0

1.21

1.23

mmol/l

8.87

238

1111

malignant neoplasm of female genital organs, including Hilmo

791

5777

1.34

12.52

3.6

2.9

1.24

mmol/l

0.07

685

4732

Non-small cell lung cancer, adenocarcinoma

289

1856

1.62

12.51

6.1

3.2

1.22

1.23

mmol/l

0.32

276

1561

Enterocolitis due to Clostridium difficile

513

3689

1.44

12.49

11.9

3.7

1.21

1.23

mmol/l

5.41

465

3165

Type 1 diabetes, strict definition, subgroup 1

227

1361

1.71

12.49

3.7

3.4

1.22

1.23

mmol/l

0.32

184

1171

Family history of malignant neoplasm

457

3213

1.46

12.49

3.9

3.2

1.23

mmol/l

0.05

407

2784

Other juvenile arthritis

149

795

1.95

12.46

3.7

3.3

1.22

1.23

mmol/l

0.53

128

670

Polycythaemia vera

161

888

1.92

12.41

3.2

1.21

1.23

mmol/l

2.16

133

739

Other disorders of conjunctiva

673

5059

1.37

12.40

4.4

4.1

1.23

mmol/l

0.24

594

4389

Disorders of tooth development and eruption

643

3873

1.38

12.39

4.6

3.3

1.23

mmol/l

0.32

575

3360

Progressive vascular leukoencephalopathy

1488

0.39

12.38

2.9

3.6

1.24

1.23

mmol/l

1.19

1248

Other and unspecified mood [affective] disorders

260

1624

1.65

12.38

4.8

3.5

1.23

mmol/l

0.36

225

1419

Status epilepticus

174

982

1.87

12.37

5.9

3.7

1.21

1.23

mmol/l

3.40

166

846

Malignant neoplasm of tonsil, including Hilmo

384

2.46

12.36

5.6

3.4

1.25

1.22

mmol/l

1.38

326

Mental retardation

153

820

1.94

12.33

4.6

4.7

1.24

1.23

mmol/l

0.66

137

715

Other bursopathies

605

4477

1.39

12.30

4.5

4.0

1.23

mmol/l

0.50

523

3850

Peripheral artery disease

2119

14238

1.19

12.27

7.4

3.8

1.21

1.23

mmol/l

20.98

1899

12131

Oter anti-inflammatory and antirheumatic agents, non-steroids

1059

4588

1.29

12.23

3.6

4.9

1.22

mmol/l

0.15

926

4017

Idiopathic thrombocytopenic purpura

152

829

1.95

12.20

5.1

3.4

1.22

mmol/l

0.62

136

710

Other sexually transmitted chlamydial diseases

1363

0.37

12.20

2.5

2.9

1.23

1.22

mmol/l

0.05

1157

Lymphoid leukaemia

266

1690

1.65

12.18

5.7

4.1

1.23

1.22

mmol/l

0.39

249

1465

Malignant neoplasm of corpus uteri, including Hilmo

442

3119

1.47

12.12

3.5

3.0

1.24

mmol/l

0.33

382

2526

Persistent mood disorders

799

6160

1.32

12.06

4.1

3.7

1.22

1.23

mmol/l

2.17

688

5360

Dermatitis due to substances taken internally

252

1581

1.66

12.05

6.8

3.6

1.22

1.23

mmol/l

0.93

221

1357

Diastasis of muscle

197

3.10

12.03

3.0

3.7

1.23

1.22

mmol/l

0.10

175

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

436

3066

1.47

12.02

4.5

3.3

1.22

mmol/l

0.95

385

2577

Coxarthrosis, primary

2949

21391

1.16

12.01

3.7

4.1

1.23

mmol/l

2.16

2540

18375

Malignant neoplasm of other connective and soft tissue, including Hilmo

188

1095

1.81

12.00

7.5

3.0

1.23

mmol/l

0.53

167

910

Malignant neoplasm, without specification of site, including Hilmo

218

1319

1.73

11.98

6.1

3.0

1.23

mmol/l

0.42

204

1105

Tobacco use

237

1467

1.69

11.97

4.5

3.9

1.22

1.23

mmol/l

0.17

216

1276

Pyoderma gangrenosum

194

3.17

11.92

4.1

3.9

1.21

1.22

mmol/l

0.48

162

Restless leg syndrome

662

4994

1.36

11.89

3.3

3.9

1.23

mmol/l

0.98

545

4329

Chronic tubulo-interstitial nephritis

181

1047

1.82

11.86

13.3

3.1

1.22

1.23

mmol/l

1.91

168

882

Benign intracranial hypertension

187

3.10

11.82

5.0

3.0

1.22

mmol/l

0.07

159

Visual field defects

396

2751

1.49

11.80

4.4

4.0

1.22

1.23

mmol/l

1.21

353

2371

Use of anticholinesterases

1829

11901

1.21

11.78

2.9

4.1

1.23

mmol/l

4.96

1457

10197

N06DA Anticholinesterases

1829

11901

1.21

11.78

2.9

4.1

1.23

mmol/l

4.96

1457

10197

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

379

2.41

11.72

2.5

3.5

1.22

mmol/l

0.01

323

Mandibular retrognathia

245

1529

1.65

11.68

3.3

3.7

1.23

mmol/l

0.58

218

1329

Other viral hepatitis, including avohilmo

250

1573

1.64

11.68

4.7

3.9

1.21

1.23

mmol/l

2.54

221

1360

Neuroendocrine tumor and carcinoma of small intestine

351

2.51

11.65

5.0

2.7

1.22

mmol/l

0.43

292

Enthesopathies of lower limb, excluding foot

974

7735

1.28

11.62

3.4

3.8

1.23

mmol/l

0.05

845

6673

Pre-eclampsia or poor fetal growth

1111

8907

1.26

11.61

3.6

3.2

1.23

mmol/l

0.25

970

7676

Sleep disorders, other/unspecified

151

830

1.90

11.61

4.0

3.7

1.22

1.23

mmol/l

1.91

128

724

Other enthesopathies

1289

10552

1.24

11.59

3.6

3.8

1.23

mmol/l

0.57

1138

9120

Fracture of lower leg, including ankle

2528

21520

1.17

11.59

4.6

3.9

1.23

mmol/l

1.26

2198

18520

Abnormal blood-pressure reading, without diagnosis

209

1263

1.73

11.59

3.4

3.7

1.23

mmol/l

0.26

179

1070

Synovial cyst of popliteal space [Baker]

357

2441

1.52

11.57

4.0

3.9

1.24

1.23

mmol/l

1.08

316

2082

Other viral hepatitis

237

1476

1.66

11.56

4.8

4.0

1.21

1.23

mmol/l

3.08

212

1274

Schizotypal disorder

103

499

2.19

11.53

2.7

4.3

1.22

1.23

mmol/l

0.16

440

Car occupant injured in other and unspecified transport accidents

748

5752

1.33

11.52

4.0

3.8

1.23

mmol/l

0.11

654

4981

Drug-induced interstitial lung disorders, unspecified

6.46

11.49

6.2

3.8

1.22

1.23

mmol/l

0.16

Peritonsillar abscess

820

6381

1.31

11.48

4.0

3.9

1.23

1.22

mmol/l

0.39

715

5565

Degenerative macular diseases

588

4388

1.38

11.48

4.4

4.0

1.22

1.23

mmol/l

2.15

494

3797

Type 1 diabetes, strict definition

241

1500

1.64

11.48

3.8

3.3

1.23

mmol/l

0.32

196

1298

Idiopathic gout

435

3091

1.46

11.47

7.1

4.1

1.21

1.22

mmol/l

1.30

397

2682

Symptoms and signs involving speech and voice

1543

12886

1.22

11.45

4.4

3.8

1.22

1.23

mmol/l

6.01

1344

11077

Leiomyoma of uterus

2830

13820

1.16

11.45

3.7

3.5

1.24

mmol/l

0.92

2400

11917

Unspecified dementia

545

3592

1.40

11.44

3.2

4.0

1.23

1.22

mmol/l

0.94

447

3082

Corneal ulcer

773

5980

1.32

11.43

4.9

3.9

1.22

1.23

mmol/l

0.79

680

5201

Maternal care for cervical incompetence

184

1083

1.79

11.41

3.7

3.3

1.23

1.24

mmol/l

0.14

157

914

Gastrointestinal stromal tumor and sarcoma

299

2.63

11.38

3.4

2.6

1.23

1.22

mmol/l

0.54

247

Disorders of continuity of bone

418

2946

1.46

11.37

5.8

3.5

1.23

mmol/l

0.37

379

2537

Assault by unspecified means

409

2.31

11.35

3.8

4.0

1.20

1.22

mmol/l

2.28

360

Alcohol withdrawal state with delirium

288

1890

1.58

11.34

4.7

4.6

1.20

1.22

mmol/l

4.21

263

1669

Disorders of phosphorus metabolism and phosphatases

125

3.79

11.32

13.3

3.3

1.22

1.23

mmol/l

0.11

108

Hyperprolactinaemia

142

773

1.93

11.30

4.1

2.6

1.23

mmol/l

0.61

126

662

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

285

1869

1.58

11.25

7.0

3.2

1.23

mmol/l

0.02

258

1570

Malignant neoplasm of tonsil

330

2.50

11.25

6.0

3.1

1.25

1.22

mmol/l

1.17

282

Enteropathic arthropathies

108

538

2.14

11.25

3.2

3.3

1.24

1.23

mmol/l

0.58

451

Other and unspecified polyneuropathies, also in other diseases

877

6921

1.30

11.23

7.3

4.1

1.22

mmol/l

1.83

782

6001

Secondary parkinsonism, excluding more controls

116

593

2.07

11.21

4.9

3.9

1.24

1.23

mmol/l

1.19

104

519

Postprocedural disorders of digestive system, not elsewhere classified

163

933

1.85

11.17

7.1

3.5

1.22

1.23

mmol/l

0.70

150

796

Superficial injury of lower leg

1145

9304

1.25

11.14

4.6

3.7

1.22

1.23

mmol/l

2.28

1015

7990

Chronic sinusitis

1884

16010

1.19

11.14

3.9

1.23

mmol/l

1.07

1626

13805

Personal history of malignant neoplasm

146

2552

0.56

11.09

4.5

3.4

1.24

mmol/l

0.08

141

2209

Adenocarcinoma and papilloma adenocarcinoma of rectum

414

2928

1.46

11.09

4.6

3.3

1.22

mmol/l

1.02

368

2469

Chronic viral hepatitis

198

1192

1.72

11.07

5.1

3.8

1.21

1.23

mmol/l

4.55

176

1034

Mycoses

1243

10199

1.24

11.07

6.1

3.9

1.22

1.23

mmol/l

1.40

1106

8819

Symptoms and signs involving emotional state

140

766

1.93

11.04

4.4

3.8

1.22

1.23

mmol/l

0.20

131

659

Abnormal involuntary movements

580

4337

1.37

11.04

4.6

3.9

1.22

1.23

mmol/l

0.57

497

3744

Melanocytic naevi, other sites/unspecified

357

2462

1.50

10.99

6.8

3.8

1.23

mmol/l

0.13

311

2131

Cluster headache, strict

145

801

1.89

10.99

3.1

3.6

1.22

1.23

mmol/l

0.35

127

700

Coxarthrosis, primary, with hip surgery

2298

18444

1.17

10.97

3.6

4.1

1.23

mmol/l

0.97

1970

15817

Impacted teeth

652

4230

1.34

10.97

3.8

3.3

1.23

1.22

mmol/l

0.48

561

3610

Chronic lymphocytic leukaemia

143

792

1.92

10.95

6.8

3.2

1.22

mmol/l

0.11

135

664

Chronic lymphocytic leukaemia, helper endpoint

143

792

1.92

10.95

6.8

3.2

1.22

mmol/l

0.11

135

664

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

143

792

1.92

10.95

6.8

3.2

1.22

mmol/l

0.11

135

664

Ehlers-Danlos syndrome, including avohilmo

248

2.71

10.90

1.9

3.3

1.22

mmol/l

0.02

206

Abnormal reflex

123

3.72

10.86

4.2

3.8

1.22

mmol/l

0.43

108

Fracture of skull and facial bones

879

6955

1.29

10.84

3.9

4.0

1.22

1.23

mmol/l

1.63

775

6038

Striae atrophicae

262

2.68

10.83

5.3

3.5

1.23

mmol/l

0.13

221

Systemic sclerosis

128

690

1.99

10.79

4.0

3.7

1.23

mmol/l

0.80

119

596

Other intervertebral disc disorders

3675

19475

1.13

10.77

3.7

3.9

1.23

mmol/l

1.22

3201

16800

Superficial injuries involving multiple body regions

126

673

1.98

10.77

4.9

3.6

1.20

1.23

mmol/l

1.74

106

579

Mental disorders, not otherwise specified

312

2102

1.53

10.73

3.5

3.6

1.23

mmol/l

1.11

279

1823

Calcific tendinitis of shoulder

255

1650

1.61

10.72

3.4

4.0

1.23

mmol/l

0.35

224

1422

Disorders of psychological development

390

2532

1.46

10.70

4.2

3.7

1.22

1.23

mmol/l

0.18

347

2174

Malignant neoplasm of tonsil and base of tongue

468

2.20

10.69

5.8

3.5

1.24

1.22

mmol/l

1.22

393

Systemic lupus erythematosus

169

990

1.80

10.68

5.4

3.6

1.23

mmol/l

0.75

160

837

Mumps

118

619

2.03

10.67

3.7

3.8

1.23

mmol/l

0.09

104

541

6-mercaptopurine

133

721

1.92

10.66

3.3

3.2

1.22

1.23

mmol/l

0.64

119

601

Thyrotoxicosis with toxic multinodular goitre

304

2054

1.55

10.63

4.3

3.8

1.23

mmol/l

0.70

270

1760

Mumps, including avohilmo

120

635

2.01

10.57

3.7

3.8

1.23

mmol/l

0.13

106

555

Other maternal disorders predominantly related to pregnancy

2254

12159

1.17

10.55

3.4

3.5

1.23

mmol/l

1.57

1916

10465

Crohn disease (strict definition, require KELA)

256

1662

1.59

10.54

3.8

3.7

1.23

mmol/l

0.19

224

1442

Open wound of lower leg

677

5209

1.33

10.54

5.6

3.9

1.22

1.23

mmol/l

0.77

619

4457

Crohn disease (strict definition, require KELA, min 2 HDR)

253

1640

1.60

10.49

3.8

3.7

1.23

mmol/l

0.18

222

1421

Malignant neoplasm of oropharynx

366

2.36

10.49

5.8

3.7

1.25

1.22

mmol/l

1.26

308

Other and unspecified injuries of lower leg

327

2238

1.51

10.46

4.2

3.5

1.23

mmol/l

0.26

289

1913

Infection due to other mycobacteria

434

2.25

10.44

7.6

3.1

1.23

mmol/l

0.09

369

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1483

12263

1.21

10.43

3.7

1.22

1.23

mmol/l

1.20

1276

10657

Cluster headache, wide

155

888

1.82

10.43

3.1

3.5

1.22

1.23

mmol/l

0.54

136

768

Endometriosis of rectovaginal septum and vagina

347

2408

1.49

10.42

3.1

3.6

1.23

1.24

mmol/l

0.07

296

2045

Acne

343

2348

1.48

10.42

5.9

3.2

1.22

mmol/l

0.01

293

1999

Bacterial intestinal infections, IBD co-morbidities

838

6636

1.29

10.42

9.5

3.9

1.22

1.23

mmol/l

5.46

761

5702

Kela reimbursement Agammaglobulinemia (D80-84)

179

3.04

10.42

6.5

4.3

1.21

1.23

mmol/l

1.37

159

Follow-up examination after treatment for conditions other than malignant neoplasms

1500

11899

0.83

10.41

3.4

3.8

1.23

mmol/l

1.18

1332

9919

Chronic Coagulation defects

110

569

2.05

10.37

6.0

3.5

1.23

mmol/l

0.31

100

481

Female genital prolapse

1283

5862

1.24

10.36

3.3

3.6

1.24

mmol/l

1.06

1090

5033

Papilloedema, unspecified

111

577

2.05

10.34

7.3

3.6

1.21

1.23

mmol/l

1.52

100

492

Malignant melanoma of skin, including Hilmo

596

4521

1.35

10.29

5.0

3.2

1.23

mmol/l

0.53

524

3779

Viral hepatitis

270

1783

1.56

10.26

4.9

3.9

1.21

1.23

mmol/l

2.30

239

1552

Mixed hyperlipidaemia

191

1169

1.72

10.25

8.2

3.4

1.21

1.23

mmol/l

1.53

169

1004

Alcoholic liver disease

425

3067

1.43

10.22

5.8

4.5

1.20

1.22

mmol/l

9.15

398

2712

Unspecified chronic bronchitis

168

993

1.77

10.22

4.6

4.0

1.22

mmol/l

0.50

147

838

Golimumab

149

851

1.83

10.20

2.7

3.8

1.24

1.23

mmol/l

2.74

141

737

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

107

3.80

10.20

13.9

3.1

1.24

1.22

mmol/l

1.27

Adenocarcinoma and ductal carcinoma of pancreas

166

980

1.78

10.19

5.9

3.1

1.22

1.23

mmol/l

0.67

153

816

Spontaneous rupture of synovium and tendon

382

2710

1.46

10.18

4.3

4.1

1.23

mmol/l

0.23

341

2340

Disorders of optic nerve and visual pathways

384

2723

1.45

10.18

5.7

3.8

1.22

1.23

mmol/l

1.05

345

2350

226

1432

1.62

10.13

3.5

3.4

1.22

mmol/l

0.14

197

1188

Malignant neoplasm of corpus uteri

396

2835

1.45

10.11

3.4

3.0

1.24

mmol/l

0.52

340

2298

Endometriosis ASRM stages 1,2

683

5288

1.32

10.11

3.1

3.3

1.23

mmol/l

1.56

562

4590

Adhesive capsulitis of shoulder

738

5777

1.31

10.10

4.4

3.9

1.23

mmol/l

0.61

650

4967

Laparoscopic right hemicolectomy

290

1965

1.55

10.08

3.9

4.1

1.23

mmol/l

0.02

257

1699

280

2.48

10.08

7.6

2.8

1.22

1.23

mmol/l

0.46

233

Primary gonarthrosis, bilateral

2523

18499

1.16

10.06

3.8

4.1

1.23

mmol/l

0.17

2172

15898

Viral hepatitis, including avohilmo

284

1905

1.54

10.03

4.8

3.9

1.22

1.23

mmol/l

1.77

249

1660

Pediculosis, acariasis and other infestations, including avohilmo

656

5054

1.32

10.00

4.5

3.8

1.23

mmol/l

0.10

589

4402

Suppurative and unspecified otitis media

1349

9951

1.21

9.98

4.4

3.6

1.22

1.23

mmol/l

1.77

1167

8624

Infections of genitourinary tract in pregnancy

369

2608

1.45

9.94

3.7

3.4

1.23

mmol/l

0.34

327

2243

Malignant neoplasm of rectosigmoid junction, including Hilmo

131

728

1.90

9.93

4.7

3.1

1.22

mmol/l

0.39

122

602

Pediculosis, acariasis and other infestations

241

1567

1.59

9.90

6.7

4.1

1.22

mmol/l

0.57

219

1373

Systemic sclerosis, icd10

126

696

1.94

9.88

4.0

3.6

1.23

mmol/l

0.94

117

601

Cervicalgia

921

7416

1.26

9.87

3.4

3.8

1.23

mmol/l

0.44

797

6342

Disorders of pituitary gland, other and/or unspecified

141

3.34

9.87

5.7

3.2

1.21

1.23

mmol/l

0.75

124

Other shoulder lesions

403

2897

1.43

9.86

4.5

3.9

1.23

mmol/l

0.46

351

2498

Acne vulgaris

267

1766

1.54

9.85

5.5

3.1

1.22

1.23

mmol/l

0.39

235

1511

Vasomotor and allergic rhinitis

1550

12810

1.20

9.83

3.1

3.8

1.23

mmol/l

1.55

1368

11057

Viral haemorrhagic fevers, not elsewhere classified/unspecified

325

2254

1.49

9.81

4.3

4.2

1.22

1.23

mmol/l

0.49

290

1970

Speech and linguistic disorders, excluding more controls

234

1410

1.59

9.80

4.3

3.6

1.23

mmol/l

0.18

212

1212

Malignant neoplasm of other connective and soft tissue

117

631

1.97

9.78

9.2

3.0

1.23

mmol/l

0.35

108

520

Chronic hepatitis, not elsewhere classified

159

940

1.78

9.76

4.4

3.7

1.22

1.23

mmol/l

1.24

149

800

D07AA Corticosteroids, weak (group I)

576

4369

1.34

9.75

3.8

3.9

1.22

1.23

mmol/l

2.18

489

3779

Strabismus

1067

8710

1.24

9.74

4.6

3.9

1.23

mmol/l

0.67

924

7555

Dronedarone medication

153

900

1.81

9.72

2.9

3.5

1.23

mmol/l

0.43

127

769

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

163

942

1.74

9.70

5.1

3.7

1.23

mmol/l

0.14

145

809

Mental retardation, wide definition

156

907

1.77

9.69

4.5

4.6

1.24

1.23

mmol/l

0.94

140

793

Social phobias

271

1808

1.53

9.66

3.2

3.4

1.22

1.23

mmol/l

0.89

220

1566

Adenocarcinoma and papillary adenocarcinoma of stomach

125

690

1.90

9.62

5.0

3.3

1.22

mmol/l

0.32

114

582

Diplopia

581

4440

1.34

9.62

4.0

4.1

1.22

1.23

mmol/l

2.40

526

3849

Non-seminoma of testis, including Hilmo

4.00

9.61

5.3

2.9

1.23

mmol/l

0.17

Open wound of forearm

403

2911

1.42

9.61

4.3

3.7

1.22

mmol/l

1.29

345

2527

Other and unspecified psoriasis

296

2027

1.51

9.59

4.1

1.22

1.23

mmol/l

0.52

273

1759

Monoarthritis, not elsewhere classified

186

1149

1.69

9.58

6.1

3.7

1.23

mmol/l

0.14

158

979

Complications of cardiac and vascular prosthetic devices, implants and grafts

111

595

2.00

9.57

8.9

3.5

1.21

1.22

mmol/l

1.11

103

508

Lumbar disc prolapse

2818

18437

1.14

9.53

3.6

3.9

1.23

mmol/l

0.52

2450

15932

Other fall from one level to another

895

7208

1.26

9.49

4.2

4.1

1.23

1.22

mmol/l

0.76

790

6268

Other disorders of eyelid

2168

17823

1.16

9.49

3.8

4.0

1.23

mmol/l

0.99

1871

15286

Dilated cardiomyopathy

500

3751

1.37

9.47

4.9

4.4

1.21

1.22

mmol/l

5.04

459

3278

Malignant neoplasm of mesothelium and soft tissue

177

1085

1.71

9.44

8.1

3.0

1.23

mmol/l

0.06

165

907

Use of rasagiline

134

767

1.88

9.43

3.1

3.9

1.22

1.23

mmol/l

0.18

109

664

Ankylosing spondylitis

343

2417

1.46

9.42

3.4

4.1

1.23

1.22

mmol/l

1.11

304

2107

Otitis externa, unspecified

470

3491

1.38

9.42

5.1

4.0

1.22

1.23

mmol/l

0.65

403

3025

Myelodysplastic syndrome, including Hilmo

139

800

1.83

9.39

5.0

3.0

1.20

1.22

mmol/l

4.03

132

670

Cystic fibrosis

5.16

9.38

6.6

3.3

1.23

mmol/l

0.03

Lichen simplex chronicus and prurigo

286

1956

1.52

9.36

6.6

3.7

1.22

1.23

mmol/l

2.46

253

1681

Kyphosis

380

2.27

9.31

5.9

3.5

1.23

mmol/l

0.06

323

Astigmatism

252

1675

1.55

9.31

6.7

3.9

1.23

mmol/l

0.48

213

1434

malignant neoplasm of female genital organs

683

5237

1.30

9.30

3.5

3.0

1.24

mmol/l

0.09

589

4303

Rotator cuff syndrome

2845

17345

1.14

9.25

3.7

4.0

1.23

mmol/l

0.26

2528

14967

Varicella [chickenpox]

170

1034

1.71

9.23

7.9

4.3

1.22

1.23

mmol/l

1.16

156

905

Peripheral arterial reconstruction

794

6353

1.28

9.17

9.2

4.0

1.21

1.22

mmol/l

10.37

708

5444

Anisometropia and aniseikonia

149

881

1.78

9.17

4.9

3.9

1.23

mmol/l

0.33

117

763

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

181

1128

1.69

9.15

4.9

3.8

1.22

1.23

mmol/l

0.52

163

961

Other/unspecified rheumatoid arthritis

566

4346

1.34

9.15

4.3

3.8

1.23

mmol/l

0.15

521

3705

Other secondary gonarthrosis

249

1668

1.56

9.11

4.6

4.2

1.23

mmol/l

0.41

220

1449

COPD, hospital admission 2, with asthma infections

1499

10962

1.19

9.11

5.3

4.1

1.21

1.22

mmol/l

13.07

1379

9374

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

271

1840

1.51

9.05

3.5

3.1

1.23

mmol/l

1.76

233

1607

Bell's palsy

500

3777

1.36

8.99

3.8

4.0

1.23

mmol/l

0.17

446

3266

Superficial injury of forearm

404

2951

1.40

8.99

3.4

3.7

1.23

mmol/l

0.06

356

2555

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

129

733

1.83

8.95

6.5

3.6

1.22

1.23

mmol/l

1.20

118

623

Carcinoma in situ of skin

419

3096

1.40

8.94

6.9

3.8

1.23

mmol/l

0.19

355

2677

Diseases of spleen

481

2.08

8.93

7.4

3.8

1.22

1.23

mmol/l

0.47

420

Infection due to other mycobacteria, including avohilmo

468

2.09

8.89

7.5

3.0

1.23

mmol/l

0.06

401

Other bacterial intestinal infections, including avohilmo

1038

8563

1.23

8.88

8.4

3.6

1.22

1.23

mmol/l

5.46

937

7336

175

2756

0.62

8.86

5.1

4.5

1.18

1.22

mmol/l

12.56

159

2422

L02BA Anti-estrogens

736

5866

1.28

8.81

5.4

3.6

1.24

mmol/l

0.33

693

4996

Amputation of toe

328

2331

1.46

8.80

12.1

4.0

1.20

1.22

mmol/l

6.63

300

2020

conjunctival haemorrhage

356

2567

1.43

8.78

4.3

4.0

1.23

mmol/l

0.18

313

2223

Other diseases of intestine

701

5556

1.29

8.76

6.2

3.8

1.22

1.23

mmol/l

2.16

612

4723

Hyperhidrosis

129

740

1.81

8.72

3.8

2.6

1.23

mmol/l

0.06

114

626

Congenital malformations of the musculoskeletal system, not elsewhere classified

321

2.30

8.70

2.7

3.7

1.22

mmol/l

0.04

274

Ehlers-Danlos syndrome

196

2.71

8.69

1.9

3.4

1.22

mmol/l

0.24

165

Other specified/unspecified hearing loss

195

2985

0.64

8.68

5.2

3.8

1.22

1.23

mmol/l

0.34

169

2588

SLE, ICD10

156

949

1.73

8.68

5.3

3.6

1.22

1.23

mmol/l

0.76

148

807

SLE, strict definition

156

949

1.73

8.68

5.3

3.6

1.22

1.23

mmol/l

0.76

148

807

Diffuse brain injury

139

815

1.77

8.67

4.3

3.7

1.22

mmol/l

0.81

119

693

Injuries involving multiple body regions

163

1001

1.70

8.65

4.6

3.9

1.21

1.23

mmol/l

1.41

140

860

Other and unspecified injuries of ankle and foot

176

1101

1.66

8.61

4.5

3.5

1.22

1.23

mmol/l

1.91

155

941

Carcinoma in situ of skin, other sites/unspecified

505

2.05

8.60

10.1

3.9

1.22

mmol/l

0.11

438

Persistent delusional disorders

325

2313

1.45

8.59

3.2

3.9

1.23

mmol/l

0.62

275

2005

Dislocation, sprain and strain of joints and ligaments of head

164

1009

1.69

8.58

4.2

3.6

1.23

mmol/l

0.46

144

865

Speech disturbances, not elsewhere classified

416

3086

1.39

8.57

4.4

3.8

1.22

1.23

mmol/l

1.94

376

2660

Hepatic failure, not elsewhere classified

172

1076

1.68

8.56

6.1

3.9

1.20

1.22

mmol/l

4.84

163

928

Dislocation of lens

440

2.10

8.55

6.1

3.6

1.23

mmol/l

0.15

373

CR(E)ST syndrome

463

2.09

8.53

4.3

3.7

1.22

1.23

mmol/l

0.93

405

Lateral epicondylitis

526

4031

1.33

8.50

3.1

3.9

1.23

mmol/l

1.02

457

3508

Undefined dementia

551

3919

1.33

8.48

3.2

3.8

1.23

1.22

mmol/l

0.56

452

3316

Crohn disease (strict definition, all UC cases excluded)

199

1287

1.60

8.45

3.0

3.7

1.22

1.23

mmol/l

0.83

169

1114

Bronchiectasis

372

2721

1.41

8.45

5.2

4.0

1.22

1.23

mmol/l

2.54

329

2316

Open wound of ankle and foot

418

3104

1.38

8.44

6.4

3.9

1.22

mmol/l

0.55

376

2702

Demyelinating diseases of the central nervous system

316

2241

1.45

8.43

3.9

3.6

1.23

mmol/l

0.28

272

1938

Poisoning by narcotics and psychodysleptics [hallucinogens]

318

2.27

8.43

5.1

3.5

1.20

1.22

mmol/l

1.59

272

Other strabismus

842

6807

1.25

8.41

4.3

3.8

1.23

mmol/l

0.64

727

5920

Carcinoma in situ of breast, other/unspecified

439

2.13

8.40

4.5

3.6

1.24

mmol/l

0.20

374

Cluster headache, strict, including avohilmo

194

1250

1.61

8.38

3.0

3.7

1.22

1.23

mmol/l

0.91

173

1088

Appendectomy

2727

23117

1.13

8.38

3.9

1.23

mmol/l

0.28

2405

19984

Malignant neoplasm of brain, including Hilmo

184

1171

1.63

8.37

5.9

3.0

1.22

1.23

mmol/l

1.26

172

983

Acute laryngitis and tracheitis

390

2815

1.39

8.35

4.3

3.5

1.22

1.23

mmol/l

1.74

331

2419

Malignant neoplasm of eye, brain and central nervous system

169

1055

1.66

8.35

5.6

3.0

1.22

1.23

mmol/l

0.11

156

884

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

184

2.79

8.33

16.0

3.1

1.24

1.22

mmol/l

1.54

150

Other infective otitis externa

100

1778

0.55

8.26

5.6

3.7

1.23

mmol/l

0.11

1530

Dementia due to Parkinsons disease, excluding more controls

116

660

1.86

8.24

2.8

4.4

1.22

mmol/l

0.12

571

Other demyelinating diseases of the central nervous system

150

913

1.71

8.24

3.0

3.4

1.22

1.23

mmol/l

0.39

129

792

Osteomyelitis of vertebra

3.98

8.23

4.8

3.4

1.19

1.23

mmol/l

2.46

Diseases of salivary glands

1408

12021

1.19

8.22

3.8

1.23

mmol/l

0.34

1221

10379

Varicella [chickenpox], including avohilmo

186

1190

1.61

8.22

7.4

4.4

1.22

1.23

mmol/l

1.12

168

1038

Amputation of ankle bones

108

603

1.90

8.21

17.9

3.6

1.20

1.22

mmol/l

2.71

520

Intestinal adhesions without obstruction

391

2893

1.39

8.20

5.4

3.9

1.21

1.23

mmol/l

4.00

347

2453

Open wound of wrist and hand

1829

15367

1.16

8.20

3.8

4.2

1.22

mmol/l

0.40

1553

13422

UC patients in KELA-register (code 208), prior to 1994

189

1222

1.62

8.19

4.7

3.9

1.22

1.23

mmol/l

0.71

165

1072

Other and unspecified disorders of vitreous body

1973

16893

1.16

8.19

4.0

1.23

mmol/l

0.43

1707

14525

Other injuries of spine and trunk, level unspecified

222

2.57

8.17

5.0

4.0

1.21

1.22

mmol/l

0.71

193

Other other unspecified disorders of the circulatory system

170

1074

1.66

8.16

5.6

3.7

1.23

mmol/l

0.04

160

932

Amputation

449

3392

1.36

8.15

11.9

3.9

1.20

1.22

mmol/l

9.13

411

2924

Decubitus ulcer and pressure area

295

2087

1.46

8.15

9.6

3.7

1.21

1.22

mmol/l

3.26

278

1785

Atrophic disorders of skin

708

5671

1.27

8.14

3.5

1.23

mmol/l

0.42

601

4830

Other chondrocalcinosis

395

2.16

8.14

5.7

4.3

1.21

1.22

mmol/l

0.49

344

Suppurative and necrotic conditions of lower respiratory tract

242

1650

1.52

8.12

6.7

4.3

1.21

1.22

mmol/l

1.86

229

1437

Other disorders of breast

334

4580

0.71

8.11

3.0

3.4

1.23

1.24

mmol/l

1.11

305

3929

Cluster headache, wide,, including avohilmo

204

1340

1.57

8.10

3.0

3.8

1.22

1.23

mmol/l

0.97

182

1166

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

420

3147

1.37

8.10

6.7

3.9

1.22

1.23

mmol/l

2.12

385

2732

Other/unspecified mastoiditis and related conditions

118

3.29

8.09

4.5

3.9

1.22

mmol/l

0.07

102

Pregnancy hypertension

1555

11948

1.18

8.09

3.7

3.4

1.23

mmol/l

0.70

1364

10269

Peripheral retinal degeneration

143

868

1.73

8.05

3.5

3.9

1.23

mmol/l

0.47

126

754

Personal history of risk-factors, not elsewhere classified

272

2.35

8.05

5.0

3.5

1.22

1.23

mmol/l

0.81

236

Postmenopausal bleeding

1212

5321

1.21

8.02

3.7

1.24

mmol/l

0.54

1038

4553

Localized skin eruption due to drugs and medicaments

322

2.27

7.97

4.9

3.9

1.22

1.23

mmol/l

1.03

283

Preterm labour and delivery

967

8008

1.23

7.97

3.9

3.5

1.23

mmol/l

0.46

818

6886

Leiomyosarcoma, including Hilmo

212

2.59

7.97

6.8

2.8

1.24

1.22

mmol/l

1.22

175

Atopic conjunctivitis

187

1211

1.60

7.95

3.1

3.5

1.23

mmol/l

0.39

167

1049

Abnormal findings in cerebrospinal fluid

4.11

7.94

7.9

4.0

1.22

1.23

mmol/l

0.42

Pruritus

503

3874

1.33

7.94

5.7

3.7

1.22

1.23

mmol/l

1.46

442

3324

Mixed disorders of conduct and emotions

378

2.09

7.93

3.9

2.9

1.22

1.23

mmol/l

0.41

318

Adenocarcinoma of pancreas

128

757

1.77

7.91

5.8

3.2

1.22

mmol/l

0.44

117

628

Atherosclerosis, excluding cerebral and coronary sclerosis

1952

13424

1.16

7.91

7.3

3.8

1.21

1.23

mmol/l

20.57

1753

11420

Calculus of lower urinary tract

236

1612

1.52

7.89

4.3

1.23

1.22

mmol/l

3.16

205

1408

Other diseases of lip and oral mucosa

1847

16142

1.16

7.88

3.9

1.23

mmol/l

0.41

1627

13900

Other extrapyramidal and movement disorders in other diseases

1114

9370

1.21

7.86

3.8

4.0

1.23

mmol/l

0.14

936

8070

Postmenopausal atrophic vaginitis

1171

5349

1.21

7.86

3.4

3.7

1.24

mmol/l

1.03

1012

4593

Other and unspecified diseases of blood and blood-forming organs

126

746

1.78

7.84

5.2

3.8

1.22

1.23

mmol/l

0.19

103

644

Ovarian dysfunction

249

1713

1.49

7.79

3.7

2.4

1.22

1.23

mmol/l

0.62

219

1439

Adrenomedullary hyperfunction

4.27

7.79

7.7

3.5

1.23

1.22

mmol/l

0.37

ILD-related respiratory insufficiency

160

1010

1.67

7.77

5.8

4.1

1.21

1.22

mmol/l

1.68

155

874

Episcleritis

212

1419

1.55

7.75

4.3

3.7

1.23

mmol/l

0.06

189

1221

Iridocyclitis in diseases classified elsewhere

506

1.96

7.70

3.9

3.8

1.24

1.23

mmol/l

0.87

437

Raynaud syndrome

364

2689

1.39

7.70

3.0

3.8

1.23

mmol/l

0.17

320

2336

Lesion of ulnar nerve

563

4416

1.30

7.70

4.6

4.2

1.22

1.23

mmol/l

0.76

510

3842

Trigeminal neuralgia

256

1783

1.48

7.69

3.4

3.7

1.23

mmol/l

0.45

228

1522

Intermittent heterotropia

209

1392

1.54

7.68

5.1

3.8

1.23

mmol/l

0.05

181

1199

Duodenal ulcer

485

3737

1.33

7.67

6.1

4.0

1.22

mmol/l

1.01

440

3195

Gingival hyperplasia

156

980

1.66

7.64

13.7

4.3

1.22

1.23

mmol/l

0.60

146

853

Chronic gastritis

910

10943

0.82

7.58

4.0

3.8

1.22

1.23

mmol/l

2.73

799

9249

Rash and other nonspecific skin eruption

409

3084

1.36

7.57

5.4

3.8

1.23

mmol/l

0.05

373

2666

Other and unspecified abdominal hernia

196

1303

1.57

7.55

5.9

4.0

1.23

mmol/l

0.30

173

1122

Scabies, including avohilmo

526

4094

1.31

7.55

4.3

3.8

1.22

1.23

mmol/l

0.72

464

3552

Biological medicines for asthma

530

1.91

7.53

3.0

3.7

1.23

mmol/l

0.01

465

Disorders of conjunctiva

3739

26357

1.11

7.52

3.8

3.9

1.23

mmol/l

0.02

3231

22738

Behavioural disorders, excluding more controls

277

2.24

7.52

3.9

4.3

1.23

1.22

mmol/l

0.19

240

Other disorders of bone

747

6065

1.25

7.52

4.8

3.5

1.22

1.23

mmol/l

0.88

673

5251

Other disorders starting during childhood or adolescence

145

882

1.67

7.51

5.1

4.0

1.23

mmol/l

0.09

129

751

Toxic effect of other and unspecified substances

261

2.33

7.51

3.7

3.9

1.21

1.23

mmol/l

0.91

232

Injuries to unspecified part of trunk, limb or body region

432

3287

1.35

7.49

5.4

3.9

1.22

1.23

mmol/l

0.60

387

2849

Aggressive periodontitis

110

636

1.84

7.49

4.4

3.9

1.22

1.23

mmol/l

0.42

547

Type1 diabetes, definitions combined, early onset

188

1226

1.56

7.47

3.8

3.6

1.22

1.23

mmol/l

0.41

152

1061

Ocular pain

349

2574

1.39

7.46

3.7

3.6

1.23

mmol/l

0.00

306

2225

Herpesviral [herpes simplex] infections, including avohilmo

1019

8538

1.21

7.43

5.3

3.5

1.22

1.23

mmol/l

2.16

897

7373

Vascular disorders of the intestines

325

2376

1.41

7.42

6.2

3.7

1.22

1.23

mmol/l

0.54

289

2014

Benign neoplasm: Endocrine pancreas

197

2.67

7.42

4.3

4.4

1.22

1.23

mmol/l

0.12

175

Bacterial, viral and other infectious agents

309

2238

1.41

7.36

5.7

4.1

1.22

1.23

mmol/l

2.57

281

1959

Anankastic personality disorder

146

909

1.66

7.35

3.1

3.4

1.23

mmol/l

0.29

116

788

Contact with nonpowered hand tool

164

1053

1.62

7.29

3.8

4.5

1.22

mmol/l

0.28

137

926

Portal vein thrombosis

430

2.01

7.28

6.5

4.2

1.23

mmol/l

0.06

376

Other and unspecified coagulation defects

203

1366

1.54

7.28

4.9

3.3

1.22

1.23

mmol/l

0.71

185

1172

Nail disorders

343

2535

1.39

7.26

6.1

3.8

1.23

mmol/l

0.09

307

2199

Gluteal tendinitis

194

1296

1.55

7.24

3.7

3.5

1.24

1.23

mmol/l

0.94

172

1104

Cardiac murmurs and other cardiac sounds

350

2560

1.38

7.23

3.8

3.6

1.23

mmol/l

0.16

302

2169

Congenital malformations and deformations of the musculoskeletal system

293

2097

1.42

7.19

4.1

3.7

1.23

mmol/l

0.10

260

1810

Atypical facial pain

223

1535

1.50

7.18

4.2

3.8

1.23

mmol/l

0.47

200

1311

Thyroiditis

292

2109

1.43

7.16

3.3

3.7

1.23

mmol/l

0.36

238

1827

Other diseases of arteries and capillaries

386

2912

1.36

7.16

7.0

3.6

1.21

1.23

mmol/l

4.74

349

2515

Myopia

462

3565

1.32

7.14

4.7

3.7

1.23

mmol/l

0.43

385

3087

Scleritis and episcleritis

241

1683

1.48

7.13

4.4

3.6

1.23

mmol/l

0.15

214

1450

Other noninfective disorders of lymphatic vessels and lymph nodes

160

1029

1.62

7.13

5.1

3.7

1.23

mmol/l

0.07

149

884

Triptan medication for migraine, min. 3 purchases

2184

14470

1.14

7.11

2.9

3.7

1.23

mmol/l

0.06

1880

12543

Somnolence, stupor and coma

187

1245

1.56

7.09

6.1

4.1

1.21

1.22

mmol/l

1.51

171

1065

Impetigo

167

1082

1.59

7.08

4.7

3.4

1.23

mmol/l

0.27

149

930

Gastric ulcer

818

6758

1.23

7.07

6.2

3.9

1.22

1.23

mmol/l

3.55

741

5745

Pre-eclampsia

726

5920

1.24

7.05

3.9

3.3

1.23

mmol/l

0.51

646

5112

Other specified/unspecified systemic involvement of connective tissue

236

1648

1.48

7.04

4.4

3.7

1.23

mmol/l

0.27

221

1418

Other/unspecified enthesopathies of lower limb, excluding foot

285

2054

1.42

7.03

3.0

3.7

1.23

mmol/l

0.25

248

1764

Primary angle-closure glaucoma

204

1389

1.53

7.03

4.6

4.0

1.23

mmol/l

0.00

177

1187

Cystic fibrosis with pulmonary manifestations

8.89

7.02

8.6

2.3

1.22

mmol/l

0.05

Other skin changes

913

7629

1.22

7.02

6.2

3.9

1.23

mmol/l

0.26

824

6553

Mild mental retardation

541

1.85

7.02

3.9

1.24

1.23

mmol/l

1.31

477

Hyperosmolality and hypernatraemia

401

2.04

7.01

5.6

3.4

1.23

mmol/l

0.01

337

Other and unspecified hydrocephalus

508

1.91

7.01

6.4

4.0

1.22

mmol/l

0.49

438

Migraine, single triptan purchase ok & required. ICD-code if available is included

3132

19192

1.11

7.00

3.1

3.9

1.23

mmol/l

1.44

2710

16591

Triptan medication for migraine, single purchase ok

3132

19192

1.11

7.00

3.1

3.9

1.23

mmol/l

1.44

2710

16591

Right bundle-branch block

167

1089

1.59

7.00

5.0

3.6

1.22

1.23

mmol/l

0.60

147

928

Bacterial, viral and other infectious agents, including avohilmo

329

2429

1.39

6.98

5.5

4.1

1.22

1.23

mmol/l

1.46

298

2122

Carcinoma in situ of other and unspecified sites

190

1279

1.55

6.97

4.4

1.22

mmol/l

0.16

165

1116

Other disorders of veins

1824

15809

1.15

6.96

4.1

3.7

1.23

mmol/l

2.58

1545

13605

Habit and impulse disorders

302

2.16

6.96

2.7

3.7

1.21

1.23

mmol/l

1.00

269

Myositis

117

702

1.75

6.94

6.3

3.9

1.22

1.23

mmol/l

0.19

100

601

Spondylolisthesis/Spondylolysis

780

6425

1.23

6.93

3.6

3.9

1.23

mmol/l

0.43

683

5501

Cerebral palsy and other paralytic syndromes

437

3367

1.33

6.92

4.8

4.0

1.22

1.23

mmol/l

0.98

402

2915

Other appendicitis

333

2470

1.38

6.90

4.3

4.1

1.23

mmol/l

0.14

297

2145

Poor fetal growth

380

2867

1.35

6.89

3.2

3.0

1.22

1.23

mmol/l

1.05

313

2473

Open wound of shoulder and upper arm

487

1.90

6.88

5.2

4.2

1.23

mmol/l

0.16

418

Other symptoms and signs involving cognitive functions and awareness

2204

17410

1.13

6.87

4.2

4.0

1.22

1.23

mmol/l

1.19

1938

14913

Disorders of iron metabolism

404

2.00

6.79

4.0

3.2

1.23

mmol/l

0.23

349

Glaucoma secondary to other eye disorders

181

1210

1.55

6.78

8.0

4.0

1.22

mmol/l

0.61

163

1037

Other conditions related to polyarteritis nodosa

4.44

6.78

6.1

5.3

1.23

1.22

mmol/l

0.33

Left bundle-branch block

321

2378

1.39

6.76

4.2

3.5

1.22

1.23

mmol/l

1.97

293

1996

Continuous positive airway pressure

377

4132

0.75

6.76

4.5

3.5

1.23

1.24

mmol/l

0.35

357

3453

Malignant neoplasm of rectosigmoid junction

412

1.99

6.75

4.6

2.7

1.23

1.22

mmol/l

0.30

336

Carcinoma in situ of skin of scalp and neck

145

929

1.65

6.75

7.0

3.8

1.22

mmol/l

0.07

128

802

Acute generalized exanthematous pustulosis

190

1284

1.53

6.75

6.8

3.6

1.22

1.23

mmol/l

0.46

168

1100

Other disorders of optic [2nd] nerve and visual pathways

256

1829

1.44

6.73

6.7

3.8

1.22

1.23

mmol/l

0.79

229

1574

Other disorders of amniotic fluid and membranes

434

3231

1.32

6.70

2.9

3.4

1.23

mmol/l

0.47

368

2802

Other and unspecified injuries of wrist and hand

157

1019

1.60

6.69

4.1

3.7

1.23

mmol/l

0.25

131

868

Otitis media, unspecified

389

2721

1.34

6.68

5.3

3.4

1.23

mmol/l

0.07

342

2323

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1114

9495

1.19

6.68

3.3

3.9

1.22

1.23

mmol/l

1.06

962

8278

Generalized skin eruption due to drugs and medicaments

167

1102

1.58

6.66

7.2

3.6

1.22

1.23

mmol/l

0.60

148

942

Carcinoma in situ, bladder

174

1162

1.57

6.66

4.4

4.3

1.22

mmol/l

0.42

151

1011

Malignant neoplasm, without specification of site

138

871

1.65

6.65

6.4

2.8

1.23

1.22

mmol/l

0.16

129

726

Localized swelling, mass and lump of skin and subcutaneous tissue

1028

12094

0.84

6.65

4.4

3.9

1.23

mmol/l

0.09

927

10405

Gestational [pregnancy-induced] hypertension

883

7364

1.21

6.65

3.2

1.23

mmol/l

0.13

761

6347

Polycystic ovarian syndrome

175

1160

1.54

6.65

2.4

2.3

1.22

1.23

mmol/l

0.70

150

964

Pre-eclampsia or eclampsia

786

6503

1.23

6.64

3.9

3.3

1.23

mmol/l

0.62

703

5601

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1746

13319

1.15

6.64

3.6

3.4

1.23

mmol/l

0.86

1528

11406

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

235

1623

1.45

6.63

5.2

3.3

1.22

1.23

mmol/l

1.16

211

1383

Antenatal screening

508

3606

0.78

6.58

2.4

3.4

1.23

mmol/l

0.16

449

3116

Atypical mycobacterium lung infection

369

2.06

6.57

8.0

4.1

1.23

mmol/l

0.11

313

Systemic lupus erythematosus, unspecified

132

830

1.67

6.56

5.0

3.6

1.22

1.23

mmol/l

0.83

124

703

Candidiasis

591

4760

1.26

6.55

7.4

3.7

1.22

1.23

mmol/l

2.31

526

4094

Other and unspecified urticaria

760

6279

1.23

6.54

4.1

3.7

1.23

mmol/l

1.04

643

5440

Pyothorax

185

1253

1.53

6.53

6.5

4.2

1.20

1.22

mmol/l

2.28

176

1085

Discitis, unspecified

483

1.90

6.53

10.1

3.7

1.21

1.22

mmol/l

0.87

404

Short Achilles tendon (acquired)

728

0.38

6.52

4.6

3.4

1.24

1.23

mmol/l

0.35

623

Atopic dermatitis, strict definition with reimbursement

1063

8679

1.19

6.52

4.3

3.5

1.23

mmol/l

0.08

926

7545

Malignant melanoma of skin

473

3714

1.30

6.51

4.9

3.2

1.23

mmol/l

0.51

414

3106

Rosacea

531

4230

1.28

6.49

4.2

3.7

1.23

mmol/l

1.26

442

3661

Other and unspecified mental retardation

274

2.17

6.47

5.3

5.5

1.22

1.23

mmol/l

0.42

241

Maternal care for known or suspected fetal abnormality and damage

284

3273

0.72

6.46

2.4

3.3

1.22

1.23

mmol/l

2.69

242

2843

Assault by bodily force

263

1898

1.42

6.42

4.6

4.0

1.22

1.23

mmol/l

0.32

233

1652

Ulcerative enterocolitis

124

770

1.68

6.42

5.7

3.8

1.22

1.23

mmol/l

0.23

118

661

Conjunctivitis (acute, non atopic)

1126

9606

1.18

6.36

4.8

3.8

1.23

mmol/l

0.14

978

8307

Neovascular glaucoma

181

1228

1.53

6.35

8.0

3.8

1.22

mmol/l

0.87

163

1052

Reactive arthropathies

335

2520

1.36

6.34

5.4

3.9

1.22

1.23

mmol/l

0.47

297

2189

Malignant neoplasm of bladder

264

1912

1.41

6.34

4.7

3.2

1.22

mmol/l

0.93

243

1600

Malignant neoplasm of cervix uteri, including Hilmo

582

1.78

6.32

4.0

2.5

1.23

mmol/l

0.08

471

Benign neoplasm: Sigmoid colon

578

7124

0.80

6.32

5.0

4.1

1.23

mmol/l

0.10

514

6162

Other and unspecified rosacea

372

2848

1.34

6.27

4.4

3.8

1.22

1.23

mmol/l

0.83

311

2469

Persons encountering health services for examination and investigation

3000

13637

1.11

6.27

4.1

3.8

1.23

1.22

mmol/l

0.62

2670

11412

Heartburn

449

3519

1.30

6.27

4.2

3.7

1.23

mmol/l

1.08

392

3008

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

189

2.41

6.26

5.5

3.0

1.24

1.22

mmol/l

1.35

159

Abdominal aortic aneurysm (AAA)

426

3292

1.31

6.25

6.2

3.9

1.21

1.22

mmol/l

1.77

385

2823

Injury of other and unspecified intrathoracic organs

259

1879

1.42

6.25

4.5

4.2

1.22

mmol/l

0.24

237

1636

Perineal laceration during delivery

339

3610

0.75

6.22

2.9

3.1

1.23

mmol/l

0.00

294

3072

Nonspecific lymphadenitis

219

1545

1.46

6.18

5.8

3.7

1.23

mmol/l

0.18

198

1337

Vitamin B12 deficiency anaemia

446

3504

1.30

6.17

4.8

3.7

1.21

1.23

mmol/l

3.95

388

2991

Postprocedural musculoskeletal disorders, not elsewhere classified

319

2402

1.37

6.14

4.2

4.1

1.23

mmol/l

0.10

284

2095

Other keratitis

437

3423

1.30

6.14

4.8

3.9

1.22

1.23

mmol/l

0.59

385

2960

Other and unspecified local infections of skin and subcutaneous tissue

394

3048

1.32

6.14

7.6

3.7

1.22

1.23

mmol/l

0.07

353

2641

Haemorrhoids and perianal venous thrombosis

1555

13582

1.15

6.13

3.9

3.7

1.23

mmol/l

0.31

1341

11531

Other local infections of skin and subcutaneous tissue

416

3243

1.31

6.11

7.4

3.7

1.23

mmol/l

0.03

373

2813

Amiodarone users

427

3348

1.31

6.08

4.8

4.4

1.21

1.22

mmol/l

3.39

396

2915

Oligomenorrhoea

135

866

1.61

6.08

2.8

3.0

1.22

1.23

mmol/l

1.23

120

740

Alzheimer’s disease (Late onset), excluding more controls

682

3632

1.24

6.07

3.2

4.0

1.23

mmol/l

0.77

549

3044

Polycystic ovarian syndrome, broad definition

335

2532

1.34

6.05

2.4

2.9

1.22

1.23

mmol/l

1.70

285

2155

Other and unspecified disorders of skin and subcutaneous tissue

128

1972

0.63

6.05

4.9

3.6

1.23

mmol/l

0.05

118

1702

Superficial injury of shoulder and upper arm

478

3793

1.28

6.05

3.8

3.9

1.23

mmol/l

0.24

399

3271

Abscess of anal and rectal regions

310

2322

1.36

6.04

5.1

3.9

1.22

mmol/l

0.62

278

2004

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

198

1378

1.48

6.03

4.3

3.9

1.22

1.23

mmol/l

0.50

174

1210

therapeutic use

972

0.48

6.03

6.4

3.4

1.23

mmol/l

0.07

819

Injuries to the wrist and hand

4612

28336

1.08

6.03

3.7

4.0

1.23

mmol/l

0.53

3963

24506

Ankylosing spondylitis, ICD10

323

2437

1.36

6.03

3.4

4.0

1.23

mmol/l

0.55

287

2127

Nummular dermatitis

350

2674

1.34

6.03

4.5

4.0

1.23

1.22

mmol/l

0.22

308

2318

Arthropathy in Crohn disease

226

2.28

6.02

3.2

3.7

1.24

1.23

mmol/l

0.80

196

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1204

10422

1.17

6.00

4.0

1.23

mmol/l

0.36

1049

9051

Volvulus

126

801

1.64

6.00

5.8

3.7

1.21

1.22

mmol/l

2.25

114

664

Cystic fibrosis, other manifestations/unspecified

6.25

6.00

6.8

3.7

1.23

1.24

mmol/l

0.11

Viral meningitis, including avohilmo

142

927

1.58

5.95

5.5

3.4

1.22

1.23

mmol/l

0.39

120

789

Female infertility, associated with anovulation

226

1609

1.43

5.95

2.5

2.9

1.22

1.23

mmol/l

1.68

198

1383

Umbilical hernia

1104

9506

1.18

5.94

5.0

4.2

1.22

mmol/l

4.49

966

8277

Other specified and unspecified disorders of eye and adnexa

1050

0.51

5.94

3.6

3.7

1.23

mmol/l

0.14

898

Oesophagitis

231

1661

1.43

5.93

5.1

4.0

1.21

1.22

mmol/l

2.56

208

1427

Melanoma in situ

207

1464

1.47

5.93

5.9

3.8

1.23

1.22

mmol/l

0.32

175

1258

Glucosamine medication

2230

16015

1.12

5.93

3.7

4.0

1.23

mmol/l

1.10

1878

13699

Other aneurysm

233

1679

1.43

5.92

7.3

3.7

1.22

mmol/l

0.40

208

1457

Reactive arthropathies, FINNGEN

261

1912

1.40

5.91

5.0

3.9

1.23

mmol/l

0.23

233

1630

Malignant immunoproliferative diseases

291

2.13

5.91

14.3

3.9

1.23

1.22

mmol/l

0.20

249

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

390

1.96

5.89

5.6

4.1

1.23

1.22

mmol/l

0.07

342

Mental and behavioural disorders associated with the puerperium

195

2.33

5.85

5.5

3.8

1.24

1.22

mmol/l

1.01

166

Cervical disc disorders

1516

13361

1.15

5.84

3.6

4.0

1.23

mmol/l

0.01

1317

11525

Sequelae of injuries of neck and trunk

121

766

1.64

5.84

3.5

3.8

1.22

1.23

mmol/l

0.31

109

663

Other peripheral vascular diseases

333

2538

1.34

5.84

4.1

3.5

1.23

mmol/l

0.13

300

2192

Other and unspecified nail disorders

106

651

1.71

5.84

4.5

3.6

1.23

mmol/l

0.13

566

Sequelae of other and unspecified infectious and parasitic diseases

195

1363

1.47

5.82

4.3

3.9

1.22

1.23

mmol/l

0.54

172

1196

Hypersomnia

325

2.02

5.82

3.0

4.3

1.23

mmol/l

0.00

286

Infectious mononucleosis, including avohilmo

249

1811

1.40

5.81

3.4

3.2

1.22

1.23

mmol/l

1.49

210

1553

Infectious mononucleosis

249

1811

1.40

5.81

3.4

3.2

1.22

1.23

mmol/l

1.49

210

1553

Alopecia areata

112

697

1.67

5.80

5.1

3.3

1.23

mmol/l

0.60

596

Microscopic polyangiitis

187

2.47

5.78

12.0

4.1

1.22

1.23

mmol/l

0.67

164

Cervicocranial syndrome

448

3552

1.29

5.76

3.6

3.8

1.23

mmol/l

0.01

390

3039

Subacute thyroiditis

148

984

1.56

5.75

3.2

3.3

1.23

mmol/l

0.24

121

861

Dystonia

222

1596

1.43

5.72

3.1

3.8

1.23

mmol/l

0.38

187

1387

Carcinoma in situ of skin of trunk

162

1104

1.54

5.70

7.5

3.9

1.24

1.22

mmol/l

1.97

138

948

Dermatophytosis

564

4596

1.25

5.69

4.6

4.1

1.22

1.23

mmol/l

0.67

502

4015

Injury of nerves and spinal cord at neck level

579

1.74

5.67

3.8

4.1

1.23

1.22

mmol/l

0.15

508

Polyarthritis, unspecified

149

995

1.55

5.67

4.0

3.5

1.23

mmol/l

0.09

137

840

Haemolytic anaemias

145

964

1.56

5.66

9.8

3.9

1.22

1.23

mmol/l

0.41

133

827

Anti-inflammatory and antirheumatic products, non-steroids

1230

5347

1.17

5.65

3.7

5.0

1.22

mmol/l

0.32

1065

4665

Maternal care for other known or suspected fetal problems

714

3706

1.22

5.63

2.7

3.3

1.22

1.23

mmol/l

2.10

587

3222

Agoraphobia

102

622

1.69

5.63

3.0

1.22

1.23

mmol/l

0.52

538

Malignant neoplasm of vulva, including Hilmo

374

1.94

5.60

5.3

2.7

1.23

mmol/l

0.46

304

Malignant neoplasm of oesophagus, including Hilmo

141

934

1.56

5.58

5.6

3.4

1.22

mmol/l

0.17

134

786

Malignant neoplasm of brain

123

789

1.61

5.57

5.6

3.0

1.22

1.23

mmol/l

0.56

115

658

Vascular dementia (undefined)

186

1288

1.47

5.57

3.7

3.9

1.23

1.22

mmol/l

1.50

161

1098

Burns and corrosions

494

3975

1.26

5.55

4.4

4.1

1.22

mmol/l

0.51

429

3466

Acute myeloid leukaemia and myelodysplastic syndromes

597

1.71

5.55

6.9

2.8

1.21

1.22

mmol/l

1.74

500

Noise effects on inner ear

1079

0.53

5.54

4.2

4.6

1.21

1.22

mmol/l

0.36

948

Juvenile rheumatoid arthirtis

445

1.82

5.54

4.3

3.0

1.22

1.23

mmol/l

0.71

371

Neuralgia and neuritis, unspecified

208

1487

1.44

5.53

5.1

3.7

1.22

1.23

mmol/l

1.12

195

1267

COPD, hospital admissions 3, with asthma pneumonia sepsis

1231

9201

1.16

5.52

5.6

4.0

1.21

1.22

mmol/l

10.79

1137

7858

Anosmia

320

1.94

5.50

2.9

1.9

1.24

mmol/l

0.04

245

Autoimmune thyroiditis

440

1.83

5.49

3.8

3.3

1.23

mmol/l

0.14

380

Uterine polyps

1175

5945

1.17

5.49

3.6

1.24

1.23

mmol/l

1.59

984

5111

Injury of eye and orbit

507

4096

1.26

5.48

4.5

4.1

1.22

1.23

mmol/l

1.47

450

3580

Pain associated with micturition

500

4041

1.26

5.47

3.7

1.23

mmol/l

0.92

448

3480

Drug-induced hypoglycaemia without coma

405

1.88

5.46

8.7

3.8

1.21

1.23

mmol/l

2.25

350

Pleural plaque without asbestos

168

1163

1.50

5.45

3.6

3.9

1.22

mmol/l

0.22

145

996

Other misadventures during surgical and medical care

106

664

1.67

5.43

7.0

4.0

1.21

1.23

mmol/l

2.01

580

Membranous nephropathy

104

2.94

5.42

20.8

4.0

1.21

1.22

mmol/l

0.26

Prolonged pregnancy

290

3264

0.75

5.41

2.6

3.4

1.23

mmol/l

0.02

240

2828

Soft tissue disorders related to use, overuse and pressure

1185

10338

1.16

5.38

3.4

3.9

1.23

mmol/l

0.43

1046

8896

Benign neoplasm: Skin, unspecified

167

1156

1.50

5.36

5.3

3.8

1.22

1.23

mmol/l

0.30

147

995

Lesion of radial nerve

151

1024

1.53

5.36

5.7

3.9

1.22

mmol/l

1.00

137

867

Dependent personality disorder

528

1.75

5.34

4.7

3.7

1.23

mmol/l

0.58

457

Abnormality of white blood cells, not elsewhere classified

218

2.23

5.33

8.8

3.9

1.21

1.23

mmol/l

1.27

191

Fissure and fistula of anal and rectal regions

976

8401

1.18

5.32

3.8

3.7

1.23

mmol/l

0.57

854

7196

Endometriosis of ovary

652

5103

1.22

5.32

3.3

3.6

1.24

1.23

mmol/l

0.06

569

4380

Contusion of other and unspecified parts of foot

189

1336

1.45

5.32

3.4

3.5

1.22

1.23

mmol/l

1.28

165

1140

Other renal tubulo-interstitial diseases

102

636

1.67

5.30

11.5

3.1

1.22

1.23

mmol/l

1.31

535

Voice disturbances

1141

9951

1.16

5.25

4.3

3.8

1.22

1.23

mmol/l

3.75

981

8561

Asthma and allergy, excluding more controls

384

2976

1.29

5.25

3.0

2.8

1.23

mmol/l

1.02

335

2513

Embedded and impacted teeth

837

5761

1.19

5.25

3.9

3.6

1.23

1.22

mmol/l

0.57

717

4968

Deep endometriosis

382

3011

1.30

5.24

3.0

3.5

1.23

mmol/l

0.03

324

2572

Polyhydramnios

151

1026

1.51

5.23

3.6

3.1

1.22

1.23

mmol/l

2.38

126

888

Allergic rhinitis

1100

9436

1.16

5.22

3.0

3.8

1.23

mmol/l

0.05

978

8213

Chronic ulcer of skin, not elsewhere classified

295

2251

1.34

5.21

8.2

3.7

1.22

1.23

mmol/l

1.34

269

1936

Ingrowing nail

204

1469

1.43

5.21

7.3

3.8

1.23

mmol/l

0.44

184

1278

Colon adenocarcinoma, helper endpoint

568

4683

1.24

5.21

4.5

4.2

1.22

1.23

mmol/l

0.40

514

4027

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

167

2.39

5.21

3.4

2.9

1.23

mmol/l

0.09

138

Other diseases of stomach and duodenum

284

2157

1.35

5.20

7.3

3.9

1.21

1.23

mmol/l

4.62

256

1849

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

235

2.18

5.19

4.0

4.4

1.22

mmol/l

0.21

207

Major anomalies of jaw size

101

631

1.66

5.18

2.9

3.7

1.23

mmol/l

0.30

545

Prurigo nodularis

114

736

1.62

5.18

7.0

3.8

1.21

1.23

mmol/l

2.23

100

632

Other and unspecified intracranial injuries

124

813

1.58

5.18

4.0

3.9

1.22

mmol/l

0.32

110

699

Other symptoms and signs involving the circulatory and respiratory systems

251

1871

1.37

5.14

3.9

3.6

1.23

mmol/l

0.27

211

1596

Benign neoplasm: Transverse colon

294

3814

0.76

5.11

4.6

4.3

1.22

1.23

mmol/l

0.38

260

3312

Pedal cyclist injured in other and unspecified transport accidents

427

3418

1.27

5.10

3.5

4.0

1.22

1.23

mmol/l

0.55

375

2952

Toxic liver disease

392

1.86

5.10

5.2

3.6

1.21

1.23

mmol/l

0.83

337

Bulimia nervosa (incl. atypical)

100

623

1.65

5.10

2.7

2.9

1.22

1.23

mmol/l

0.43

529

Family history of certain disabilities and chronic diseases leading to disablement

169

1180

1.47

5.10

2.7

3.0

1.22

1.23

mmol/l

0.76

145

1001

Arthropathy in ulcerative colitis

305

1.98

5.09

2.9

3.8

1.24

1.23

mmol/l

0.42

266

Allergic contact dermatitis

513

4191

1.24

5.07

3.5

3.6

1.23

mmol/l

0.46

448

3633

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

362

2823

1.29

5.06

4.0

3.8

1.23

mmol/l

0.05

323

2437

Brain meningioma, including Hilmo

197

1419

1.43

5.06

3.9

3.1

1.23

mmol/l

0.04

180

1186

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

113

2.72

5.06

3.8

3.7

1.21

1.22

mmol/l

0.48

Malignant neoplasm of vulva

279

2.05

5.05

5.7

2.8

1.22

1.23

mmol/l

0.57

232

False labour

938

4986

1.18

5.04

2.7

3.4

1.22

1.23

mmol/l

3.47

800

4347

Disorders of oesophagus in diseases classified elsewhere

103

655

1.65

5.03

9.6

3.8

1.21

1.23

mmol/l

2.67

561

Non-small cell lung cancer, adenocarcinoma, helper endpoint

289

2215

1.34

5.01

6.1

4.1

1.22

mmol/l

0.00

276

1918

Pneumococcal septicemia

135

909

1.54

5.01

6.3

4.0

1.22

mmol/l

0.03

119

779

Viral infections of the central nervous system

270

2045

1.35

5.01

6.7

3.8

1.22

1.23

mmol/l

0.91

236

1761

Superficial injury of ankle and foot

433

3476

1.26

5.00

4.1

3.9

1.22

1.23

mmol/l

0.82

380

3002

Diabetic neuropathy

522

4273

1.24

4.98

7.8

4.5

1.21

1.22

mmol/l

1.75

471

3761

Use of antiglaucoma preparations and miotics

348

2734

1.30

4.96

5.9

3.7

1.23

mmol/l

0.26

301

2322

Viral pneumonia (known virus, not influenza)

124

823

1.57

4.96

10.2

3.7

1.22

1.23

mmol/l

0.97

118

701

Panniculitis affecting regions of neck and back

143

976

1.51

4.94

3.7

3.3

1.23

mmol/l

0.02

132

821

Pneumonia derived septicemia

140

953

1.52

4.92

6.2

4.0

1.22

mmol/l

0.11

124

810

Paralytic ileus

158

1102

1.48

4.90

5.1

3.7

1.21

1.22

mmol/l

1.89

139

932

Fracture of neck

256

1936

1.36

4.87

4.0

4.2

1.22

mmol/l

0.14

220

1668

Other menopausal disorders

1121

5443

1.16

4.85

2.9

3.6

1.24

mmol/l

0.06

919

4689

Paralytic strabismus

286

2197

1.33

4.85

5.4

4.0

1.22

mmol/l

0.03

253

1888

Fall involving bed

158

1108

1.48

4.83

5.3

3.9

1.22

mmol/l

0.35

145

942

Primary coxarthrosis, bilateral

1323

11730

1.14

4.82

3.4

4.1

1.23

mmol/l

0.21

1139

10040

Viral infections of the central nervous system, including avohilmo

289

2223

1.33

4.81

6.5

3.8

1.22

1.23

mmol/l

0.59

252

1917

Open wound of abdomen, lower back and pelvis

114

746

1.58

4.80

5.4

4.0

1.21

1.22

mmol/l

1.02

643

Use of rotigotine

328

1.93

4.79

2.9

4.0

1.21

1.23

mmol/l

1.37

280

Other bacterial agents as the cause of diseases classified to other chapters

284

2.00

4.79

9.9

3.9

1.22

mmol/l

0.24

244

Other neurotic disorders

190

1375

1.42

4.79

4.1

3.9

1.22

1.23

mmol/l

1.03

161

1184

Parkinson's disease

669

5648

1.20

4.78

3.1

4.1

1.23

mmol/l

0.74

563

4865

Hydrocele

426

3436

1.26

4.76

6.2

4.6

1.21

mmol/l

0.22

374

3002

Contact with sharp glass

133

900

1.52

4.76

3.9

3.7

1.23

mmol/l

0.06

112

774

Erosion of teeth , including avohilmo

979

8503

1.16

4.75

5.0

3.8

1.23

mmol/l

0.16

854

7418

Burns and corrosions of external body surface, specified by site

389

3108

1.27

4.75

4.6

4.0

1.22

mmol/l

0.74

332

2700

Viral meningitis

132

894

1.52

4.74

5.8

3.5

1.22

1.23

mmol/l

0.46

112

761

Retinal detachments and breaks

1550

13877

1.13

4.74

4.7

3.9

1.23

mmol/l

0.06

1324

12008

Disorders of puberty

226

2.07

4.73

2.8

3.0

1.23

mmol/l

0.21

194

Acquired haemolytic anaemia

106

688

1.61

4.73

11.2

3.6

1.22

1.23

mmol/l

1.15

590

Other abnormal findings in urine

455

1.76

4.73

6.7

4.1

1.23

1.22

mmol/l

0.17

395

Polyp of the female genital tract

1231

6123

1.15

4.72

3.6

1.24

1.23

mmol/l

1.05

1044

5255

Acute lymphocytic leukaemia, including Hilmo

2.83

4.71

5.5

3.2

1.24

1.23

mmol/l

0.25

Acute lymphocytic leukaemia, helper endpoint

2.83

4.71

5.5

3.2

1.24

1.23

mmol/l

0.25

Acute lymphocytic leukaemia

2.83

4.71

5.5

3.2

1.24

1.23

mmol/l

0.25

Sequelae of injuries of head

194

1411

1.41

4.71

3.6

4.3

1.22

mmol/l

1.32

162

1236

Cerebral atherosclerosis

394

1.82

4.71

4.5

3.9

1.23

1.22

mmol/l

0.81

331

Other and unspecified nerve root and plexus disorders, also in other diseases

820

7040

1.18

4.70

3.6

3.9

1.23

mmol/l

0.70

702

6099

Malignant neoplasm of accessory sinuses

3.89

4.70

8.5

4.4

1.23

1.21

mmol/l

0.99

Unspecified privation

254

3323

0.75

4.68

5.3

4.0

1.22

1.23

mmol/l

0.70

227

2888

Use of donepezil

1011

8416

1.16

4.68

2.8

4.0

1.23

mmol/l

2.18

809

7178

Cutaneous lupus erythematosus

107

698

1.60

4.68

5.0

3.6

1.23

mmol/l

0.02

594

Suppurative otitis media, unspecified

624

1.63

4.67

5.0

3.4

1.22

1.23

mmol/l

0.62

525

Appendicitis, broad definition

3101

25710

1.09

4.67

4.0

1.23

mmol/l

0.19

2734

22246

Other and unspecified trigeminal disorders

426

1.78

4.66

5.1

3.5

1.22

1.23

mmol/l

0.42

370

Asthma and allergy

384

3022

1.27

4.66

3.0

2.9

1.23

mmol/l

0.85

335

2553

Arterial embolism and thrombosis

242

1826

1.36

4.65

10.0

3.7

1.21

1.22

mmol/l

1.96

228

1568

Diseases of appendix

3130

25873

1.09

4.64

4.0

1.23

mmol/l

0.14

2760

22386

Acne, including avohilmo

665

4528

1.20

4.62

4.8

3.2

1.22

mmol/l

0.15

551

3872

Carcinoma in situ of skin of upper limb, including shoulder

130

891

1.53

4.57

7.5

3.7

1.23

1.22

mmol/l

0.31

111

769

Intracerebral haemorrhage

550

4580

1.22

4.57

5.1

4.1

1.22

1.23

mmol/l

1.14

491

3869

Ulcer of vagina/vulva

121

814

1.54

4.56

3.7

3.3

1.23

mmol/l

0.01

104

690

Bullous disorders

239

1809

1.36

4.55

5.3

3.9

1.23

mmol/l

0.88

218

1543

Disorders of endocrine glands in diseases classified elsewhere

5.33

4.55

21.3

3.5

1.25

1.24

mmol/l

0.14

Other/unspecified enthesopathies, not elsewhere classified

337

2665

1.29

4.55

3.8

4.0

1.23

mmol/l

0.25

306

2292

Other or unspecified common variable immunodeficiency

3.12

4.54

5.7

3.6

1.21

1.23

mmol/l

0.69

Inflammatory diseases of female pelvic organs

2679

16847

1.09

4.53

3.6

3.5

1.23

mmol/l

2.01

2269

14410

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

258

1978

1.34

4.52

3.7

3.9

1.23

mmol/l

0.79

217

1707

Chromosomal abnormalities, not elsewhere classified

366

1.80

4.52

4.1

4.7

1.22

1.23

mmol/l

0.25

312

Congenital malformations of the respiratory system, including avohilmo

467

1.72

4.51

4.0

1.24

1.23

mmol/l

0.18

405

Malignant neoplasm of cervix uteri

391

1.79

4.51

3.9

2.3

1.22

1.23

mmol/l

0.55

321

Other disorders of the musculoskeletal system and connective tissue

610

5136

1.21

4.50

3.8

4.1

1.23

mmol/l

0.16

526

4455

Malignant neoplasm of oral cavity, including Hilmo

163

1161

1.44

4.50

5.3

3.1

1.24

1.23

mmol/l

0.83

155

975

Malignant neoplasm of oesophagus

103

671

1.59

4.49

5.7

3.4

1.22

mmol/l

0.01

570

Sequelae of injuries, of poisoning and of other consequences of external causes

892

7739

1.17

4.46

3.9

4.0

1.22

1.23

mmol/l

2.53

779

6753

Hypertension, Pulmonary Arterial

206

2.13

4.45

4.9

3.6

1.22

1.23

mmol/l

0.40

175

MS-disease / Multiple Sclerosis

247

1880

1.34

4.45

3.9

3.5

1.23

mmol/l

0.32

208

1618

Abrasion of teeth

1497

13427

1.12

4.44

3.5

3.8

1.23

mmol/l

0.01

1256

11615

Aphakia

340

1.84

4.44

4.5

3.8

1.22

1.23

mmol/l

0.07

288

Peripheral artery operations in Hilmo

528

4391

1.22

4.43

11.1

3.8

1.21

1.22

mmol/l

9.22

470

3766

Disorders of puberty, all

267

1.94

4.43

3.9

3.3

1.23

mmol/l

0.29

230

Von Willebrand disease

313

1.89

4.41

4.2

3.6

1.23

mmol/l

0.03

265

Personal history of other diseases and conditions

340

2682

1.28

4.41

4.5

3.1

1.22

1.23

mmol/l

4.18

289

2285

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

336

1.86

4.40

9.3

3.9

1.23

mmol/l

0.09

289

Obstructed labour due to malposition and malpresentation of fetus

506

5642

0.82

4.39

3.1

3.3

1.23

mmol/l

0.05

444

4898

Pure hyperglyceridaemia

628

1.61

4.38

5.3

3.1

1.21

1.22

mmol/l

2.32

531

Other bullous disorders

115

773

1.55

4.38

5.1

3.9

1.24

1.23

mmol/l

0.92

104

657

Intercostal neuropathy

215

2.11

4.38

4.6

3.9

1.23

1.22

mmol/l

0.21

186

Maternal care for known or suspected abnormality of pelvic organs

801

4638

1.18

4.37

3.0

3.4

1.22

1.23

mmol/l

4.40

697

4038

Paranoid personality disorder

410

1.75

4.36

3.2

3.8

1.23

1.22

mmol/l

0.33

354

Exposure to other specified factors

3063

28331

0.92

4.36

4.2

3.9

1.22

1.23

mmol/l

2.75

2666

24507

Melanoma in situ of trunk

451

1.73

4.35

4.6

4.3

1.23

1.22

mmol/l

0.30

395

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

309

2436

1.30

4.33

7.1

3.7

1.22

1.23

mmol/l

0.75

287

2092

Benign neoplasm: salivary glands, exclude unknown (D119)

350

2801

1.28

4.33

4.8

4.0

1.22

1.23

mmol/l

2.75

307

2432

Other peripheral vertigo

388

3142

1.26

4.32

3.7

4.0

1.23

mmol/l

0.16

340

2703

Endometriosis of fallopian tube

188

2.17

4.32

3.3

3.5

1.23

mmol/l

0.22

160

Abnormality of red blood cells

142

2.39

4.32

5.8

4.1

1.20

1.22

mmol/l

1.10

121

Other/unspecified synovitis and tenosynovitis

446

3659

1.24

4.32

4.0

3.8

1.23

mmol/l

0.76

376

3146

Parkinson's disease, including avohilmo

693

5924

1.19

4.32

3.1

4.1

1.23

mmol/l

0.85

583

5095

Otalgia

320

2533

1.29

4.29

4.0

3.7

1.23

mmol/l

0.40

279

2193

Trigger finger

580

4881

1.20

4.29

4.4

3.8

1.23

mmol/l

0.10

496

4207

Allergic colitis

350

1.79

4.27

3.6

3.8

1.24

1.23

mmol/l

0.45

302

Achalasia of cardia

507

1.68

4.27

4.6

4.1

1.21

1.23

mmol/l

1.17

432

Use of levodopa decarboxylase inhibitor

612

5186

1.20

4.26

3.2

4.1

1.23

1.22

mmol/l

0.63

512

4467

Tonsillectomy and adenotomy

1656

12759

0.90

4.23

3.7

1.23

mmol/l

0.19

1427

11160

Fall on and from stairs and steps

1089

9618

1.14

4.23

4.1

3.9

1.22

1.23

mmol/l

0.83

926

8304

Other adrenocortical overactivity

104

2.58

4.23

11.4

3.0

1.23

mmol/l

0.18

Erythema nodosum

124

853

1.51

4.22

4.6

3.7

1.22

1.23

mmol/l

0.62

109

727

Malignant neoplasm of oral cavity

128

884

1.49

4.22

5.9

3.2

1.24

1.23

mmol/l

1.03

120

741

Benign neoplasm of middle ear and respiratory system

307

2427

1.29

4.21

3.8

4.1

1.22

mmol/l

0.15

277

2118

Hypotension due to drugs

448

1.72

4.20

6.2

4.1

1.21

1.22

mmol/l

1.39

388

Henoch-Schönlein purpura nephritis (HSPN)

2.87

4.20

18.4

3.9

1.21

1.22

mmol/l

0.28

Other disorders of bone density and structure

642

1.58

4.19

4.6

3.1

1.23

mmol/l

0.05

548

Hereditary factor VIII deficiency

3.40

4.18

2.1

3.9

1.23

mmol/l

0.20

Fenamates

595

3408

1.20

4.18

3.5

4.9

1.23

mmol/l

1.36

517

2966

Benign neoplasm: Cerebral meninges

402

3282

1.25

4.18

4.3

3.8

1.23

mmol/l

0.08

356

2807

Injury of blood vessels at lower leg level

112

2.56

4.17

12.4

4.3

1.21

1.22

mmol/l

0.56

Benign neoplasm of meninges

441

3635

1.24

4.17

4.3

3.8

1.23

mmol/l

0.05

393

3104

Overexertion and strenuous or repetitive movements

220

2884

0.75

4.16

4.0

1.22

1.23

mmol/l

0.43

194

2514

Prolapse and hernia of ovary and fallopian tube

1303

0.63

4.15

3.6

1.24

1.23

mmol/l

0.45

1062

Dementia in other diseases classified elsewhere

196

1463

1.38

4.15

4.2

4.0

1.23

1.22

mmol/l

0.73

159

1271

Proteinuria and renal glomerular damage; focal glomerulonephritis

5.02

4.14

17.1

7.1

1.22

mmol/l

0.02

Acute nephritic syndrome

534

1.64

4.13

13.7

3.4

1.22

1.23

mmol/l

0.45

463

Cramp and spasm

180

1327

1.39

4.10

3.9

3.6

1.22

1.23

mmol/l

1.75

157

1143

Congenital malformations of the nervous system

455

1.68

4.10

6.8

3.5

1.23

mmol/l

0.16

388

Blepharochalasis

1334

11961

1.13

4.09

3.5

4.0

1.23

mmol/l

0.43

1133

10264

Sequelae of infectious and parasitic diseases, including avohilmo

277

2170

1.30

4.07

4.6

3.8

1.22

mmol/l

0.22

242

1876

Hallux valgus (acquired)

1403

8991

1.12

4.07

3.5

3.7

1.23

mmol/l

0.34

1178

7661

Superficial injury of wrist and hand

758

6545

1.17

4.07

3.7

4.0

1.23

mmol/l

0.00

664

5685

Burns and corrosions of multiple and unspecified body regions

543

1.62

4.07

3.2

4.2

1.23

1.22

mmol/l

0.76

469

Sacroiliitis, not elsewhere classified

153

1097

1.42

4.06

2.8

3.3

1.23

mmol/l

0.10

140

934

Nonpyogenic thrombosis of intracranial venous system

242

1.98

4.05

7.5

3.6

1.21

1.23

mmol/l

1.23

209

Glaucoma, exfoliation

488

4073

1.22

4.05

3.5

3.9

1.23

mmol/l

0.88

417

3439

Nephropathy induced by other drugs, medicaments and biological substances

3.77

4.05

25.8

4.7

1.20

1.21

mmol/l

0.17

Benign neoplasm of major salivary glands

385

3140

1.25

4.03

4.7

4.0

1.21

1.23

mmol/l

2.93

341

2726

Other noninflammatory disorders of vulva and perineum

365

2956

1.25

4.03

3.7

3.3

1.23

mmol/l

1.36

302

2527

Allergic asthma (mode), excluding more controls

742

6240

1.17

4.01

3.3

2.9

1.23

mmol/l

0.46

649

5230

Striking against or struck by other objects

1237

11022

1.13

4.01

4.0

4.1

1.22

mmol/l

0.82

1073

9616

Pustular psoriasis

183

1360

1.38

3.99

4.0

3.9

1.23

mmol/l

0.30

157

1179

Other congenital malformations

279

2190

1.29

3.99

4.9

3.8

1.23

mmol/l

0.38

252

1894

Spasmodic torticollis

129

905

1.47

3.98

3.3

3.5

1.22

1.23

mmol/l

1.00

111

778

Congenital malformations of the respiratory system

414

1.71

3.97

4.2

4.1

1.24

1.23

mmol/l

0.38

358

Burn and corrosion of shoulder and upper limb, except wrist and hand

499

1.64

3.97

3.5

4.0

1.23

mmol/l

0.06

426

Alcohol-induced acute pancreatitis

131

921

1.47

3.96

6.6

4.5

1.20

1.22

mmol/l

2.22

117

805

Disorders of orbit

171

1259

1.40

3.96

3.7

3.8

1.23

mmol/l

0.10

154

1086

Disorders of optic nerve, not elsewhere classified

605

1.59

3.95

5.0

3.8

1.22

1.23

mmol/l

0.15

525

Brain meningioma

184

1370

1.38

3.95

3.8

3.0

1.24

1.23

mmol/l

0.15

167

1143

Cryoglobulinemia

4.25

3.94

15.4

5.2

1.20

1.22

mmol/l

0.28

Chondrocostal junction syndrome [Tietze]

150

1082

1.43

3.94

3.5

3.6

1.23

mmol/l

0.01

131

922

Viral encephalitis, not elsewhere classified/unspecified

525

1.63

3.93

9.2

3.9

1.22

1.23

mmol/l

0.43

454

Benign neoplasm: Parotid gland

314

2513

1.28

3.93

4.6

4.0

1.22

1.23

mmol/l

2.67

275

2180

Other specified congenital malformation syndromes affecting multiple systems

286

1.85

3.93

7.1

5.1

1.22

1.23

mmol/l

0.25

255

Certolizumab pegol

415

1.70

3.92

2.4

3.2

1.23

mmol/l

0.02

352

Problems related to social environment

112

766

1.51

3.91

4.2

3.5

1.22

1.23

mmol/l

0.11

105

657

Assault by blunt object

302

1.83

3.91

4.2

4.3

1.22

1.23

mmol/l

0.24

269

Congenital malformations of great arteries

354

1.75

3.91

3.5

5.0

1.22

1.23

mmol/l

0.53

308

Arterial embolism and thrombosis of lower extremity artery

147

1059

1.43

3.89

9.4

3.6

1.21

1.22

mmol/l

1.63

136

912

Seronegative juvenile rheumatoid arthritis

339

1.77

3.89

2.9

3.3

1.21

1.22

mmol/l

0.74

296

Acute appendicitis, no complications

2150

19634

1.09

3.88

3.8

4.0

1.23

mmol/l

0.42

1888

17034

Optic neuritis

146

1050

1.43

3.87

4.4

3.4

1.22

1.23

mmol/l

0.72

134

904

Malignant neoplasm of palate

3.34

3.87

3.5

3.6

1.33

1.21

mmol/l

0.99

Amblyopia ex anopsia

142

1017

1.43

3.85

5.7

3.9

1.23

mmol/l

0.13

123

881

Inflammatory diseases of the central nervous system

305

2437

1.27

3.84

5.6

3.9

1.21

1.23

mmol/l

3.80

278

2120

Delivery

1635

7796

1.11

3.83

3.5

3.8

1.23

mmol/l

0.12

1378

6594

Endometriosis ASRM stages 3,4

875

7679

1.15

3.81

3.2

3.4

1.24

1.23

mmol/l

0.10

755

6551

Disorders of breast

2070

16722

1.10

3.81

3.4

3.5

1.24

1.23

mmol/l

2.60

1823

14253

Impacted maxillary molar

173

1279

1.37

3.81

3.0

3.2

1.23

1.22

mmol/l

0.46

157

1082

Childhood allergy (age < 16)

353

2351

1.25

3.80

3.2

3.3

1.22

mmol/l

0.34

299

1962

Dermatopolymyositis (FG)

351

1.76

3.80

6.1

3.0

1.21

1.23

mmol/l

2.10

286

Retinal vascular occlusion

516

4357

1.20

3.79

5.4

4.1

1.23

mmol/l

0.27

445

3769

Exclusion endpoint for clefts

364

1.73

3.78

6.5

4.8

1.22

1.23

mmol/l

0.24

319

Male infertility

122

851

1.46

3.78

6.8

4.2

1.23

1.22

mmol/l

0.82

115

775

Erectile dysfunction

299

2392

1.28

3.77

4.6

4.7

1.21

mmol/l

0.10

259

2103

Special screening examination for neoplasms

166

2226

0.73

3.76

3.9

1.22

mmol/l

0.13

145

1867

Postzoster neuralgia

485

1.64

3.76

7.1

3.7

1.22

mmol/l

0.15

417

Mental and behavioural disorders of puerperium, not classified elsewhere

233

1.93

3.75

5.5

3.4

1.24

1.22

mmol/l

0.94

199

Other or ill-defined heart diseases

188

1414

1.36

3.74

6.9

3.6

1.22

1.23

mmol/l

1.46

168

1209

Arnold-Chiari syndrome

163

2.13

3.74

3.6

3.7

1.23

1.22

mmol/l

0.61

140

Left ventricular outflow tract obstruction, narrow definition

162

1193

1.39

3.72

4.8

4.6

1.22

mmol/l

0.05

143

1037

Melanocytic naevi of trunk

456

3811

1.21

3.72

6.5

3.9

1.23

mmol/l

0.10

399

3313

Other conjunctival vascular disorders and cysts

101

687

1.53

3.71

3.9

4.1

1.24

1.23

mmol/l

1.24

594

Lichen sclerosus et atrophicus

490

4127

1.21

3.71

3.1

3.5

1.24

mmol/l

0.02

409

3525

Other/unspecified postprocedural disorders of ear and mastoid process

0.00

3.71

0.0

3.7

—

1.22

—

Malignant neoplasm of ureter, including Hilmo

214

2.00

3.70

8.0

3.2

1.21

1.22

mmol/l

0.23

173

Other disorders of penis

325

2623

1.26

3.69

4.1

4.6

1.22

mmol/l

0.64

280

2329

Tooth agenesis EXCLUDE clefts and syndromes

106

723

1.49

3.68

4.3

3.9

1.23

mmol/l

0.20

617

Mycoses, including avohilmo

4092

29319

1.07

3.67

4.2

3.9

1.23

mmol/l

1.11

3565

25312

Pilonidal cyst

260

2047

1.29

3.67

3.6

3.4

1.22

mmol/l

0.16

224

1782

Retinal vascular disorders

522

4426

1.20

3.66

5.4

4.0

1.23

mmol/l

0.19

450

3826

Infection of intervertebral disc (pyogenic)

363

1.74

3.66

8.8

3.7

1.23

1.22

mmol/l

0.44

303

Asthma and opportunity respiratory infection

199

1521

1.35

3.66

4.1

3.7

1.22

1.23

mmol/l

1.68

180

1288

Sequelae of injuries of upper limb

355

2901

1.24

3.65

3.8

4.1

1.22

1.23

mmol/l

1.11

310

2524

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

295

1.82

3.64

5.5

3.3

1.23

mmol/l

0.01

254

Nystagmus and other irregular eye movements

340

1.75

3.64

4.9

3.8

1.23

mmol/l

0.27

290

Other and unspecified acne

294

1.80

3.63

10.1

3.1

1.23

1.22

mmol/l

0.10

251

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

347

1.74

3.63

5.7

5.1

1.23

mmol/l

0.18

300

Toxic effects of substances chiefly nonmedicinal as to source

395

3263

1.23

3.63

3.5

4.1

1.22

1.23

mmol/l

1.50

343

2844

Secondary parkinsonism+Parkinsonism in other disease

119

839

1.47

3.63

5.0

4.0

1.24

1.22

mmol/l

1.62

107

721

Secondary parkinsonism

116

815

1.47

3.61

4.9

4.0

1.24

1.22

mmol/l

1.57

104

698

Chronic hepatitis NAS

342

1.76

3.60

4.4

3.4

1.22

1.23

mmol/l

0.63

293

Renal cell carcinoma of kidney

120

847

1.46

3.59

7.4

3.0

1.23

1.22

mmol/l

0.37

110

705

Abscess of tendon sheath

160

2.14

3.59

5.7

3.9

1.23

mmol/l

0.44

140

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

538

1.58

3.57

9.2

3.8

1.22

1.23

mmol/l

0.46

465

Adenomyosis (Endometriosis of uterus)

530

4500

1.19

3.56

3.2

3.6

1.23

1.24

mmol/l

2.56

433

3846

Radial styloid tenosynovitis [de Quervain]

196

1496

1.34

3.55

3.3

3.6

1.23

mmol/l

0.97

170

1281

Acute bronchiolitis

158

1050

1.38

3.54

6.5

3.4

1.23

mmol/l

0.31

143

887

Early lumbar disc prolapse, operated

269

2136

1.27

3.53

3.6

1.22

1.23

mmol/l

1.46

243

1879

Injury of unspecified body region

296

2384

1.26

3.52

5.8

4.0

1.22

1.23

mmol/l

0.58

266

2056

Other and unspecified epidermal thickening

106

735

1.49

3.52

9.8

3.6

1.21

1.23

mmol/l

1.23

621

Autonomic disorders

661

1.52

3.52

3.3

3.8

1.21

1.23

mmol/l

1.12

566

Other and unspecified vascular occlusions

400

3326

1.22

3.52

4.4

4.0

1.23

mmol/l

0.32

337

2891

Cardiomyopathy, Hypertrophic obstructive

476

1.62

3.52

6.0

3.9

1.21

1.23

mmol/l

1.44

404

Thrombotic microangiopathy

141

2.21

3.50

12.4

4.0

1.22

mmol/l

0.08

122

Hirsutism in women

420

1.65

3.50

3.1

2.7

1.22

1.23

mmol/l

0.35

355

Carcinoma in situ of skin of lower limb, including hip

106

740

1.50

3.48

7.1

3.8

1.23

1.22

mmol/l

0.53

637

Lipoprotein deficiency

3.19

3.48

1.9

3.4

1.21

1.22

mmol/l

0.58

Desensitization to allergens

1214

0.66

3.48

2.3

3.4

1.23

mmol/l

0.02

1039

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

639

1.53

3.47

5.8

4.0

1.22

1.23

mmol/l

0.36

554

Perioral dermatitis

614

1.53

3.46

3.5

3.0

1.23

mmol/l

0.11

522

Retinoschisis and retinal cysts

101

698

1.50

3.46

6.1

3.7

1.22

1.23

mmol/l

0.34

608

Generalized epilepsy

133

961

1.41

3.46

4.1

3.7

1.21

1.23

mmol/l

2.42

121

816

Blood alcohol or alcohol intoxication level

549

1.56

3.45

4.1

3.8

1.21

1.23

mmol/l

1.80

469

Alzheimer’s disease, strict definition

1006

9096

0.88

3.44

3.1

4.0

1.23

mmol/l

1.65

814

7771

Hypertrichosis

501

1.58

3.44

3.6

2.8

1.23

mmol/l

0.06

428

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

2.72

3.43

7.5

4.5

1.23

1.22

mmol/l

0.20

Salpingitis and oophoritis

690

6010

1.16

3.43

3.6

3.5

1.23

1.24

mmol/l

1.91

580

5154

Ventricular septal defect, a heart condition

405

1.65

3.43

4.9

4.6

1.22

1.23

mmol/l

0.39

346

Tularaemia, including avohilmo

487

1.60

3.42

5.1

4.2

1.22

1.23

mmol/l

0.24

427

Other sexually transmitted chlamydial diseases, including avohilmo

164

2178

0.75

3.42

2.8

3.1

1.22

mmol/l

0.52

133

1853

Other congenital malformations of circulatory system

682

1.50

3.41

3.6

4.1

1.22

1.23

mmol/l

0.95

588

Disorder of the sleep-wake schedule

384

1.67

3.41

5.8

4.1

1.23

mmol/l

0.06

343

Other congenital malformations of nervous system

183

2.00

3.41

3.7

4.4

1.24

1.22

mmol/l

0.90

158

Anomalies of dental arch relationship, including avohilmo

670

5255

1.16

3.41

4.0

3.7

1.23

mmol/l

0.31

589

4548

Diseases of middle ear and mastoid

2243

16944

1.09

3.40

4.4

3.8

1.22

1.23

mmol/l

2.28

1957

14614

Pustulosis palmaris et plantaris

163

1224

1.37

3.38

3.8

3.9

1.23

mmol/l

0.55

140

1058

Inflammatory disease of uterus

491

4167

1.19

3.38

3.1

3.3

1.23

mmol/l

1.99

415

3596

Fracture at wrist and hand level

1316

11875

1.11

3.36

3.9

4.0

1.22

1.23

mmol/l

0.85

1143

10322

Vestibular neuronitis

349

2878

1.23

3.36

3.2

4.1

1.23

mmol/l

0.19

303

2495

Postprocedural disorders of ear and mastoid process, not elsewhere classified

235

0.32

3.36

2.5

3.3

1.21

1.22

mmol/l

—

207

Malignant neoplasm of eye and adnexa, including Hilmo

387

1.67

3.35

6.7

2.7

1.23

mmol/l

0.63

327

Open wound of hip and thigh

115

816

1.45

3.35

3.2

3.8

1.21

1.23

mmol/l

1.17

700

Parkinson's disease, strict definition

608

5265

1.17

3.32

2.9

4.1

1.23

1.22

mmol/l

0.57

512

4537

Disorders of lacrimal system and orbit in diseases classified elsewhere

100

695

1.49

3.32

3.2

3.4

1.22

1.23

mmol/l

1.03

588

Macular pucker

693

6060

1.16

3.31

4.5

4.0

1.23

mmol/l

0.34

594

5246

Contact with heat and hot substances

184

1409

1.33

3.30

5.2

4.0

1.22

1.23

mmol/l

0.52

150

1222

Complications associated with artificial fertilization

333

1.70

3.29

2.0

2.9

1.23

mmol/l

0.02

293

Herpesviral keratitis and keratoconjunctivitis

168

1274

1.35

3.28

5.1

3.7

1.22

1.23

mmol/l

0.32

150

1077

Alzheimer’s disease (Late onset)

929

8575

0.88

3.27

3.1

4.1

1.23

mmol/l

1.46

749

7311

Conduct disorder

380

1.65

3.26

3.9

4.1

1.23

mmol/l

0.08

335

Subjective visual disturbances

1050

9419

1.12

3.26

4.1

3.9

1.22

1.23

mmol/l

1.76

931

8070

Other and unspecified haemorrhagic conditions

422

1.63

3.26

6.8

3.3

1.21

1.23

mmol/l

1.01

367

Exposure to other specified electric current

512

0.49

3.25

5.3

3.5

1.24

1.23

mmol/l

0.37

437

Rare circulating lymphoid malignancy

125

2.23

3.24

11.7

3.2

1.24

1.22

mmol/l

0.69

100

Dislocation, sprain and strain of joints and ligaments of thorax

129

941

1.41

3.23

4.6

3.8

1.23

mmol/l

0.03

118

811

Obstructed labour due to maternal pelvic abnormality

405

4810

0.83

3.22

3.4

3.5

1.24

mmol/l

0.36

352

4133

Oral lichen planus and hypothyroidism or thyroxine medication

594

1.53

3.22

3.3

3.7

1.23

1.24

mmol/l

0.20

508

Bacterial pneumonia, not elsewhere classified

1335

12892

0.90

3.21

6.2

3.3

1.22

1.23

mmol/l

9.53

1218

10874

Status post-ami

851

7274

0.88

3.21

5.5

3.7

1.22

1.23

mmol/l

5.14

778

6140

Crushed, pushed or stepped on by crowd or human stampede

138

1856

0.73

3.20

3.3

3.6

1.23

mmol/l

0.08

128

1603

Sequelae of infectious and parasitic diseases

263

2115

1.26

3.20

4.6

3.8

1.22

mmol/l

0.32

231

1832

Other and unspecified iridocyclitis

175

1340

1.34

3.18

3.7

3.8

1.23

mmol/l

0.30

156

1145

Injury of urinary and pelvic organs

520

1.55

3.18

4.8

3.7

1.22

mmol/l

0.14

452

Malignant neoplasm of larynx, including Hilmo

480

1.57

3.16

5.4

3.4

1.21

1.22

mmol/l

0.92

409

Recurrent aphthous stomatitis , including avohilmo

561

4844

1.17

3.16

4.5

3.8

1.22

1.23

mmol/l

1.19

503

4168

Ectopic pregnancy

616

5355

1.16

3.15

3.4

1.23

1.24

mmol/l

0.76

520

4623

Other mental disorders due to brain damage and dysfunction and to physical disease

494

4230

1.18

3.14

4.5

4.2

1.23

mmol/l

0.35

417

3677

Injury of nerves at wrist and hand level

128

937

1.40

3.13

3.0

4.4

1.22

1.23

mmol/l

0.21

110

808

Granulomatous disorders of skin and subcutaneous tissue

103

728

1.46

3.13

6.3

3.4

1.23

mmol/l

0.34

625

Other disorders of pigmentation

182

1406

1.33

3.13

4.4

3.4

1.23

mmol/l

0.35

156

1198

Fistulae involving female genital tract

475

1.58

3.12

5.5

3.2

1.23

1.24

mmol/l

0.37

395

Other salmonella infections

138

1025

1.38

3.11

4.4

3.6

1.22

1.23

mmol/l

0.31

114

873

Allergic asthma (mode)

742

6372

1.14

3.10

3.3

3.0

1.23

mmol/l

0.22

649

5364

Non-small cell lung cancer, squamous

167

1274

1.34

3.09

4.2

3.3

1.24

1.22

mmol/l

3.42

157

1067

Other congenital malformations of urinary system

2.37

3.08

17.0

4.7

1.25

1.22

mmol/l

2.56

Other obstructed labour

261

2108

1.26

3.07

3.2

3.3

1.23

mmol/l

0.38

228

1804

Posteruptive colour changes of dental hard tissues

2.65

3.07

5.0

3.3

1.24

1.23

mmol/l

0.43

Congenital malformations of aortic and mitral valves

136

1009

1.38

3.06

4.8

4.5

1.23

1.22

mmol/l

0.14

120

876

Carcinoma in situ of cervix uteri

321

2647

1.23

3.06

3.7

3.1

1.23

mmol/l

0.66

265

2261

Common variable immunodeficiency

142

2.11

3.06

4.7

3.5

1.22

mmol/l

0.05

118

Benign neoplasm of bone and articular cartilage

294

2407

1.24

3.05

4.1

3.8

1.23

mmol/l

0.15

250

2097

Atypical virus infections of central nervous system, including avohilmo

259

1.80

3.04

4.3

3.6

1.24

1.23

mmol/l

0.50

226

Motorcycle rider injured in other and unspecified transport accidents

172

1320

1.32

3.04

3.6

4.1

1.22

mmol/l

0.57

159

1159

Stomatitis and related lesions

763

6747

1.14

3.04

4.8

3.9

1.22

1.23

mmol/l

0.97

677

5847

Tic and related disorders

190

1.89

3.02

3.8

5.6

1.22

mmol/l

0.16

174

Other localized connective tissue disorders

560

1.52

3.02

6.1

3.6

1.24

1.23

mmol/l

0.20

482

Acute posthaemorrhagic anaemia

137

1023

1.37

3.00

7.5

3.3

1.21

1.22

mmol/l

1.57

125

864

Other diseases of upper respiratory tract

5059

25082

1.05

2.99

3.9

4.0

1.23

mmol/l

1.08

4395

21587

Vascular dementia

403

3283

1.20

2.99

3.8

4.0

1.23

1.22

mmol/l

1.73

356

2828

Muscle strain

118

860

1.40

2.99

4.1

4.0

1.23

mmol/l

0.52

101

730

Hypertrophic cardiomyopathy

161

1234

1.34

2.96

6.2

4.2

1.22

mmol/l

0.39

147

1072

Congenital dyserythropoietic anaemia

6.40

2.96

2.0

4.4

1.21

mmol/l

—

Dementia due to Parkinson's disease

116

849

1.41

2.95

2.8

4.0

1.22

mmol/l

0.08

720

Other epidermal thickening

175

1357

1.32

2.94

8.2

3.7

1.22

1.23

mmol/l

1.16

155

1150

Malignant neoplasm of floor of mouth

103

2.28

2.94

5.0

3.4

1.25

1.22

mmol/l

0.44

Acute appendicitis

2831

24664

1.07

2.93

4.0

1.23

mmol/l

0.17

2497

21357

Deficiency of other B group vitamins

588

1.49

2.93

5.5

3.6

1.22

1.23

mmol/l

0.40

507

Congenital iodine-deficiency syndrome/hypothyroidism

111

806

1.42

2.92

5.0

3.7

1.22

1.23

mmol/l

0.87

105

694

Persons encountering health services in circumstances related to reproduction

1876

13579

0.92

2.90

3.6

4.0

1.23

mmol/l

0.59

1665

11842

Inflammation of lacrimal passages (acute and unspecified)

516

1.53

2.90

4.6

3.5

1.23

mmol/l

0.16

434

Abnormal serum enzyme levels

1013

10823

0.90

2.89

5.1

4.3

1.22

mmol/l

1.67

939

9362

Contact with other hot fluids

103

738

1.43

2.89

4.1

3.9

1.22

1.23

mmol/l

0.84

638

Myelodysplastic syndrome

324

1.67

2.89

5.7

3.0

1.20

1.22

mmol/l

3.24

267

Conjunctivitis

3197

24257

1.06

2.87

3.8

1.23

mmol/l

0.66

2749

20922

Residual foreign body in soft tissue

174

1352

1.31

2.85

3.3

4.1

1.22

mmol/l

0.13

157

1175

Other disorders of choroid

405

1.60

2.84

5.0

3.8

1.22

1.23

mmol/l

0.38

352

Other encephalitis

101

725

1.43

2.84

5.6

3.8

1.21

1.23

mmol/l

1.86

629

Carcinoma in situ of cervix uteri, exocervix

146

2.03

2.83

5.3

3.7

1.23

mmol/l

0.01

132

Pneumothorax

251

2041

1.25

2.82

5.6

3.7

1.22

mmol/l

1.13

235

1767

Other specified/unspecified spondylopathies

104

753

1.42

2.81

5.2

3.3

1.22

1.23

mmol/l

0.63

626

Intrahepatic Cholestasis of Pregnancy (ICP)

207

1646

1.28

2.80

3.1

1.22

1.23

mmol/l

1.76

183

1414

Atypical virus infections of central nervous system

258

1.76

2.80

4.4

3.6

1.24

1.23

mmol/l

0.42

225

Other disorders affecting eyelid function

265

0.36

2.79

1.8

3.8

1.24

1.23

mmol/l

—

227

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

154

1181

1.33

2.79

4.4

3.5

1.22

1.23

mmol/l

0.24

133

1016

Mucinous and mucinous cystic tumor of rectum

106

2.23

2.77

2.7

3.1

1.21

1.22

mmol/l

0.12

Acute gastritis

289

2391

1.23

2.76

6.2

3.9

1.23

mmol/l

0.29

258

2043

Other vitreous opacities

163

1265

1.32

2.76

4.5

3.9

1.22

mmol/l

0.04

147

1087

Ankylosing spondylitis, strict definition

136

1028

1.35

2.74

3.3

4.0

1.22

1.23

mmol/l

0.48

125

883

Spermatocele

265

2174

1.24

2.74

4.5

4.7

1.21

mmol/l

0.07

236

1909

Graves ophthalmopathy

698

1.43

2.73

3.2

3.6

1.22

1.23

mmol/l

1.20

593

Other contact dermatitis

284

2347

1.23

2.72

4.4

3.6

1.23

mmol/l

0.55

246

2016

Hypersensitivity angiitis

135

2.08

2.72

11.9

4.3

1.24

1.22

mmol/l

0.99

114

Venous complications and haemorrhoids in the puerperium

291

1.69

2.71

2.6

2.9

1.23

1.24

mmol/l

0.17

253

Behavioural disorders

391

1.57

2.71

3.9

1.23

mmol/l

0.04

336

Hemiplegia

179

1407

1.30

2.71

5.3

3.8

1.22

1.23

mmol/l

0.46

164

1206

Dermatopolymyositis

402

1.58

2.70

6.0

3.8

1.21

1.23

mmol/l

1.48

348

Non-invasive ventilation

556

5492

0.87

2.70

6.6

3.2

1.22

1.24

mmol/l

9.53

525

4609

Other abnormal immunological findings in serum

515

1.50

2.70

5.5

3.6

1.23

mmol/l

0.08

438

Rapidly progressive nephritic syndrome

2.80

2.70

22.1

4.7

1.21

mmol/l

0.23

Malignant neoplasm of anus and anal canal, including Hilmo

307

1.66

2.68

6.9

2.7

1.23

1.22

mmol/l

0.12

256

Other and unspecified disorders of pigmentation

156

1.96

2.68

6.3

3.7

1.22

mmol/l

0.06

138

Allergic purpura

103

750

1.41

2.67

6.5

3.5

1.22

1.23

mmol/l

0.41

645

Other and specified injuries of hip and thigh

659

1.44

2.66

4.4

3.9

1.22

1.23

mmol/l

0.30

569

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

207

1658

1.27

2.66

3.1

3.2

1.22

1.23

mmol/l

1.39

183

1428

Patellar tendinitis

322

1.63

2.65

3.9

4.0

1.21

1.22

mmol/l

0.79

272

Retinal haemorrhage

106

779

1.40

2.64

10.8

4.0

1.22

1.23

mmol/l

0.04

670

Trochanteric bursitis

612

5397

1.15

2.63

3.2

3.7

1.24

1.23

mmol/l

1.04

532

4581

Disorders of tyrosine metabolism

4.41

2.61

8.4

3.3

1.23

1.22

mmol/l

—

Chronic suppurative otitis media

146

1881

0.76

2.60

4.9

3.7

1.22

1.23

mmol/l

0.69

124

1601

Plantar fascial fibromatosis

364

3093

1.19

2.59

3.3

3.9

1.23

mmol/l

0.07

319

2664

Propionic acid derivatives

1169

5347

1.11

2.58

3.7

5.0

1.22

mmol/l

0.09

1010

4665

Other secondary coxarthrosis

131

997

1.35

2.58

4.1

3.6

1.24

1.23

mmol/l

1.28

119

848

Other drug-induced secondary parkinsonism

272

1.70

2.58

5.3

3.6

1.25

1.23

mmol/l

1.00

231

Other and unspecified injuries of shoulder and upper arm

117

875

1.37

2.58

5.3

3.8

1.22

1.23

mmol/l

0.82

102

752

Retinal detachment with retinal break

503

4386

1.16

2.58

4.7

4.1

1.22

1.23

mmol/l

0.20

436

3851

Alzheimer disease

1591

10521

1.09

2.57

3.3

4.1

1.23

mmol/l

2.56

1295

8995

Single spontaneous delivery

1596

7781

1.09

2.57

3.5

3.8

1.24

1.23

mmol/l

0.20

1343

6581

Flatulence and related conditions

256

1.71

2.57

3.5

3.3

1.22

1.23

mmol/l

0.48

221

Colonic or urogenital fistula

1047

9525

1.11

2.57

4.0

1.23

mmol/l

0.16

919

8254

Dermatitis herpetiformis

481

1.51

2.55

4.6

3.9

1.24

1.23

mmol/l

1.28

409

Intentional self-harm by smoke, fire and flames

3.21

2.54

4.0

4.6

1.21

1.22

mmol/l

0.22

Disorder of lipoprotein metabolism, unspecified

522

4568

1.16

2.54

5.4

3.3

1.22

1.23

mmol/l

1.37

464

3833

Other surgical follow-up care

113

842

1.37

2.54

4.4

2.8

1.23

mmol/l

0.41

102

703

Other specified disorders of muscle

105

775

1.39

2.53

4.0

4.1

1.22

1.23

mmol/l

0.29

100

658

Hypothermia

490

1.50

2.53

5.7

4.0

1.20

1.22

mmol/l

1.22

429

Pregnancy, childbirth and the puerperium

1219

5814

1.10

2.51

3.4

3.7

1.23

mmol/l

0.06

1022

4911

Combined immunodeficiencies

266

1.69

2.51

4.7

3.8

1.25

1.23

mmol/l

0.85

237

Other articular cartilage disorders

624

1.43

2.50

3.3

3.5

1.23

mmol/l

0.13

524

Paraplegia, diplegia of upper limbs

574

1.45

2.50

4.7

3.7

1.21

1.22

mmol/l

1.12

493

Burns and corrosions of multiple body regions

205

1.78

2.48

3.5

4.3

1.24

1.22

mmol/l

0.76

179

Lesion of lateral popliteal nerve

178

1417

1.28

2.48

6.1

4.2

1.22

mmol/l

0.79

158

1222

Atopic dermatitis

1989

16938

0.93

2.47

3.7

3.6

1.23

mmol/l

0.99

1713

14684

Medullary carcinoma of thyroid gland, including Hilmo

3.12

2.46

12.3

2.5

1.27

1.22

mmol/l

0.94

Ovarian dysfunction, other/unspecified

125

2.03

2.46

4.8

3.5

1.23

mmol/l

0.07

108

Carcinoma in situ of skin of ear and external auricular canal

461

1.51

2.46

6.6

3.9

1.21

mmol/l

0.30

391

Haemorrhagic and haematological disorders of fetus and newborn

209

1.73

2.45

8.7

6.4

1.24

mmol/l

0.10

188

Abnormal findings in nipple discharge synovial fluid wound secretions

387

1.55

2.45

5.0

3.6

1.22

1.23

mmol/l

0.92

337

Dislocation, sprain and strain of joint and ligaments of hip

147

1146

1.31

2.45

4.1

3.9

1.23

1.22

mmol/l

1.06

133

980

Disorders of eyelid in diseases classified elsewhere

122

928

1.35

2.43

4.9

3.6

1.23

mmol/l

0.53

109

787

732

1.39

2.41

5.4

3.8

1.21

1.22

mmol/l

1.83

620

Carcinoma in situ of other and unspecified digestive organs

173

1380

1.28

2.41

5.0

4.0

1.22

1.23

mmol/l

0.33

151

1187

Burn and corrosion of hip and lower limb, except ankle and foot

579

1.44

2.38

3.6

3.8

1.22

mmol/l

0.45

494

Delivery, wide proxy

1355

6617

1.09

2.38

3.2

3.7

1.23

mmol/l

0.20

1143

5566

Struck by thrown, projected or falling objec

171

1361

1.28

2.38

4.7

4.1

1.22

mmol/l

0.44

149

1174

Myocardial infarction, unclassifiable

769

7625

0.89

2.37

5.6

4.0

1.21

1.22

mmol/l

8.00

680

6537

Acute nasopharyngitis (common cold)

356

3017

1.18

2.37

4.9

4.0

1.22

mmol/l

1.28

322

2654

Other diseases of gallbladder

169

1346

1.28

2.37

4.9

3.5

1.23

mmol/l

0.13

146

1131

Personality and behavioural disorders due to brain disease, damage and dysfunction

357

1.56

2.37

3.7

4.1

1.23

1.22

mmol/l

0.26

318

Other melanin hyperpigmentation

727

1.39

2.36

3.4

3.6

1.23

mmol/l

0.35

625

Other diseases of peritoneum

167

1330

1.28

2.35

4.9

3.6

1.22

1.23

mmol/l

0.51

139

1139

Use of ropinirole

139

1084

1.32

2.35

2.5

4.3

1.22

mmol/l

0.03

107

944

Degenerative diseases of the nervous system

1740

11663

1.08

2.34

3.3

4.1

1.23

mmol/l

2.66

1425

9995

Encephalitis

105

786

1.37

2.34

5.6

3.7

1.21

1.23

mmol/l

2.36

683

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

447

5117

0.86

2.34

4.3

1.22

1.23

mmol/l

0.79

393

4437

Background retinopathy and retinal vascular changes

582

1.43

2.34

8.2

4.1

1.23

mmol/l

0.02

508

Combined immunodeficiency, unspecified

3.94

2.33

7.0

5.1

1.24

1.21

mmol/l

—

Bicuspidal aortic valve syndrome

120

916

1.34

2.33

4.0

4.3

1.22

mmol/l

0.04

107

801

Other disorders of eye and adnexa

525

4626

1.15

2.32

3.6

3.8

1.23

mmol/l

0.02

453

3986

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

149

1173

1.30

2.32

3.6

3.9

1.23

mmol/l

0.49

134

1009

Localized scleroderma [morphea]

409

1.52

2.31

3.2

3.5

1.24

1.23

mmol/l

0.30

354

Melanocytic naevi

1185

10899

1.09

2.31

5.8

3.8

1.23

mmol/l

0.05

1020

9437

Nontraumatic intracranial haemmorrhage

840

7608

1.11

2.30

4.9

4.0

1.22

1.23

mmol/l

2.74

745

6435

Other and unspecified disorders of adult personality and behaviour

114

2.03

2.30

2.2

2.6

1.23

mmol/l

0.10

105

Other nutritional anaemias

257

1.66

2.28

3.7

3.8

1.22

mmol/l

0.07

220

Sulfonylureas

1445

10641

1.09

2.28

5.6

4.0

1.22

1.23

mmol/l

6.84

1254

9051

Surgical ablation of atrial fibrillation

149

0.32

2.26

1.6

4.3

1.23

1.22

mmol/l

—

129

Diseases of tongue

232

1921

1.23

2.26

4.1

3.3

1.23

mmol/l

0.09

199

1649

Disorders of myoneural junction and muscle in diseases classified elsewhere

212

1.74

2.26

7.4

3.5

1.22

1.23

mmol/l

0.28

185

Pemphigoid

115

880

1.34

2.25

5.1

3.7

1.23

1.22

mmol/l

0.45

107

749

Inflammatory disorders of male genital organs, not elsewhere classified

257

1.64

2.25

6.5

3.7

1.21

1.22

mmol/l

0.04

229

Abnormalities of forces of labour

218

2639

0.82

2.24

2.9

3.3

1.24

1.23

mmol/l

0.27

193

2290

Guttate psoriasis

346

1.55

2.24

3.8

1.21

1.23

mmol/l

0.74

298

Neuroendocrine tumor and carcinoma of stomach

123

1.99

2.23

2.5

2.6

1.22

1.23

mmol/l

0.48

103

Motor neuron disease (with DMD)

477

1.46

2.23

2.9

4.5

1.22

1.23

mmol/l

0.90

418

Arteriovenous malformation of cerebral vessels

275

1.63

2.22

4.3

4.2

1.22

1.23

mmol/l

0.17

245

Chondropathies

522

4612

1.14

2.22

3.5

3.9

1.22

1.23

mmol/l

0.80

462

4019

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, including Hilmo

2.81

2.22

3.7

3.8

1.26

1.21

mmol/l

0.94

Speech and linguistic disorders

237

1883

1.22

2.22

4.4

3.8

1.23

mmol/l

0.18

215

1617

Complications of genitourinary prosthetic devices, implants and grafts

716

1.38

2.22

5.7

3.3

1.22

1.23

mmol/l

0.69

601

Benign neoplasm: Small intestine

157

1253

1.28

2.21

4.7

4.0

1.23

mmol/l

0.22

144

1079

Haemangioma, any site

306

2604

1.19

2.21

3.8

3.9

1.23

mmol/l

0.79

276

2259

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

651

5829

1.13

2.21

3.7

3.2

1.23

mmol/l

0.67

539

5001

Early complications of trauma

155

1233

1.28

2.21

5.7

4.2

1.22

1.23

mmol/l

0.32

138

1069

!Aliquae complicationes praecoces traumatis

155

1233

1.28

2.21

5.7

4.2

1.22

1.23

mmol/l

0.32

138

1069

Other intracranial haemorrhages

124

961

1.32

2.20

4.3

4.0

1.21

1.22

mmol/l

0.50

113

822

Use of levodopa decarbox-comt-inhibitor

128

998

1.32

2.19

3.1

4.1

1.22

mmol/l

0.04

104

859

Graves ophthalmopathy, strict

624

1.40

2.19

3.4

3.7

1.22

1.23

mmol/l

1.01

530

Vulvovaginal ulceration/inflammation in other diseases

227

1882

1.22

2.18

4.7

3.1

1.23

mmol/l

0.52

193

1622

Other prurigo

325

1.57

2.18

9.2

4.0

1.21

1.23

mmol/l

1.35

280

Poisoning by medicine, drug-induced

300

1.59

2.18

6.1

3.7

1.21

1.23

mmol/l

1.05

264

COPD-related respiratory insufficiency

463

4070

1.15

2.18

7.9

4.2

1.20

1.22

mmol/l

10.27

430

3497

Abscess of external ear

316

1.57

2.17

5.2

3.5

1.22

1.23

mmol/l

0.35

278

Third [oculomotor] nerve palsy

532

1.44

2.17

7.2

3.7

1.23

mmol/l

0.01

463

Anxious personality disorder

380

1.51

2.17

2.6

3.3

1.22

1.23

mmol/l

0.30

333

Other bursitis of hip

625

1.40

2.17

3.0

3.4

1.23

mmol/l

0.11

528

Benign neoplasm of mouth and pharynx

402

3500

1.16

2.17

4.7

4.1

1.22

1.23

mmol/l

0.54

357

3056

Haemangioma and lymphangioma, any site

326

2794

1.18

2.16

3.8

4.0

1.23

mmol/l

0.40

296

2428

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

115

883

1.33

2.16

3.0

3.5

1.23

mmol/l

0.05

104

758

Anorexia

382

1.51

2.16

6.8

3.8

1.21

1.23

mmol/l

0.93

327

Atopic dermatitis, strict definition

945

8438

1.10

2.15

4.2

3.6

1.23

mmol/l

0.12

827

7329

Benign neoplasm: Rectum

599

6690

0.89

2.14

4.1

1.23

mmol/l

0.87

527

5798

Injury of intra-abdominal organs

617

1.39

2.14

4.7

3.9

1.21

1.22

mmol/l

1.13

531

Burn and corrosion of trunk

101

764

1.35

2.12

4.9

4.0

1.22

1.23

mmol/l

0.50

655

Use of rivastigmine

725

6538

1.12

2.11

2.9

4.0

1.23

mmol/l

1.74

567

5561

Drug-induced fever

2.92

2.11

11.8

6.2

1.19

1.21

mmol/l

—

Benign neoplasm: Descending colon

193

2342

0.81

2.11

4.5

4.1

1.23

mmol/l

0.50

177

2050

Short stature, not elsewhere classified

241

1.60

2.10

7.6

4.8

1.23

mmol/l

0.05

206

Other benign neoplasm of uterus: Other parts/unspecified

178

1453

1.26

2.10

3.6

3.5

1.24

mmol/l

0.06

137

1232

Unspecified urinary incontinence

267

3146

0.84

2.10

3.6

3.7

1.23

mmol/l

0.20

226

2675

Pregnancy with abortive outcome

2765

13648

1.06

2.10

3.5

1.23

mmol/l

1.28

2338

11681

Injury of muscle and tendon at wrist and hand level

463

4078

1.15

2.10

3.2

4.3

1.23

1.22

mmol/l

0.93

409

3579

Sexual assault by bodily force

2.49

2.09

2.5

3.7

1.22

mmol/l

0.04

Stenosis and insufficiency of lacrimal passages

371

3224

1.17

2.08

3.5

3.7

1.23

mmol/l

0.18

317

2761

Mandibular retrognathia AND surgery (BSSO)

577

1.40

2.08

2.9

3.2

1.23

mmol/l

0.40

495

Bullous keratopathy

241

1.66

2.08

5.9

3.8

1.23

mmol/l

0.09

210

Pterygium

116

900

1.32

2.07

5.2

4.2

1.22

mmol/l

0.10

104

772

Motor neuron disease ALS

468

1.45

2.07

2.9

3.9

1.22

1.23

mmol/l

0.83

409

Benign neoplasm: Other and unspecified parts of small intestine

470

1.45

2.07

4.5

3.8

1.24

1.23

mmol/l

0.95

403

Infarction of spleen

195

1.74

2.06

3.7

1.22

mmol/l

0.05

172

Infective bursitis

105

804

1.34

2.05

5.6

4.2

1.22

mmol/l

0.11

701

Other/unspecified reactive arthropathies

220

1833

1.22

2.05

4.9

3.8

1.23

mmol/l

0.09

198

1590

Spontaneous abortion

1740

10910

1.07

2.04

3.2

3.5

1.23

mmol/l

0.45

1495

9367

Maternal care for known or suspected disproportion

963

0.72

2.03

3.0

3.3

1.23

mmol/l

0.04

855

Congenital malformations of trachea and bronchus

258

1.62

2.03

3.7

3.8

1.25

1.23

mmol/l

0.48

223

Oesophageal obstruction

141

1124

1.28

2.03

5.8

3.9

1.22

mmol/l

0.29

131

962

Campylobacter enteritis

692

1.36

2.03

4.3

3.7

1.22

1.23

mmol/l

0.37

594

Other obstetric trauma

1237

0.75

2.02

3.3

2.9

1.24

1.23

mmol/l

0.45

1054

Vascular diseases of the intestine

155

1249

1.27

2.02

6.3

3.5

1.22

1.23

mmol/l

0.36

140

1061

Tibial collateral bursitis [Pellegrini-Stieda]

290

1.57

2.02

2.5

3.0

1.22

1.23

mmol/l

0.65

246

Nontoxic diffuse goitre

117

912

1.31

2.01

3.7

1.22

1.23

mmol/l

1.51

105

794

Artificial joint re-operation

288

2465

1.19

2.01

4.7

4.0

1.22

1.23

mmol/l

1.78

268

2131

Other specified/unspecified deforming dorsopathies

446

1.45

2.01

3.7

3.5

1.22

1.23

mmol/l

0.61

378

Corns and callosities

250

2113

1.20

2.01

7.6

3.6

1.22

1.23

mmol/l

1.00

225

1827

Benign neoplasm: Skin of eyelid, including canthus

499

5607

0.88

2.00

4.4

4.0

1.23

mmol/l

0.09

442

4833

Crystalline deposits in vitreous body

251

1.62

2.00

3.5

4.1

1.23

1.22

mmol/l

0.16

219

Procreative management

1157

8803

1.09

2.00

4.5

4.0

1.23

mmol/l

0.43

1023

7672

Oral leukoplakia, including avohilmo

806

0.69

2.00

3.2

4.1

1.24

1.23

mmol/l

0.23

703

Exposure to other and unspecified inanimate mechanical forces

174

2124

0.81

2.00

5.9

4.0

1.22

mmol/l

0.04

147

1848

Hair colour and hair shaft abnormalities

114

1.99

2.00

2.8

4.3

1.21

1.22

mmol/l

0.22

Lipodystrophy, not elsewhere classified

0.00

1.99

0.0

3.7

—

1.23

—

Right hemicolectomy

225

1887

1.21

1.99

5.3

3.9

1.22

1.23

mmol/l

0.32

207

1623

Abnormal findings on antenatal screening of mother

202

1671

1.22

1.99

2.2

2.7

1.22

1.23

mmol/l

1.45

162

1442

Bilateral sagittal split ramus osteotomy operation

102

782

1.33

1.96

3.0

3.2

1.23

mmol/l

0.32

678

Use of pergolide

0.00

1.96

0.0

3.7

—

1.22

—

Other and unspecified disease of Bartholin gland

848

0.70

1.95

3.1

3.4

1.22

1.23

mmol/l

0.91

723

Additional codes for the location of defect, injury or illness

209

1743

1.22

1.95

3.6

3.7

1.24

1.23

mmol/l

1.42

192

1503

Other acquired deformities of musculoskeletal system and connective tissue

155

1254

1.26

1.95

3.5

4.0

1.22

1.23

mmol/l

0.23

135

1095

Carcinoma in situ of colon

117

918

1.31

1.95

5.1

4.3

1.22

1.23

mmol/l

0.18

100

798

Ulcerative proctitis

200

1660

1.22

1.95

3.6

1.23

mmol/l

0.10

184

1437

Melanocytic naevi of other and unspecified parts of face

137

1705

0.79

1.92

3.2

3.5

1.23

mmol/l

0.17

116

1466

Benign neoplasm: Ascending colon

460

5176

0.88

1.92

4.6

4.2

1.22

1.23

mmol/l

0.38

419

4478

Postinfectious hypothyroidism

145

1.82

1.92

4.9

3.6

1.22

1.23

mmol/l

0.27

127

Respiratory tuberculosis, clinically confirmed

318

1.53

1.92

5.1

3.9

1.22

1.21

mmol/l

0.35

266

Coronary artery bypass grafting

1024

6997

1.09

1.91

5.2

3.8

1.21

1.23

mmol/l

6.33

889

5917

Trichomoniasis

247

1.62

1.91

4.3

3.6

1.24

1.23

mmol/l

0.10

209

Trichomoniasis, including avohilmo

271

1.58

1.90

4.0

3.6

1.24

1.23

mmol/l

0.22

231

Circumscribed brain atrophy

668

0.67

1.90

3.1

3.9

1.24

1.23

mmol/l

0.85

574

Effects of heat and light

207

1.67

1.89

3.7

4.2

1.23

1.22

mmol/l

0.35

182

Drug-induced aplastic anaemia

2.84

1.89

6.8

6.7

1.22

1.21

mmol/l

—

Other enthesopathy of foot (+metatarsalgia)

376

3294

1.15

1.89

4.0

3.7

1.23

mmol/l

1.17

338

2816

Olecranon bursitis

216

1815

1.21

1.87

4.4

1.21

1.22

mmol/l

1.60

194

1601

Medical observation and evaluation for suspected diseases and conditions

2805

13636

1.05

1.86

4.3

3.8

1.23

1.22

mmol/l

0.76

2572

11412

Other symptoms and signs involving the urinary system

376

3300

1.15

1.86

4.7

3.9

1.22

mmol/l

0.43

326

2862

Hypertrophic disorders of skin

185

1533

1.22

1.85

3.1

3.3

1.22

1.23

mmol/l

0.73

169

1320

LeFortI or BSSO operation

119

940

1.29

1.84

2.9

3.2

1.23

mmol/l

0.43

103

811

Hallux rigidus

430

4845

0.88

1.83

3.8

1.23

mmol/l

0.05

364

4115

Other disorders of central nervous system

305

1.52

1.83

2.9

3.6

1.23

mmol/l

0.43

264

Loose body in joint

600

1.36

1.83

3.7

3.5

1.22

mmol/l

0.29

514

Use of amantadine

456

1.42

1.82

3.3

3.9

1.23

mmol/l

0.18

398

Small fibre neuropathy

112

882

1.30

1.82

6.4

4.1

1.22

mmol/l

0.09

102

768

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS